- Staat
- -
- Alter
- 69,0
- Geschlecht
- M
- Eingang
- 08.08.2023
- Impfdatum
- 06.02.2022
- Beginn
- 24.03.2022
- Tage bis Beginn
- 46,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Acute respiratory failure
Chronic respiratory failure
Respiratory failure
Symptomtext
ACUTE RESPIRATORY FAILURE CHRONIC HYPOXEMIC RESPIRATORY FAILURE ACUTE ON CHRONIC HYPOXEMIC RESPIRATORY FAILURE
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute respiratory failure
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 30,0
- Geschlecht
- M
- Eingang
- 01.06.2023
- Impfdatum
- 27.01.2022
- Beginn
- 09.09.2022
- Tage bis Beginn
- 225,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Acute respiratory failure
Symptomtext
ACUTE RESPIRATORY FAILURE
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute respiratory failure
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 84,0
- Geschlecht
- F
- Eingang
- 27.04.2023
- Impfdatum
- 31.03.2021
- Beginn
- 10.06.2022
- Tage bis Beginn
- 436,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
Acute respiratory failure
Hypertension
Urinary tract infection
Symptomtext
ACUTE ON CHRONIC RESPIRATORY FAILURE 8/24/2022 ACUTE UTI ACUTE ON CHRONIC RESPIRATORY FAILURE 8/24/2022 HTN (HYPERTENSION)
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute respiratory failure
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 80,0
- Geschlecht
- M
- Eingang
- 05.09.2022
- Impfdatum
- 07.02.2022
- Beginn
- 21.08.2022
- Tage bis Beginn
- 195,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: nein
Acute kidney injury
Acute respiratory failure
Anaemia macrocytic
Angiogram
Body temperature increased
COVID-19
COVID-19 pneumonia
Constipation
Cutaneous vasculitis
Dyspnoea
Exposure to SARS-CoV-2
Haematoma
Hyperlipidaemia
Hypertension
Hypoxia
Pancytopenia
Productive cough
SARS-CoV-2 test positive
Symptomtext
Narrative: Pt presented to ED on 8/21/2022 at 2245 with c/o productive cough x 3-4 days and SOB, occurring over past day. Pt reports COVID exposure through family friend. Pt admitted with primary diagnosis of: Acute COVID 19 infection Acute on chronic hypoxic respiratory failure AKI on stage IIIb CKD RUE hematoma - resolving Pt hospitalized 8/22/22 - 8/26/22. ADDITIONAL DIAGNOSES: Type II DM HTN HLD Chronic hypoxic respiratory failure on 4 liters 02 due COPD Chronic CHF due diastolic dysfunction Stage IIIb CKD ETOH dependence Leukocytoclastic vasculitis Macrocytic anemia/pancytopenia Chronic Constipation: h/o Tubular Adenoma HOSPITAL COURSE: Patient is a 79 yo gentleman with Stage IIIb CKD, Chronic CHF due to diastolic dysfunction,chronic hypoxic respiratory failure due to COPD, Type II DM, parosymal afib/aflutter, alcohol dependence who was admitted on 8/21/22 with acute COVID 19 pneumonia. He was admitted to the medical floor on airborne precautions and started on decadron and remdesivir. There was concern for PE given hypoxia, COVID and indeterminate V/Q (unable to obtain CTA due to AKI on admission). However the patient could not anticoagulation due to RUE hematoma at blood pressure cuff site. BLE US were negative for DVT. Hypoxia resolved.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute respiratory failure
- Hospital-Tage
- -
- Labordaten
- COVID positive 8/21/2022 Vital Signs * Temperature 100.7 F (38.2 C) Pulse 59 Respirations 24 Blood Pressure 153/62 Pain scale recorded: 0 Pulse Oximetry 97 Oxygen 3 L/Min Nasal Cannula
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 80,0
- Geschlecht
- M
- Eingang
- 16.05.2022
- Impfdatum
- 26.01.2022
- Beginn
- 01.05.2022
- Tage bis Beginn
- 95,0
- Dosis
- 3
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: ja
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
Brain death
COVID-19
Cough
Haemorrhage intracranial
Oropharyngeal pain
SARS-CoV-2 test positive
Symptomtext
pt presented with cough and sore throat 1 day after discharge from hospital . Was discharged then presented again 2 weeks later with intracranial bleed, pt is not expected to survive, brain death being confirmed.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Brain death
- Hospital-Tage
- -
- Labordaten
- COVID positive on 5/1/22 and 5/14/22
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- diabetes, CHF, HTN, CKD, pacemaker, MI, CAD, anemia, TIA
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NC
- Alter
- 48,0
- Geschlecht
- M
- Eingang
- 04.03.2022
- Impfdatum
- 22.02.2022
- Beginn
- 23.02.2022
- Tage bis Beginn
- 1,0
- Dosis
- 3
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: ja
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: ja
Abdominal X-ray
Anticoagulant therapy
Axillary pain
Blood magnesium decreased
Chills
Computerised tomogram thorax abnormal
Dyspnoea
Echocardiogram
Fatigue
Flank pain
Laboratory test
Pain
Pulmonary embolism
Pyrexia
Thrombosis
Ultrasound Doppler abnormal
Symptomtext
Hours after receiving the vaccine booster and into the night of February 22, 2022 at approximately 12:00pm, patient began experiencing the typical side effects to include body aches and fatigue. By the following morning, February 23, 2022, his symptoms included fever, chills, body aches, and fatigue. At 10:00pm of February 23, 2022 (approximately 34 hours after the booster) patient had a sudden onset of excruciating right sided pain that radiated from his axilla down to the bottom of his ribcage. With this he was also noted to be gasping with each breath due to the intensity of the pain. At that time, we discussed the potential for the need to call EMS for transport, but was able get relief from the pain with over the counter analgesics. The following day, February 24, 2022 at 2:00pm (approximately 50 hours after the booster) the excruciating pain returned at which time we went ER. An initial work up which included lab work and xrays was completed to r/o the gall bladder. They then completed a CT scan of the chest which revealed pulmonary embolus bilaterally. A heparin infusion was started immediately and patient was then admitted and moved to inpatient status. While inpatient he also had an ECHO and an ultrasound of his legs which revealed blood clots in both legs as well. He was placed on a NC at 3L and 100% O2. On Saturday, February 26, 2022, the heparin was dc'd and he was started on Lovenox injections BID. On February 27, 2022, his oxygen was dc'd and later that same day he was discharged to home with orders to follow up with his primary care provider and hematology.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pulmonary embolism
- Hospital-Tage
- 4,0
- Labordaten
- Abdominal xrays 2/24/2022 Routine labs 2/24/2022 Low Mg CT of chest 2/24/2022 bilateral pulmonary embolism Genetic lab to be sent out 2/25/2022 Echo 2/25/2022 WNL Ultrasound of legs 2/25/2022 Blood clots bilaterally
- Aktuelle Erkrankungen
- NONE
- Vorgeschichte
- Left sided hemiplegia
- Andere Medikamente
- Tegratol, Baclofen, Zyrtec, Atorvastatin, Flonase, Albuterol (PRN) and One a Day Men's Multivitamin
- Allergien
- No known allergies
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 60,0
- Geschlecht
- M
- Eingang
- 27.02.2022
- Impfdatum
- 11.02.2022
- Beginn
- 24.02.2022
- Tage bis Beginn
- 13,0
- Dosis
- 3
- Route/Site
- IM / RA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: nein
Death
Myocardial infarction
Symptomtext
I was informed on 2/24/22 at 9:46pm by patient's son who I work with via text that patient had a heart attack and patient left for the hospital on an ambulance. I was informed via text that patient died on 2/24/22 at 10:53pm. Patient's son came in to the pharmacy on 2/26/22 around 5pm and told me that they are looking in to if Moderna was related to patient's cause of death.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- flucelvax quadrivalent
- Allergien
- no known allergies
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 54,0
- Geschlecht
- F
- Eingang
- 14.02.2022
- Impfdatum
- 01.01.2022
- Beginn
- 01.02.2022
- Tage bis Beginn
- 31,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Anaphylactic shock
Dysphagia
Dyspnoea
Throat tightness
Symptomtext
Anaphylactic shock EpiPen Auto-injection emergency room care
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Anaphylactic shock
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- Nothing
- Vorgeschichte
- Radial styloid tenosynovitis [de Quervian] surgery on October 18 2021
- Andere Medikamente
- I took ibuprofen one day before the vacation
- Allergien
- I had no allergies
- Vorherige Impfungen
- Headiq
- Staat
- OH
- Alter
- 48,0
- Geschlecht
- F
- Eingang
- 04.02.2022
- Impfdatum
- 02.02.2022
- Beginn
- 02.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: ja
Cardio-respiratory arrest
Chest discomfort
Dyspnoea
Electrocardiogram
Pharyngeal swelling
Dysphagia
Heart rate increased
Rash
Throat irritation
Symptomtext
Patient had an itchy throat, neck rash, elevated heart rate, trouble swallowing and taking a deep breath. Gave Benadryl 25mg and standard Epinephrine dose.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Cardio-respiratory arrest
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 73,0
- Geschlecht
- M
- Eingang
- 22.05.2023
- Impfdatum
- 25.01.2022
- Beginn
- 04.08.2022
- Tage bis Beginn
- 191,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Symptom recurrence
Thrombotic stroke
Symptomtext
PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE ACUTE STROKE DUE TO THROMBOSIS OF UNSPECIFIED ARTERY 8/23/2022 -- RECURRENCE OF SAME SYMPTOMS
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Thrombotic stroke
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 31,0
- Geschlecht
- F
- Eingang
- 04.05.2023
- Impfdatum
- 05.02.2022
- Beginn
- 31.08.2022
- Tage bis Beginn
- 207,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Deep vein thrombosis
Symptomtext
PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE ACUTE DVT, UNSPECIFIED VEIN
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Deep vein thrombosis
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- -
- Geschlecht
- U
- Eingang
- 25.04.2023
- Impfdatum
- -
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 3
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: ja
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: nein
COVID-19
Cardiac function test abnormal
Carditis
Chest X-ray normal
Chest pain
Dyspnoea
Electrocardiogram normal
Immunisation reaction
Impaired work ability
Myocarditis
Palpitations
Pericarditis
Symptomtext
After taking the Moderna booster shot after work around 6:00 PM at the Pharmacy, by the time I got to work the next morning at 8:00 AM I had heart palpitations, severe chest pain and trouble breathing. I immediately left work and my husband drove me to the local Emergency Room. The run an ekg and chest X-ray and tell me I am fine and send me home, saying that I had a bad reaction to the Moderna vaccine. On 2/13/2023, I?m rushed into the Same hospital ER for the same reason heart palpitations, chest pains and trouble breathing and the hospital admitted me and I was in the cardiac unit for 48 hours. The heart doctor ran every test on my heart and said that I have myocarditis and pericarditis; due to having had Covid 19 three times in the last three years and then taken the Moderna shot three times caused the inflammation of my heart.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Myocarditis
- Hospital-Tage
- 2,0
- Labordaten
- 3/16/2022, 2/13/2023, 2/14/2023, pending echocardiogram on 5/5/2023.
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NJ
- Alter
- 49,0
- Geschlecht
- M
- Eingang
- 14.02.2023
- Impfdatum
- 08.02.2022
- Beginn
- 18.10.2022
- Tage bis Beginn
- 252,0
- Dosis
- N/A
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
Accident at work
Activated partial thromboplastin time
Activated protein C resistance
Anticoagulant therapy
Beta-2 glycoprotein antibody
Blood fibrinogen
Blood gases
Cardiac telemetry
Cardiolipin antibody
Differential white blood cell count
Electrocardiogram
Fibrin D dimer
Full blood count
Gene mutation identification test
International normalised ratio increased
Laboratory test
Meniscus injury
Metabolic function test
Symptomtext
After work injury on 10/4/22, detected blood clot in lower left leg on 10/18/22. Injury to pes anserine plus small tear in medial meniscus. Doppler confirmed clot on 10/26/22. 5mg of Eliquis prescribed by Local Medical Center on 10/26/22. Drove to alternate Medical Center on 11/24 with pain. New clots detected in hospital. Now it was 4 clots in the lower left leg and 1 clot in the left wrist. Hospital said Eliquis failure. INR was 1.0. Spent 6 days in hospital transitioning from heparin IV to Warfarin, 5mg given. INR climbed to 3.25, then warfarin lowered to 4mg. Current INR remains around 2.7. Next doppler to be given on 4/17/23, expect clots to be gone by then. Current orthopedic states that timing and
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Thrombosis
- Hospital-Tage
- 6,0
- Labordaten
- initial doppler done by Local Medical Imaging on 10/26/22. Tests done on 10/26/22 by Local Medical Center: Blood Gas, venous 3, CBC wit
- Aktuelle Erkrankungen
- unknown
- Vorgeschichte
- minor heart aorta issue - monitored by Dr.
- Andere Medikamente
- multivitamin
- Allergien
- unknown
- Vorherige Impfungen
- -
- Staat
- NY
- Alter
- 35,0
- Geschlecht
- F
- Eingang
- 03.11.2022
- Impfdatum
- 02.02.2022
- Beginn
- 03.02.2022
- Tage bis Beginn
- 1,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: ja
ER: ja
Erholt: nein
Atrial tachycardia
Blood test
Cardiac ablation
Cardiac electrophysiologic study
Chest pain
Dizziness
Dizziness postural
Echocardiogram
Electrocardiogram ST segment depression
Electrocardiogram T wave abnormal
Electrocardiogram ambulatory abnormal
Fear
Impaired work ability
Iron deficiency anaemia
Loss of personal independence in daily activities
Medical diet
Orthostatic hypotension
Presyncope
Symptomtext
The morning after receiving the Moderna COVID-19 vaccine I woke up with severe dizziness and near-syncope upon standing. I made an appointment to see my Primary Care Doctor and had an appointment scheduled for February 11, 2022. Dr decided to do vitals, blood work, EKG and exam. My blood pressure lying was 98/60 lying and 130/80 standing with associated dizziness. My EKG showed Sinus Tachycardia with Nonspecific ST depression and Diffuse nonspecific T-abnormalities. Dr decided to start me on a high sodium diet with increased fluid intake. On Monday February 14, 2022 I followed up with Dr and I had less dizziness complaints over the weekend. Dr advised me that I had a severe iron deficiency anemia and recommended starting on an Iron supplement and Vitamin C supplement. He also recommended follow-up with Dr MD, a Cardiologist. I had an appointment with Dr on Monday February 21st, 2022. I went to work as an Emergency Room Registered Nurse and felt Chest Pain on February 17, 2022, so I was admitted to the hospital under Observation Status. I was discharged the same day. I advised Dr of my hospital stay and he wanted me to follow with the Cardiologist. I saw Dr on 2/21/22 and he performed vital signs which showed orthostatic hypotension, an EKG which was abnormal and a one-week Holter monitor. After returning the Holter monitor, Dr called to inform me that I had episodes of severe tachycardia shown on the Holter and I should see Dr MD, an electrophysiologist. I made an appointment with Dr on March 16, 2022. I also returned to a follow up appointment with my PCP who started me on Midodrine 2.5mg three times a day for the orthostatic hypotension. I then saw Dr who had looked over my Holter monitor and advised that I had atrial tachycardia, and he recommended a Cardiac Ablation. I followed up with Dr again on April 5th, 2022 who advised me my iron levels had returned to normal and to increase Midodrine to 5mg three times a day. I underwent an Electrophysiology Study and a successful Cardiac Ablation on April 19, 2022 at Hospital and had to stay overnight. Following the procedure, I continued to have orthostatic hypotension and associated dizziness. I followed up with Dr on Monday May 9, 2022, who I advised of my continuing symptoms, so he had me do an event monitor for a month. I returned to my PCP on May 2, 2022 who advised me to start Fludrocortisone 0.1mg once a day, increase Midodrine to 10mg three times a day, and to follow with a nephrologist, Dr. D.O. I saw Dr. on May 12, 2022 who advised to start eating small meals throughout the day. I saw Dr again on June 15, 2022. He explained the monitor showed no abnormalities, so my ablation was successful, so he suggested follow-up with my PCP Dr. I finally returned to work due to running out of disability time on Friday June 17, 2002, after having been out on medical leave since February 17, 2022. I saw Dr again on July 25, 2022 for a follow-up. I have since continued to the current date, the Florinef 0.1mg and Midodrine 10mg three times a day and still have episodes of dizziness upon standing along with a number of syncopal episodes. The events following my vaccine administration has changed my ability to work, as I am unable to stand quickly or to stand for long periods of time as a Registered Nurse. It also impacts my daily life, as I feel dizzy often, fear passing out and now have heat intolerance.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Presyncope
- Hospital-Tage
- 1,0
- Labordaten
- Bloodwork 12-lead EKG Echocardiogram Medications Electrophysiology Study Cardiac Ablation
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Major Depression Obsessive Compulsive Disorder Anxiety Attention Deficit Disorder Mirgraine
- Andere Medikamente
- Vyvanse 70 mg Klonopin 1mg in am and 0.5mg at pm Cymbalta 100mg Abilify 7mg
- Allergien
- Shellfish
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 30,0
- Geschlecht
- F
- Eingang
- 26.04.2022
- Impfdatum
- 23.03.2022
- Beginn
- 24.03.2022
- Tage bis Beginn
- 1,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: ja
Anaphylactic reaction
Symptomtext
Systemic: Allergic: Anaphylaxis-Severe, Additional Details: Patient develop reaction 1-2 days after recieving the shot. patient was admitted into ER. She called the pharmacy on 4/22/22 to report incident
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Anaphylactic reaction
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- IA
- Alter
- 70,0
- Geschlecht
- M
- Eingang
- 07.04.2022
- Impfdatum
- 05.04.2022
- Beginn
- 06.04.2022
- Tage bis Beginn
- 1,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Abnormal sensation in eye
Eyelid ptosis
Facial paralysis
Symptomtext
Patient developed drooping of the right side of his face with drooping of the corner of the mouth and scratchy sensation with droopiness of the right eye. Symptoms started yesterday and presented to the office today. Has a history of Bell's Palsy in 2020. 2nd booster vaccine was given earlier this week at a health department.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Facial paralysis
- Hospital-Tage
- -
- Labordaten
- No medical tests or lab tests obtained. Prescription medication given with recheck needed in 1 week.
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Diabetes Mellitus Type II, atrial fibrillation, BPH, HTN, OSA
- Andere Medikamente
- Amiodarone, Vitamin D3, Farxiga, furosemide, lopid, hydrea, metformin, MVI, primidone, flomax and xarelto
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 71,0
- Geschlecht
- F
- Eingang
- 29.03.2022
- Impfdatum
- 03.02.2022
- Beginn
- 01.02.2022
- Tage bis Beginn
- -
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Condition aggravated
Electrocardiogram ambulatory
Fatigue
Headache
Loss of consciousness
Interchange of vaccine products
SARS-CoV-2 antibody test
Palpitations
SARS-CoV-2 test negative
Somnolence
Syncope
Symptomtext
woke up at 5AM on 4Feb2022 and passed out in her bathroom.; her first primary series was J&J vaccine; slept for the next 24 hours; woke up with a headache for 2-3 days afterwards.; Extreme fatigue for 2-3 days afterwards; This spontaneous case was reported by a consumer and describes the occurrence of LOSS OF CONSCIOUSNESS (woke up at 5AM on 4Feb2022 and passed out in her bathroom.) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient's past medical history included COVID-19 (COVID-19 (had it in Nov2020), was reported.) in November 2020. Previously administered products included for Product used for unknown indication: J&J vaccine (First primary series was J&J vaccine was reported.) and J&J vaccine (First primary series was J&J vaccine was reported.). Past adverse reactions to the above products included No adverse event with J&J vaccine and J&J vaccine. On 03-Feb-2022 at 2:00 PM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Feb-2022 at 2:00 PM, after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced INTERCHANGE OF VACCINE PRODUCTS (her first primary series was J&J vaccine). On 04-Feb-2022 at 5:00 AM, the patient experienced LOSS OF CONSCIOUSNESS (woke up at 5AM on 4Feb2022 and passed out in her bathroom.) (seriousness criterion medically significant). In February 2022, the patient experienced SOMNOLENCE (slept for the next 24 hours), HEADACHE (woke up with a headache for 2-3 days afterwards.) and FATIGUE (Extreme fatigue for 2-3 days afterwards). At the time of the report, LOSS OF CONSCIOUSNESS (woke up at 5AM on 4Feb2022 and passed out in her bathroom.), SOMNOLENCE (slept for the next 24 hours), HEADACHE (woke up with a headache for 2-3 days afterwards.) and FATIGUE (Extreme fatigue for 2-3 days afterwards) outcome was unknown and INTERCHANGE OF VACCINE PRODUCTS (her first primary series was J&J vaccine) had resolved. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In February 2022, SARS-CoV-2 antibody test: negative (Negative) Took a COVID-19 test and it came out negative. No concomitant medication was reported. No treatment medication was reported. Patient weight was reported as 150 without units. Company Comment: This is a spontaneous case of interchange of vaccine products for this 71-year-old, female patient with past drug history of administration of two doses of the Johnson&Johnson COVID-19 vaccine, who experienced the unexpected, serious (medically significant) event of loss of consciousness and other associated unexpected and expected, non-serious events. The event loss of consciousness occurred 15 hours after administration of the booster dose of the Moderna mRNA-1273 vaccine. The start dates of the other events were not provided. Fifteen hours after vaccination, the patient woke up and passed out in the bathroom. She then slept for the next 24 hours. She woke up on an unspecified date with headache and extreme fatigue for 2 to 3 days. The patient stated that the side effects felt similar to when she had COVID-19 in Nov2020. However, she took a COVID-19 test and the result was negative. Treatment information was not provided. The outcomes of the events were unknown at the time of the report. The benefit-risk relationship of the Moderna mRNA-1273 vaccine is not affected by this report. Further information has been requested.; Sender's Comments: This is a spontaneous case of interchange of vaccine products for this 71-year-old, female patient with past drug history of administration of two doses of the Johnson&Johnson COVID-19 vaccine, who experienced the unexpected, serious (medically significant) event of loss of consciousness and other associated unexpected and expected, non-serious events. The event loss of consciousness occurred 15 hours after administration of the booster dose of the Moderna mRNA-1273 vaccine. The start dates of the other events were not provided. Fifteen hours after vaccination, the patient woke up and passed out in the bathroom. She then slept for the next 24 hours. She woke up on an unspecified date with headache and extreme fatigue for 2 to 3 days. The patient stated that the side effects felt similar to when she had COVID-19 in Nov2020. However, she took a COVID-19 test and the result was negative. Treatment information was not provided. The outcomes of the events were unknown at the time of the report. The benefit-risk relationship of the Moderna mRNA-1273 vaccine is not affected by this report. Further information has been requested.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Loss of consciousness
- Hospital-Tage
- -
- Labordaten
- Test Date: 202202; Test Name: COVID-19 Test; Test Result: Negative ; Result Unstructured Data: Took a COVID-19 test and it came out negative
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Medical History/Concurrent Conditions: COVID-19 (COVID-19 (had it in Nov2020), was reported.)
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 71,0
- Geschlecht
- F
- Eingang
- 29.03.2022
- Impfdatum
- 03.02.2022
- Beginn
- 01.02.2022
- Tage bis Beginn
- -
- Dosis
- 3
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Condition aggravated
Electrocardiogram ambulatory
Fatigue
Headache
Loss of consciousness
Interchange of vaccine products
SARS-CoV-2 antibody test
Palpitations
SARS-CoV-2 test negative
Somnolence
Syncope
Symptomtext
woke up at 5AM on 4Feb2022 and passed out in her bathroom.; her first primary series was J&J vaccine; slept for the next 24 hours; woke up with a headache for 2-3 days afterwards.; Extreme fatigue for 2-3 days afterwards; This spontaneous case was reported by a consumer and describes the occurrence of LOSS OF CONSCIOUSNESS (woke up at 5AM on 4Feb2022 and passed out in her bathroom.) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient's past medical history included COVID-19 (COVID-19 (had it in Nov2020), was reported.) in November 2020. Previously administered products included for Product used for unknown indication: J&J vaccine (First primary series was J&J vaccine was reported.) and J&J vaccine (First primary series was J&J vaccine was reported.). Past adverse reactions to the above products included No adverse event with J&J vaccine and J&J vaccine. On 03-Feb-2022 at 2:00 PM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Feb-2022 at 2:00 PM, after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced INTERCHANGE OF VACCINE PRODUCTS (her first primary series was J&J vaccine). On 04-Feb-2022 at 5:00 AM, the patient experienced LOSS OF CONSCIOUSNESS (woke up at 5AM on 4Feb2022 and passed out in her bathroom.) (seriousness criterion medically significant). In February 2022, the patient experienced SOMNOLENCE (slept for the next 24 hours), HEADACHE (woke up with a headache for 2-3 days afterwards.) and FATIGUE (Extreme fatigue for 2-3 days afterwards). At the time of the report, LOSS OF CONSCIOUSNESS (woke up at 5AM on 4Feb2022 and passed out in her bathroom.), SOMNOLENCE (slept for the next 24 hours), HEADACHE (woke up with a headache for 2-3 days afterwards.) and FATIGUE (Extreme fatigue for 2-3 days afterwards) outcome was unknown and INTERCHANGE OF VACCINE PRODUCTS (her first primary series was J&J vaccine) had resolved. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In February 2022, SARS-CoV-2 antibody test: negative (Negative) Took a COVID-19 test and it came out negative. No concomitant medication was reported. No treatment medication was reported. Patient weight was reported as 150 without units. Company Comment: This is a spontaneous case of interchange of vaccine products for this 71-year-old, female patient with past drug history of administration of two doses of the Johnson&Johnson COVID-19 vaccine, who experienced the unexpected, serious (medically significant) event of loss of consciousness and other associated unexpected and expected, non-serious events. The event loss of consciousness occurred 15 hours after administration of the booster dose of the Moderna mRNA-1273 vaccine. The start dates of the other events were not provided. Fifteen hours after vaccination, the patient woke up and passed out in the bathroom. She then slept for the next 24 hours. She woke up on an unspecified date with headache and extreme fatigue for 2 to 3 days. The patient stated that the side effects felt similar to when she had COVID-19 in Nov2020. However, she took a COVID-19 test and the result was negative. Treatment information was not provided. The outcomes of the events were unknown at the time of the report. The benefit-risk relationship of the Moderna mRNA-1273 vaccine is not affected by this report. Further information has been requested.; Sender's Comments: This is a spontaneous case of interchange of vaccine products for this 71-year-old, female patient with past drug history of administration of two doses of the Johnson&Johnson COVID-19 vaccine, who experienced the unexpected, serious (medically significant) event of loss of consciousness and other associated unexpected and expected, non-serious events. The event loss of consciousness occurred 15 hours after administration of the booster dose of the Moderna mRNA-1273 vaccine. The start dates of the other events were not provided. Fifteen hours after vaccination, the patient woke up and passed out in the bathroom. She then slept for the next 24 hours. She woke up on an unspecified date with headache and extreme fatigue for 2 to 3 days. The patient stated that the side effects felt similar to when she had COVID-19 in Nov2020. However, she took a COVID-19 test and the result was negative. Treatment information was not provided. The outcomes of the events were unknown at the time of the report. The benefit-risk relationship of the Moderna mRNA-1273 vaccine is not affected by this report. Further information has been requested.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Loss of consciousness
- Hospital-Tage
- -
- Labordaten
- Test Date: 202202; Test Name: COVID-19 Test; Test Result: Negative ; Result Unstructured Data: Took a COVID-19 test and it came out negative
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Medical History/Concurrent Conditions: COVID-19 (COVID-19 (had it in Nov2020), was reported.)
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NJ
- Alter
- 52,0
- Geschlecht
- M
- Eingang
- 05.03.2022
- Impfdatum
- 05.03.2022
- Beginn
- 05.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: ja
Loss of consciousness
Syncope
Symptomtext
The patient fainted and unconscious for a few minutes. She woke-up after tapping and calling her name. Contacted emergency services.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Loss of consciousness
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- OR
- Alter
- 52,0
- Geschlecht
- F
- Eingang
- 05.03.2022
- Impfdatum
- 31.01.2022
- Beginn
- 01.02.2022
- Tage bis Beginn
- 1,0
- Dosis
- 1
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Blood oestrogen
Blood oestrogen decreased
Blood pressure increased
Blood pressure measurement
Chills
Heart rate
Heart rate increased
Myocarditis
Nasopharyngitis
Palpitations
Pericarditis
Pyrexia
SARS-CoV-2 test
Vaccination complication
Vaccination site induration
Vaccination site movement impairment
Vaccination site pain
Vaccination site swelling
Symptomtext
Myocarditis; Pericarditis; my blood pressure was sky high/y blood pressure 166/139.; pulse was high/My pulse was 116; my heart was pounding bad; really sick with the shot; hurt so bad couldn't lift arm.; estrogen was low; arm got hard/arm was rock hard; arm got very swollen/very swollen/arm was huge and very swollen; arm was tender/arm hurt; fever; chills; like getting a cold; This spontaneous case was reported by a nurse and describes the occurrence of MYOCARDITIS (Myocarditis) and PERICARDITIS (Pericarditis) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient's past medical history included COVID-19. On 31-Jan-2022, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Feb-2022, the patient experienced NASOPHARYNGITIS (like getting a cold), PYREXIA (fever) and CHILLS (chills). On an unknown date, the patient experienced MYOCARDITIS (Myocarditis) (seriousness criterion medically significant), PERICARDITIS (Pericarditis) (seriousness criterion medically significant), BLOOD PRESSURE INCREASED (my blood pressure was sky high/y blood pressure 166/139.), HEART RATE INCREASED (pulse was high/My pulse was 116), PALPITATIONS (my heart was pounding bad), VACCINATION COMPLICATION (really sick with the shot), VACCINATION SITE MOVEMENT IMPAIRMENT (hurt so bad couldn't lift arm.), BLOOD OESTROGEN DECREASED (estrogen was low), VACCINATION SITE INDURATION (arm got hard/arm was rock hard), VACCINATION SITE SWELLING (arm got very swollen/very swollen/arm was huge and very swollen) and VACCINATION SITE PAIN (arm was tender/arm hurt). The patient was treated with ASPIRIN [ACETYLSALICYLIC ACID] on 01-Feb-2022 at an unspecified dose and frequency; LORAZEPAM on 01-Feb-2022 for Anxiety, at an unspecified dose and frequency and DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) on 01-Feb-2022 at an unspecified dose and frequency. At the time of the report, MYOCARDITIS (Myocarditis), PERICARDITIS (Pericarditis), BLOOD PRESSURE INCREASED (my blood pressure was sky high/y blood pressure 166/139.), HEART RATE INCREASED (pulse was high/My pulse was 116), PALPITATIONS (my heart was pounding bad), VACCINATION COMPLICATION (really sick with the shot), NASOPHARYNGITIS (like getting a cold), VACCINATION SITE MOVEMENT IMPAIRMENT (hurt so bad couldn't lift arm.), BLOOD OESTROGEN DECREASED (estrogen was low), VACCINATION SITE INDURATION (arm got hard/arm was rock hard), VACCINATION SITE SWELLING (arm got very swollen/very swollen/arm was huge and very swollen), PYREXIA (fever), CHILLS (chills) and VACCINATION SITE PAIN (arm was tender/arm hurt) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In August 2021, SARS-CoV-2 test: positive Positive. On an unknown date, Blood oestrogen: low (Low) Low. On an unknown date, Blood pressure measurement: around 90/58 aroung 90/58 and 166/139 it was 166/139. On an unknown date, Heart rate: 116 116. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Patient reported that it was almost time for second shot and stated that she was very concerned about, patient woke up around 1 am her heart was pounding bad. Patient pulse was 116 and stayed like that for three hours scared. Patient stated that caller took treatment and it calmed down and slowly started subsiding. Reporter stated that prescribed estrogen this past friday, Patient got myocarditis and pericarditis symptoms because her estrogen was low. Patient reported that wear heart monitor for 48 hours and awaiting results. Also having a stress test done this month. Patient took lorazepam during episode of high blood pressure and increased pulse. Reporter stated that it helped. Concomitant medication included: vitamins. CC: This case concerns a 52-year-old, female patient with past medical history of Covid-19 infection, who experienced the expected serious AESI events of Myocarditis and Pericarditis. The event occurred on an unknown dates after the first dose of mRNA-1273 (Moderna covid-19 vaccine). The patient woke up in the morning with a pounding heart, pulse of 116. Patient was also reported to have low estrogen level and was prescribed estrogen for treatment. This patient's past history of Covid-19 infection and low estrogen level remains a confounder. The benefit-risk relationship of mRNA-1273 (Moderna covid-19 vaccine) is not affected by this report. This case was linked to MOD-2022-499057 (Patient Link).; Sender's Comments: This case concerns a 52-year-old, female patient with past medical history of Covid-19 infection, who experienced the expected serious AESI events of Myocarditis and Pericarditis. The event occurred on an unknown dates after the first dose of mRNA-1273 (Moderna covid-19 vaccine). The patient woke up in the morning with a pounding heart, pulse of 116. Patient was also reported to have low estrogen level and was prescribed estrogen for treatment. This patient's past history of Covid-19 infection and low estrogen level remains a confounder. The benefit-risk relationship of mRNA-1273 (Moderna covid-19 vaccine) is not affected by this report.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Myocarditis
- Hospital-Tage
- -
- Labordaten
- Test Name: estrogen; Result Unstructured Data: Low; Test Name: Blood pressure; Result Unstructured Data: aroung 90/58; Test Name: Blood pressure; Result Unstructured Data: it was 166/139; Test Name: pulse rate; Result Unstructured Data: 116; Test Date: 202108; Test Name: COVID-19 virus test; Result Unstructured Data: Positive
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Medical History/Concurrent Conditions: COVID-19
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 22,0
- Geschlecht
- M
- Eingang
- 01.03.2022
- Impfdatum
- 19.01.2022
- Beginn
- 19.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Hypotension
Syncope
Symptomtext
Systemic: Hypotension-Mild, Systemic: Fainting / Unresponsive-Mild
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Syncope
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NJ
- Alter
- 42,0
- Geschlecht
- F
- Eingang
- 18.02.2022
- Impfdatum
- 11.02.2022
- Beginn
- 12.02.2022
- Tage bis Beginn
- 1,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Chills
Pyrexia
Sleep disorder
Syncope
Symptomtext
Fever and chills started at 4am on Saturday, February 12th. This led to me walking in the middle of the night and getting up and passing out on the floor. I woke back up but was not 100% for 2 more days.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Syncope
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- Nonr
- Vorgeschichte
- None
- Andere Medikamente
- None
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- NY
- Alter
- 35,0
- Geschlecht
- M
- Eingang
- 12.02.2022
- Impfdatum
- 26.01.2022
- Beginn
- 06.02.2022
- Tage bis Beginn
- 11,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Anaphylactic reaction
Full blood count
Metabolic function test
Pruritus
Urticaria
Symptomtext
First generalized itchiness, then hives, then difficulty breathing. I went to the ER and was given epinephrine and was treated emergently for concerns over anaphylaxis. Since 02/08/22, I have been to the ER twice and have used my epi pen once. I am still breaking out into hives and have no idea what it could be from aside the vaccine. I have never had hives or allergies in the past, I was always healthy and since the booster this has since changed.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Anaphylactic reaction
- Hospital-Tage
- -
- Labordaten
- CBC, CMP 02/11
- Aktuelle Erkrankungen
- NONE
- Vorgeschichte
- NONE
- Andere Medikamente
- Vitamin D
- Allergien
- NONE
- Vorherige Impfungen
- -
- Staat
- AZ
- Alter
- 20,0
- Geschlecht
- M
- Eingang
- 03.02.2022
- Impfdatum
- 02.02.2022
- Beginn
- 02.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Asthenia
Dizziness
Flushing
Hyperhidrosis
Syncope
Tinnitus
Unresponsive to stimuli
Visual impairment
Symptomtext
Systemic: Dizziness / Lightheadness-Medium, Systemic: Fainting / Unresponsive-Medium, Systemic: Flushed / Sweating-Medium, Systemic: Tinnitus-Mild, Systemic: Visual Changes/Disturbances-Mild, Systemic: Weakness-Mild
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Syncope
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NY
- Alter
- 33,0
- Geschlecht
- F
- Eingang
- 02.02.2022
- Impfdatum
- 31.01.2022
- Beginn
- 01.02.2022
- Tage bis Beginn
- 1,0
- Dosis
- 3
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: ja
Chills
Hospitalisation
Laboratory test
Vomiting
Symptomtext
I started vomiting at 2 AM and continued until hospitalization at around 9 AM. I also had severe chills and a body temperature around 94 degrees when I am usually around 97. I was throwing up every 15-20 min. Was treated with plenty of fluids, plus magnesium, NS bolus, Pepcid, potassium chloride, Toradol, and Zofran.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Hospitalisation
- Hospital-Tage
- -
- Labordaten
- Electrolytes we?re checked and off so given magnesium and potassium to correct them.
- Aktuelle Erkrankungen
- Potential omicron exposure (more than 14 days prior)
- Vorgeschichte
- None
- Andere Medikamente
- Birth control (Ortho tricyclin lo) Antidepressant (Lexapro 25mg)
- Allergien
- None
- Vorherige Impfungen
- My second dose of Phizer I also threw up but not as severely. Due to symptoms such as nausea, weakness, fatigue, severe headache
- Staat
- CA
- Alter
- 22,0
- Geschlecht
- F
- Eingang
- 24.01.2022
- Impfdatum
- 24.01.2022
- Beginn
- 24.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Cold sweat
Feeling cold
Hyperhidrosis
Seizure like phenomena
Syncope
Tremor
Symptomtext
Patient had syncopal episode approx. 7-10 minutes post vaccination while sitting in waiting area. Partner reports patient had seizure-like episode and was shaking. Duration is unknown, partner reports about 30 seconds. Then notified clinic staff. Patient was brought into clinic room and had return of consciousness. She was diaphoretic, with cool and clammy skin. Kept laying inclined on patient on exam table for post monitoring. A/Ox3, vital signs stable. She reports hx of fainting in past post blood draw but has not experienced with vaccination. Skin tone returned to normal. Patient reports feeling better after post monitoring. Partner will transport home via personal vehicle.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Seizure like phenomena
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 32,0
- Geschlecht
- F
- Eingang
- 23.01.2022
- Impfdatum
- 22.01.2022
- Beginn
- 22.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Syncope
Unresponsive to stimuli
Symptomtext
Systemic: Fainting / Unresponsive-Mild, Additional Details: The patient has a long history of fainting with vaccines but she did not tell us this. We gave her the moderna vaccine and she seemed fine. As we were about to inject the Flu vaccine she fainted. She was fine right away though. She stayed for 30 minutes and drank water.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Syncope
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 85,0
- Geschlecht
- M
- Eingang
- 14.06.2023
- Impfdatum
- 03.05.2022
- Beginn
- 19.04.2023
- Tage bis Beginn
- 351,0
- Dosis
- 4
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
Barrett's oesophagus
Chronic respiratory failure
Hyponatraemia
Hypotension
Symptomtext
I95.9 HYPOTENSION 4/22/2023 HYPONATREMIA J96.10 CHRONIC RESPIRATORY FAILURE 1/17/2023 HYPONATREMIA I95.9 HYPOTENSION 4/22/2023 BARRETTS ESOPHAGUS J96.10 CHRONIC RESPIRATORY FAILURE 1/17/2023 BARRETTS ESOPHAGUS
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Hypotension
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 68,0
- Geschlecht
- M
- Eingang
- 02.05.2023
- Impfdatum
- 31.12.2021
- Beginn
- 10.06.2022
- Tage bis Beginn
- 161,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
Hypotension
Metabolic encephalopathy
Symptomtext
I95.9 HYPOTENSION 6/24/2022 METABOLIC ENCEPHALOPATHY
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Hypotension
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MD
- Alter
- 78,0
- Geschlecht
- F
- Eingang
- 21.04.2023
- Impfdatum
- 20.04.2022
- Beginn
- 17.02.2023
- Tage bis Beginn
- 303,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: ja
COVID-19
Chills
Feeling cold
Pain
Pyrexia
SARS-CoV-2 test positive
Tremor
Urinary tract infection
Urine analysis abnormal
Symptomtext
I was on a shopping trip with my granddaughter on 2/17/2023, and I was suddenly seized by chills, and I was shaking all over and felt cold. I then went out to the car and turned on the heated seat. While I was in the car waiting on my granddaughter, I fell asleep at one point. I was the driver, but when my granddaughter saw me, she insisted on driving me home. At this point, I felt pretty sure that I had COVID-19. When I got home,though, I took a home antigen test and got a negative result. I then took some Tylenol and went to bed. The following morning on 2/18/2023, I took another home antigen test and got another negative result. I had a fever of 100 and intermittent chills. I called the 24-hour number for the medical group that runs the practice where my PCP works. They told me that I needed to go to the ER or a walk-in clinic. I then called the on-call doctor at the practice and spoke to her personally. I had previously gone to the clinic and had a urinalysis done earlier in the week, and the on-call physician informed me that I had a urinary tract infection. The on-call doctor was concerned on account of my chills and fever. I remembered that when I had had a kidney infection many years before, I had had chills and fever. The doctor was unsure whether I should go to the ER. I didn't really want to go to the ER, so the doctor ordered an antibiotic whose name I don't recall. She then instructed me that if I didn't feel better the following day, I should go to the ER. I took two doses of the antibiotic, and the following morning, I didn't feel better, so I went to the ER on 2/19/2023. They did a COVID-19 test, other bloodwork, and a urinalysis. They also started an IV. They gave me something for pain, because I hurt all over, and I felt like I had flank pain. A few hours later, I was told that I had tested positive for COVID-19. Interestingly, though, I tested negative for a urinary tract infection when the urinalysis was done. I was then discharged, but before I left, I asked for Paxlovid. However, they refused to prescribe it to me because of the medications I was taking. I ended up calling my PCP's practice and then getting the Paxlovid prescription. I was given low-dose Paxlovid. The doctor told me to stop taking atorvastatin while I was on the Paxlovid and to watch my blood pressure and blood sugar. I took the Paxlovid for five days, and I started feeling better by 2/21/2023. I isolated for five days from the time I was diagnosed. During my illness, I had no cough or other respiratory symptoms. After 2/21/2023, I steadily got better.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Tremor
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Diabetes, Type II; Hypertension; High Cholesterol; Hypothyroidism; History of Heart Valve Replacement
- Andere Medikamente
- Levothyroxine; Metoprolol; Spironolactone; Metformin; Pantoprazole; Baby Aspirin; Loratadine; Atorvastatin; Fenofibrate; Famotidine; Multivitamin; Vitamin B12; Vitamin B Complex
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- IL
- Alter
- 50,0
- Geschlecht
- F
- Eingang
- 17.02.2023
- Impfdatum
- 28.12.2021
- Beginn
- 01.03.2022
- Tage bis Beginn
- 63,0
- Dosis
- 2
- Route/Site
- SYR / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Abdominal pain
Asthenia
Cervical radiculopathy
Computerised tomogram abdomen abnormal
Diarrhoea
Disturbance in attention
Emotional poverty
Faeces discoloured
Hepatic steatosis
Hypothyroidism
Impaired work ability
Insomnia
Laboratory test
Magnetic resonance imaging neck
Malaise
Medical diet
Mobility decreased
Musculoskeletal disorder
Symptomtext
I was very sick from the 1st shot had to miss work for 2 days. Nauseous, extreme pain all over. 2nd shot I was sick for a whole week and missed work because of it. Nauseous and even more extreme pain than the first shot. Could barely move and couldn't sleep because of the pain. Adverse events started right away but didn't get diagnosed until March 2022 for Hypothyroidism, now on levothyroxine for that. No energy, couldn't focus, no feeling (emotions) at all. Later 2022 was diagnosed with fatty liver disease and cervical radioculapthy. Have changed lifestyle and eating habits to help with fatty liver disease. Chiropractor for musculoskeletal issues. Symptoms for fatty liver chronic diarrhea that was green and watery or very mushy. Chronic abdominal pain, nausea, my skin feels like it's on fire and like glass in my hands. Severe neck pain so I bought a new pillow and try to stretch it out every day. Chiro helps with pain management. The new diet has helped some with the abdominal pain and I've lost 17 lbs. Still have to watch what I eat and I cut out Mt dew and anything with high fructose corn syrup. I also am using stevia instead of sugar for a sweetener. More raw protein like eggs, bacon, steak, and less carbohydrates.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Mobility decreased
- Hospital-Tage
- -
- Labordaten
- 11/23/2022 CT scan abdomen day liver disease. 12/14/2022 MRI of neck radioculapthy. Lab tests Oct 19 2022
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- High blood pressure anxiety depression migraine
- Andere Medikamente
- Zegerid topomax gabapentin Tylenol ibuprofen losartan
- Allergien
- Latex poison ivy
- Vorherige Impfungen
- Flu shot
- Staat
- MI
- Alter
- 76,0
- Geschlecht
- M
- Eingang
- 11.11.2022
- Impfdatum
- 16.01.2021
- Beginn
- 15.09.2022
- Tage bis Beginn
- 607,0
- Dosis
- 4
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
COVID-19
Chest pain
SARS-CoV-2 test positive
Symptomtext
09/15/22 presents to ED for "chest pain". PMHx of "CAD (on plavix) and previous stents, Ischemic CMP with ICD"
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Chest pain
- Hospital-Tage
- -
- Labordaten
- 09/15/22 SARS-CoV-2 (COVID-19) detected
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 27,0
- Geschlecht
- M
- Eingang
- 29.08.2022
- Impfdatum
- 15.04.2021
- Beginn
- 15.08.2022
- Tage bis Beginn
- 487,0
- Dosis
- 3
- Route/Site
- UN / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: ja
Asthenia
COVID-19
Chest pain
Chills
Dizziness
Fatigue
Feeling abnormal
Pain
Pyrexia
SARS-CoV-2 test positive
Sepsis
Symptomtext
Pt to ED 8/14 for weakness/fatigue/chills/fever for several days. Pt COVID+ 8/15, rx for Decadron/remdesivir. 8/16 pt a+Ox4, denies any pain, pt repositioned for comfort, no sob noted. 8/17 pt blood pressure is 84/48., , Pt denies any pain, pt A & O x 4. 8/19 Pt "I don't feel good" and then complained of left chest pain that radiates down side and dizziness. 8/20 pt remains A&Ox4. 8/25 pt Aox3, sepsis BPA firing score 7. Vital signs stable. 8/26 Pt cleared for discharge. IV removed, no complications. Pt discharged 8/26.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Chest pain
- Hospital-Tage
- 13,0
- Labordaten
- see above
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Tracheocutaneous fistula following tracheostomy (CMS/HCC) Tracheocutaneous fistula following tracheostomy (CMS/HCC) Chronic asthma without complication Pneumonia Colitis Nausea & vomiting Ileus (CMS/HCC) Constipation, chronic Decubitus ulcer of left ankle Hypotension Debility Anxiety and depression Primary hypertension Paraplegia (CMS/HCC) Hyponatremia H/O tracheostomy Asymptomatic bacteriuria History of tracheostomy Quadriplegia (CMS/HCC) Bicytopenia Hyperglycemia Bilateral diffuse ground glass opacities on imaging of the lung Bullous eruption, localized to the abdomen Bilateral hydronephrosis Nephrolithiasis Neurogenic bladder Seizure (CMS/HCC) Urinary tract infection associated with indwelling urethral catheter (CMS/HCC) Urinary tract infection with hematuria Fecaloma (CMS/HCC) Peripheral vascular disease of extremity (CMS/HCC) Ulcer of right foot with muscle involvement without evidence of necrosis (CMS/HCC) Obstruction of suprapubic catheter (CMS/HCC) Sepsis secondary to UTI (CMS/HCC) History of DVT (deep vein thrombosis) on Xarelto Gram negative septicemia (CMS/HCC) Chronic suprapubic catheter (CMS/HCC) Hydronephrosis of right kidney Developmental delay Seizure disorder (CMS/HCC) E. coli and Proteus UTI Nonadherence to medication-- >needs encouragement to take laxatives Bacteremia due to Escherichia coli Tracheostomy dependent (CMS/HCC) Gross hematuria Decubitus ulcer of left thigh, stage 4 (CMS/HCC) Abrasion of left leg Alteration in skin integrity due to moisture Excoriation of periwound skin Fever Osteomyelitis of right foot (CMS/HCC) General weakness SIRS (systemic inflammatory response syndrome) (CMS/HCC) Protein-calorie malnutrition, mild (CMS/HCC) Fecal incontinence Xerosis cutis Incontinence associated dermatitis Decubitus ulcer of right ischium, stage 4 (CMS/HCC) Decubitus ulcer of ischium, unstageable, left (CMS/HCC) Diarrhea Chills Decubitus ulcer of sacral region, unstageable (CMS/HCC)
- Andere Medikamente
- acetaminophen (TYLENOL) 325 MG PO Tab acetaminophen (TYLENOL) 325 MG PO Tab albuterol (PROVENTIL, VENTOLIN, PROAIR) HFA 108 (90 Base) MCG/ACT INHAL Aero Soln albuterol-ipratropium (DUONEB) 0.5-2.5 (3) MG/3ML INHAL Solution amLODIPine (NORVA
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 74,0
- Geschlecht
- M
- Eingang
- 28.07.2022
- Impfdatum
- 24.02.2022
- Beginn
- 23.07.2022
- Tage bis Beginn
- 149,0
- Dosis
- 4
- Route/Site
- UN / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Dyspnoea
Rhonchi
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dyspnoea
- Hospital-Tage
- 3,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 74,0
- Geschlecht
- M
- Eingang
- 28.07.2022
- Impfdatum
- 17.02.2022
- Beginn
- 17.07.2022
- Tage bis Beginn
- 150,0
- Dosis
- 3
- Route/Site
- UN / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Dyspnoea
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dyspnoea
- Hospital-Tage
- 6,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- OR
- Alter
- 51,0
- Geschlecht
- F
- Eingang
- 26.07.2022
- Impfdatum
- 25.04.2022
- Beginn
- 10.07.2022
- Tage bis Beginn
- 76,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Asthenia
Dyspnoea
Fatigue
Feeling abnormal
Headache
Lower respiratory tract infection
Oropharyngeal pain
Respiratory tract congestion
Rhinorrhoea
SARS-CoV-2 test positive
Sleep disorder
Symptomtext
On July 10, 2022 in the middle of the night I woke up and felt congested with runny nose and it was hard to breathe. I went back to sleep. The next morning I had sore throat and headache as well. I also experienced foggy brain. I used Sudafed and drank Gatorade and got back in bed. The following day I used Nyquil and Dayquil to help with symptoms. I was able to work from home but I had super low energy. The major congestion subsided on day 4. I had the sore throat, headache and runny nose for about 7 days. I tested positive again on July 16th. I still had fatigue, sore throat and headache. I tested negative on July 20th. I felt good enough to ride my bike. As of today I still have a little cold in my chest. I just don't feel 100% yet.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dyspnoea
- Hospital-Tage
- -
- Labordaten
- Home COVID-19 test, positive
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- Anxiety
- Andere Medikamente
- Iron
- Allergien
- N/A
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 83,0
- Geschlecht
- M
- Eingang
- 25.07.2022
- Impfdatum
- 01.02.2022
- Beginn
- 01.07.2022
- Tage bis Beginn
- 150,0
- Dosis
- 3
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Asthenia
Atrial fibrillation
CHA2DS2-VASc-score
COVID-19
COVID-19 pneumonia
Condition aggravated
Dementia
General physical health deterioration
Haematuria
Mental impairment
Montreal cognitive assessment abnormal
Pneumonia
Pyrexia
SARS-CoV-2 test positive
Symptomtext
Provider D/C note: "83-year-old male with a past medical history significant for persistent atrial fibrillation not on anticoagulation, dilated cardiomyopathy with history of have breath that was recovered, aortic stenosis, hypothyroid, hypertension, BPH and dementia who presented with weakness and fever. Patient was treated for a right lower lobe pneumonia but ultimately was found to have COVID prior to discharge. Patient defervesced and was in isolation for 10 days. Patient had no acute events and was doing well. Patient has had a recent decline per the hospital visits and a recent decline in mental status as well. Moca 2/30 was repeated this hospitalization as well the last patient has severe dementia. Patient was discharged for rehab unlikely placement. Hospital Course: COVID PNA, resolved - patient was treated with antibiotics prior to COVID(+), completed course with possible right lower lobe pneumonia - COVID positive 07/07/2022, discontinued precautions 07/17/2022 Persistent Atrial fibrillation, CHADS-VASC=5 - not on anticoagulation due to intermittent hematuria - rate controlled with metoprolol Dilated Cardiomyopathy w/ Hx of HFrEF, recovered - continue home bb, mra, ace-i - stopped home lasix as patient is euvolemic, monitor weights, can restarted patient needs. Severe Aortic Stenosis - follows with cardiology they were monitoring progression Hypothyroid - continue home levothyroxine HTN, controlled - continue ace-i BPH - continue home tamsulosin Severe Dementia with Depression, High risk delirium - seroquel nightly - sertraline, bupropion - MOCA 2/30 - Severe dementia Issues Requiring Follow Up: PCP - post hospital follow-up and to help with placement with PACE"
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- COVID-19 pneumonia
- Hospital-Tage
- 21,0
- Labordaten
- COVID detected PCR 07/07/22.
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Hypothyroidism Anxiety and depression Benign localized prostatic hyperplasia without lower urinary tract symptoms (LUTS) Cancer of prostate with intermediate recurrence risk (stage T2b-c or Gleason 7 or PSA 10-20) (*) HTN (hypertension) Hyperlipidemia, unspecified Hypertensive heart disease without heart failure Mitral valve disorder Nonrheumatic aortic valve stenosis Gait disorder Obesity Paroxysmal atrial fibrillation (HCC) DCM (dilated cardiomyopathy) (*) Dementia (*)
- Andere Medikamente
- Wellbutrin Drisdol Xalatan Synthroid Prinivil Toprol XL Miralax Seroquel Senna S Zoloft Aldactone Flomax
- Allergien
- Vicodin
- Vorherige Impfungen
- -
- Staat
- OR
- Alter
- 37,0
- Geschlecht
- F
- Eingang
- 21.07.2022
- Impfdatum
- 28.02.2022
- Beginn
- 02.03.2022
- Tage bis Beginn
- 2,0
- Dosis
- UNK
- Route/Site
- SYR / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Abdominal pain upper
Condition aggravated
Decreased appetite
Diarrhoea
Dizziness
Headache
Inflammation
Migraine
Nausea
Pain
Polyp
Pyrexia
Symptomtext
Much milder fever for same number of days (3) as full shot gave me. Possibly from the pain and fever it exaggerated/worsened/increased the pain and inflammation of the polyps in/on my skull/brain WHICH in past 10 years I had only inflamed that bad 2x, if not counting years 2018-2022. Once the fever and pain went down it wasn't as severe (to the point I had to put a lot of "advil" cream on 1/2 to 3/4 my head to be able to see and even think). My appetite came back, but not as well as year before when I got the full dose covid shot. Like as in migraines, I get an inflamed other times strong dull pain top of stomach (1st thought was my liver or pancreas, still can't say they are fine because not getting any priority care done first that should been done 10 or 15 years ago) sometimes with nausea which I hadn't had those effects since 2017. I know I'm ALSO having nausea And diarrhea because of a main side-effect of the pain cream I have to use or else I get a 12 to 48 hour migraine or experience inflammation light headedness & lights like I'm having one. So the booster might have increased/brought back/worsened the string of effects from the fever/headache/inflammation.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Condition aggravated
- Hospital-Tage
- -
- Labordaten
- n/a
- Aktuelle Erkrankungen
- Moderate to severe occasional inflammation of polyps in left side skull/brain causing migraine like side-effects (lights, sensitivity to light, dull pain like sewing needle in nerve/s of eyes jaws sinus mostly on left side. Happening because can't get a intelligent medical place with neurologist to fix what I know is causing it, attempts for 1 taking 4 months they still aren't saying what form/s or references to send them! Whoever "they" are in online messages).
- Vorgeschichte
- Seizures, BUT they may be brought on by the prescription for them (possible side effect)& the brain polyps the slow med places around me (insurance has on the list & can't see any others or else less coverage of course) don't know how to get a neurologist to see on the CT scan I had to DEMAND to get from basic practitioner.
- Andere Medikamente
- Keppra 1000mg 2x/day; Lamictal 100mg 1x/day (instructed by a moron, should been 2x day), Aleve 2 to 3x week, Diclofenac Sodium Topical Gel/cream (1%) 1 or 2x/day 3 or 4x week, CoQ10 & Zinc (50mg)1x that week.
- Allergien
- Most meats, gluten, most herbal remedies
- Vorherige Impfungen
- Severe fever (105), very weak and lightheaded, inflammation of head, temporary loss of hearing & sight, loss of appetite, minor
- Staat
- GA
- Alter
- 68,0
- Geschlecht
- F
- Eingang
- 08.07.2022
- Impfdatum
- 07.04.2022
- Beginn
- 15.06.2022
- Tage bis Beginn
- 69,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: ja
COVID-19
Chills
Cough
Fatigue
Headache
Pharyngeal paraesthesia
Pyrexia
SARS-CoV-2 test positive
Secretion discharge
Symptomtext
June 15, 2022 I had a bad headache and was coughing, a low grade fever , chills and felt fatigue. I felt a lot of mucus congestion in my throat, like making it hard to talk without having to cough. I took a home test and it was positive. I went to ER. I was prescribed Paxlovid and took it for a week. I felt better on that third day. On June 27th, 2022 I started to feel the symptoms again and tested on a home test again. After consulting with my doctor I decided not to take another Paxlovid, I just waited it out at home. I currently have a tingling in my throat with a slight cough lingering.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pharyngeal paraesthesia
- Hospital-Tage
- -
- Labordaten
- Covid-19 PCR Test- 06/15/2022- Positive
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- High Cholesterol; Hypothyroidism
- Andere Medikamente
- Crestor; Armor Thyroid; Vitamin D, Omega# Oil; CoQ10
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 67,0
- Geschlecht
- F
- Eingang
- 23.05.2022
- Impfdatum
- 05.04.2022
- Beginn
- 11.05.2022
- Tage bis Beginn
- 36,0
- Dosis
- 4
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Asthenia
COVID-19
Dyspnoea
Exposure to SARS-CoV-2
Fatigue
Head discomfort
Headache
Malaise
Mobility decreased
Nasopharyngitis
Pulmonary congestion
Pyrexia
SARS-CoV-2 test positive
Symptomtext
I FIRST HAD SYMPTOMS WEDNESDAY EVENING MAY 11TH, THEY WERE MILD AND FELT LIKE A COLD. I KNEW I HAD BEEN EXPOUSED. ON THURSDAY I STILL FELT LIKE I HAD A COLD HEAD ACHE AND CHEST CONGESTION. I DID A COVID TEST AROUND 3PM AND IT CAME BACK POSITIVE. I WAS EXETERMLY TIRED AND COULDNT GET OUT OF BED.THEY HAD TO BRING ME MEALS. I WAS REALLY TIRED AND HAD ALOT OF SYMPTOMS LIKE HEAD ACHE AND CHEST AND HEAD CONGESTION. ON THE 16TH I STARTED FEELING I HAD ENOUGH ENERGY TO GET OUT OF BED. I WAS STILL TESTING POSITIVE. ON TUESDAY I STOPPED ISOLATING AND I WORE A MASK BUT I DIDNT GOT OUT I STAYED IN THE HOUSE. AND WOULD MEET FAMILY MEMEBERS OUTSIDE. I STARTED GOING OUT WEDNESDAY AND I REALIZED I GOT TIRED FAST AND THAT HAPPENED FOR THE NEXT FEW DAYS. SO NOW AM JUST TAKING IT EASY BECAUSE I STILL FIND MYSELF BEING TIRED AND SHORT OF BREATH. ON FRIDAY THE 20TH I THOUGHT I WAS RELAPSING BUT I WAS NEGATIVE. AND I ALSO HAD A FEVER WHILE I WAS IN BED AND ON THE 20TH BUT THAT HAS GONE AWAY.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dyspnoea
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- No
- Vorgeschichte
- No
- Andere Medikamente
- SYNTHRIOD WELLBURTON XL MEDROXY PROGESTERONE ESTROGEN PATCH
- Allergien
- Peanuts; tree nuts
- Vorherige Impfungen
- -
- Staat
- MO
- Alter
- 65,0
- Geschlecht
- F
- Eingang
- 13.05.2022
- Impfdatum
- 08.02.2022
- Beginn
- 09.02.2022
- Tage bis Beginn
- 1,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Arthralgia
Blood pressure increased
Burning sensation
Cardiac function test normal
Echocardiogram
Electrocardiogram
Electrocardiogram ambulatory
Eye pain
Gait disturbance
Head discomfort
Headache
Heart rate increased
Joint swelling
Loss of personal independence in daily activities
Muscular weakness
Musculoskeletal stiffness
Ocular discomfort
Ocular hyperaemia
Symptomtext
I experienced extreme head pressure, pain in my head, extreme pulsing in my head and sinuses, my heart was pounding and racing, my neck was stiff, I had difficulty walking, my eyes were bloodshot and painful, hard to focus my eyes, I had a burning sensation in my veins, stabbing joint pain, weakness in my legs, and two swollen pockets behind my knees. The two swollen pockets behind my knees have not resolved. I was an avid hiker and active person before the vaccine and it has greatly affected my life. After 2 months the head pressure, sinus pressure, elevated blood pressure, and eye pressure improved. The cardiologist ran tests and that there was no long term damage to my heart, but confirmed pulse rate and blood pressure were elevated. In the last 2 weeks my blood pressure is beginning to settle down a bit, but my pulse has not returned to normal range.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Palpitations
- Hospital-Tage
- -
- Labordaten
- echocardiogram on 2/18/2022, Doppler echo on 2/18/2022, EKG, wore a cardiac monitor for two weeks
- Aktuelle Erkrankungen
- No
- Vorgeschichte
- No
- Andere Medikamente
- multivitamin, probiotic, melatonin
- Allergien
- No
- Vorherige Impfungen
- -
- Staat
- PR
- Alter
- 71,0
- Geschlecht
- F
- Eingang
- 30.04.2022
- Impfdatum
- 01.02.2022
- Beginn
- 01.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: ja
Chest X-ray
Condition aggravated
Electrocardiogram
Hypertensive crisis
Scan myocardial perfusion
Symptomtext
Hypertensive Crisis that required two visits to the emergency room, the immediate days after the fourth dose of Moderna's Vaccine. Hypertensive Crisis finally required hospitalization for one week and subsequent treatment to control pressure. Getting the pressure to be completely stabilized took more than a month.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Condition aggravated
- Hospital-Tage
- 6,0
- Labordaten
- Chest X-rays, Electrocardiogram, Adenosine myocardial perfusion imaging.
- Aktuelle Erkrankungen
- Hypertension, Rheumatoid Arthritis
- Vorgeschichte
- Rheumatoid Arthritis
- Andere Medikamente
- Enalapril, Hydrochlorothiazide, Aspirin, Pepcid, trichord.
- Allergien
- Penicillin
- Vorherige Impfungen
- -
- Staat
- NY
- Alter
- 65,0
- Geschlecht
- M
- Eingang
- 12.04.2022
- Impfdatum
- 11.04.2022
- Beginn
- 11.04.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Arthralgia
Mobility decreased
Pain in extremity
Symptomtext
SEVERE ARM/SHOULDER PAIN, UNABLE TO MOVE OR RAISE ARM
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Mobility decreased
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- ME
- Alter
- -
- Geschlecht
- M
- Eingang
- 06.04.2022
- Impfdatum
- 01.04.2022
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Body temperature
Mobility decreased
Myalgia
Pyrexia
Symptomtext
Could not move; Fever with temperature 101.5F; Body was aching like crazy; This spontaneous case was reported by a consumer and describes the occurrence of MOBILITY DECREASED (Could not move), PYREXIA (Fever with temperature 101.5F) and MYALGIA (Body was aching like crazy) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 vaccination. No Medical History information was reported. On 01-Apr-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MOBILITY DECREASED (Could not move), PYREXIA (Fever with temperature 101.5F) and MYALGIA (Body was aching like crazy). At the time of the report, MOBILITY DECREASED (Could not move), PYREXIA (Fever with temperature 101.5F) and MYALGIA (Body was aching like crazy) had not resolved. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In April 2022, Body temperature: 101.5 (High) 101.5 Fahrenheit. No concomitant medication was reported by reporter. Patient took second booster of Moderna on 01-Apr-2022. Patient did not take any treatments for side effects.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Mobility decreased
- Hospital-Tage
- -
- Labordaten
- Test Date: 202204; Test Name: Body temperature; Result Unstructured Data: 101.5 Fahrenheit
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MD
- Alter
- 86,0
- Geschlecht
- M
- Eingang
- 01.04.2022
- Impfdatum
- 01.03.2022
- Beginn
- 11.03.2022
- Tage bis Beginn
- 10,0
- Dosis
- 3
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Asthenia
Chronic obstructive pulmonary disease
Condition aggravated
Dyspnoea
Pneumonia
Symptomtext
Patient presents to the emergency department with complaints of shortness of breath and associated weakness. He was subsequently admitted for management of pneumonia and COPD exacerbation. Patient was discharged home 4 days later in stable condition.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Condition aggravated
- Hospital-Tage
- 4,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 45,0
- Geschlecht
- M
- Eingang
- 21.03.2022
- Impfdatum
- 03.02.2022
- Beginn
- 07.02.2022
- Tage bis Beginn
- 4,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Chest pain
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Chest pain
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 34,0
- Geschlecht
- M
- Eingang
- 19.03.2022
- Impfdatum
- 01.02.2021
- Beginn
- 19.02.1921
- Tage bis Beginn
- -
- Dosis
- UNK
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Hypoaesthesia
Paraesthesia
Symptomtext
Patient complains of numbness and tingling in fingers and toes. Patient states he can bite his fingers and not feel it
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Paraesthesia
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 37,0
- Geschlecht
- F
- Eingang
- 11.03.2022
- Impfdatum
- 03.02.2022
- Beginn
- 03.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Chest pain
Lymphadenopathy
Symptomtext
chest pains, swollen lymphnodes
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Chest pain
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- PR
- Alter
- 56,0
- Geschlecht
- M
- Eingang
- 04.03.2022
- Impfdatum
- 25.01.2022
- Beginn
- 25.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Blood creatine phosphokinase
Dizziness
Electrocardiogram
Full blood count
Laboratory test
Metabolic function test
Pyrexia
SARS-CoV-2 test
Tremor
Troponin
Urine analysis
Vision blurred
Symptomtext
Patient goes to the emergency room a few hours after being vaccinated against Covid 19. Patient indicated to the nurse on duty " I have tremors, dizziness, fever and blurred vision after being vaccinated the symptoms began". Doctor on duty orders laboratories and treatment.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Tremor
- Hospital-Tage
- -
- Labordaten
- BMP, U/A, CPK, CBC, COVID 19 AG, TROPONIN, EKG (01/25/2022)
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- Patient refers, "previous vaccine caused me allergy but I want to get vaccinated because they ask for the vaccine for everything
- Vorherige Impfungen
- MODERNA FIRST AND SECOND DOSES
- Staat
- PR
- Alter
- 27,0
- Geschlecht
- F
- Eingang
- 28.02.2022
- Impfdatum
- 28.02.2022
- Beginn
- 28.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Exposure during pregnancy
Palpitations
Symptomtext
The patient reports that after the administration of the vaccine she felt palpitations. Patient with 21 weeks of gestation. The Doctor recommends observing her for 30 minutes which she refers to feeling well and Doctor discharges her.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Palpitations
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- It is unknown.
- Vorgeschichte
- It is unknown.
- Andere Medikamente
- It is unknown.
- Allergien
- NKA
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 34,0
- Geschlecht
- F
- Eingang
- 24.02.2022
- Impfdatum
- 13.02.2022
- Beginn
- 22.02.2022
- Tage bis Beginn
- 9,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Blood glucose normal
Migraine
Visual impairment
Vomiting
Symptomtext
Vision was white as if someone was shining a light in my eyes, had a migraine so bad that came next felt like someone was splitting my head with an axe, and started vomiting. Checked my blood sugar levels and it dropped to 60. Next episode started the same, checked again and it was 76. Keep having repeat episodes of blood sugar dropping, has no resolved yet. No prior history of diabetes or low blood sugars.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Migraine
- Hospital-Tage
- -
- Labordaten
- Included above using blood glucose monitor
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- Adderall 20mg 2x daily
- Allergien
- Acetaminophen
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 44,0
- Geschlecht
- F
- Eingang
- 22.02.2022
- Impfdatum
- 11.02.2022
- Beginn
- 12.02.2022
- Tage bis Beginn
- 1,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Dyspnoea
Tachycardia
Symptomtext
PATIENT COMPLAINING OF TACHYCARDIA AND SHORTNESS OF BREATH. PATIENT CALLED HER PRIMARY CARE PHYSICIAN. PATIENT WILL TAKE PRESCRIPTON PRESCRIBED FOR HIGH BLOOD PRESSURE. PATIENT STATES BLOOD PRESSURE IS CURRENTLY 124/85.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dyspnoea
- Hospital-Tage
- -
- Labordaten
- NO TESTS
- Aktuelle Erkrankungen
- NONE
- Vorgeschichte
- HIGH BLOOD PRESSURE
- Andere Medikamente
- UNKNOWN
- Allergien
- NONE
- Vorherige Impfungen
- -
- Staat
- CT
- Alter
- 57,0
- Geschlecht
- M
- Eingang
- 22.02.2022
- Impfdatum
- 24.01.2022
- Beginn
- 24.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Arthralgia
Limb injury
Paraesthesia
Symptomtext
Error: Shoulder Joint Injury (prolonged pain, tingling, etc.)-
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Paraesthesia
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NY
- Alter
- 20,0
- Geschlecht
- F
- Eingang
- 17.02.2022
- Impfdatum
- 02.02.2022
- Beginn
- 04.02.2022
- Tage bis Beginn
- 2,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Dyspnoea
Rash papular
Swelling face
Symptomtext
Papular rash on face and arms started 5 days after booster dose some facial swelling Some intermittent shortness of breath on and off for 3 days after
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dyspnoea
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Mild Intermittent Asthma Anxiety Raynaud's
- Andere Medikamente
- Oral Contraceptive- Tri Sprintec
- Allergien
- Sun Block
- Vorherige Impfungen
- -
- Staat
- VA
- Alter
- 20,0
- Geschlecht
- M
- Eingang
- 12.02.2022
- Impfdatum
- 11.02.2022
- Beginn
- 11.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- SYR / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Arthralgia
Cough
Dizziness
Fatigue
Hypoaesthesia
Migraine
Nausea
Vomiting
Symptomtext
Numbness of right arm Aches and joint pain Migraine. Next morning Dizziness only an hour after. Fatigue. Nausea 4 hours after. Coughing 3 hours after. Puking. About 7 hours after vacc
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Migraine
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- HHT otherwise known as Osler Weber Rendu Syndrome
- Andere Medikamente
- None
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 48,0
- Geschlecht
- F
- Eingang
- 07.02.2022
- Impfdatum
- 03.02.2022
- Beginn
- 07.02.2022
- Tage bis Beginn
- 4,0
- Dosis
- UNK
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Chills
Dyspnoea
Hyperhidrosis
Myalgia
Pain
Symptomtext
6 hours after injections chills and sweats started, 8-10 hrs after injection muscle pains started stronger in the gluts and hamstrings, but pain all over body, they all continue about 30 hrs after injection. 2/7/22 - 3 days after injection, started having shortness of breath intermittently.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dyspnoea
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- none
- Andere Medikamente
- none
- Allergien
- none
- Vorherige Impfungen
- 40 hrs of sever body pains,fever, headache, chills, sweats after 2nd Moderna Vaccine Covid19 on 2/4/21 - age 47 years old - 1-
- Staat
- KY
- Alter
- 19,0
- Geschlecht
- F
- Eingang
- 07.02.2022
- Impfdatum
- 03.02.2022
- Beginn
- 04.02.2022
- Tage bis Beginn
- 1,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Chest X-ray
Chest discomfort
Dehydration
Dyspnoea
Dyspnoea exertional
Electrocardiogram
Fatigue
Heart rate increased
Hypoacusis
Laboratory test
Painful respiration
Symptomtext
Pt was vaccinated on Thursday Feb 3rd. Reports that on Friday Feb 4that 6am she woke up with a rapid heartrate of 154, Shortness of Breath, heaviness in chest and pain with inhalation. She also reported that at times she could not hear well out of one ear. Her mother contacted the primarily medical provider and was advised to go to an Emergency room for cardiac workup. Patient went to a larger area Emergency Department where she underwent multiple EKG's, 2 Chest X-Rays and lab work over several hours. She received 2 bags of fluids for dehydration prior to discharge and was advised to make an appointment with cardiologist. Her symptoms had slightly improved but were still present on 2/5,2/6 and 2/7. After 2/5 she reported that her heartrate would elevate into the 130s with activity, And occasionally she would have elevated heartrate with rest. She also reported that she was tired and would get short of breath with walking long distances.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dehydration
- Hospital-Tage
- -
- Labordaten
- 2/7/22- EKG
- Aktuelle Erkrankungen
- diagnosed with celiac disease and anemia late December 2021
- Vorgeschichte
- Celiac disease
- Andere Medikamente
- Oral Birth Control
- Allergien
- recently diagnosed gluten allergy
- Vorherige Impfungen
- -
- Staat
- NY
- Alter
- 26,0
- Geschlecht
- M
- Eingang
- 05.02.2022
- Impfdatum
- 03.02.2022
- Beginn
- 04.02.2022
- Tage bis Beginn
- 1,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Arthralgia
Chest pain
Chills
Fatigue
Headache
Lymphadenopathy
Myalgia
Nausea
Pyrexia
Vaccine positive rechallenge
Symptomtext
Patient developed fever up to 103.5 degrees Fahrenheit, chills, rigors, acute chest pain, diffuse joint and muscle pain, fatigue, nausea, severe headache, and lymphadenopathy of the left axial, total submandibular, and left supraclavicular regions. These symptoms lasted approximately 48 hours, and the lymphadenopathy is ongoing, as is the nausea and fatigue.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Chest pain
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Asthma
- Andere Medikamente
- None
- Allergien
- None
- Vorherige Impfungen
- Exact same symptoms after second dose of moderna vaccine in 01/2021; Lot number 037K20A
- Staat
- SC
- Alter
- 74,0
- Geschlecht
- F
- Eingang
- 04.02.2022
- Impfdatum
- 04.02.2022
- Beginn
- 04.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Paraesthesia oral
Symptomtext
Patient described odd sensation on tongue. Felt some tingling on tongue. No swelling or other ill effects.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Paraesthesia oral
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- Ceclor, Penicillin
- Vorherige Impfungen
- -
- Staat
- IN
- Alter
- 30,0
- Geschlecht
- M
- Eingang
- 28.01.2022
- Impfdatum
- 28.01.2022
- Beginn
- 28.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Nausea
Paraesthesia
Throat tightness
Symptomtext
The patient received a Moderna COVID booster. When he arrived he was sweaty. He was asked if he was sick and he stated no verbally and on his VAR. The vaccine was administered. Approximately 20 minutes after his vaccine he said he felt tingly all over and he said he might vomit. The patient also said he felt as if his throat was swelling shut. The patient was seated, and blood pressure and o2 assessed. BP was 157/94, O2 was 97. Cold compresses were applied to the patients neck and emergency was called. The patient was given oral diphenhydramine 50mg which he swallowed with water. He was then given epinephrine 0.3mg IM in the right thigh. The patient said he immediately felt better. The squad arrived and transported him to the ER. The patient informed the squad that he had started a new medication within the last 24 hours as well (med unknown). The patient was transported to the hospital. Upon follow up with the hospital, we received additional information. The patient was seen in a different ER this morning (1/28/22 8:58am electronic stamp) but did not disclose this information. The patient was assessed for a possible abscess, but the findings from the ER are not clear.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Paraesthesia
- Hospital-Tage
- -
- Labordaten
- None to report.
- Aktuelle Erkrankungen
- Possible abscess
- Vorgeschichte
- Anxiety, Arthritis, Asthma, Bipolar disorder, Chronic kidney disease, depression, diabetes, hypertension, obsessive compulsive disorder, postoperative nausea and vomiting, post-traumatic stress disorder, restless leg syndrome, schizoaffective disorder.
- Andere Medikamente
- Spravato 84mg, Invega Trinza 819mg, there are others but they are unknow to the pharmacy
- Allergien
- Ibuprofen, Aleve, Fentanyl
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 36,0
- Geschlecht
- M
- Eingang
- 19.01.2022
- Impfdatum
- 18.01.2022
- Beginn
- 19.01.2022
- Tage bis Beginn
- 1,0
- Dosis
- 3
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Chest discomfort
Dyspnoea
Pyrexia
Vomiting
Symptomtext
About 1 hour after receiving the booster shot, fever set in. The fever has averaged 100 degrees or more the last 20 hours roughly, temperature is checked by infrared thermometer. Since 1AM this morning I have been throwing up, even when I drink water it comes right back up. Tightness in chest, and it?s hard to breathe.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dyspnoea
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- Zoloft
- Allergien
- None
- Vorherige Impfungen
- Myocarditis
- Staat
- OR
- Alter
- 68,0
- Geschlecht
- F
- Eingang
- 24.04.2023
- Impfdatum
- 22.04.2022
- Beginn
- 06.09.2022
- Tage bis Beginn
- 137,0
- Dosis
- 4
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
COVID-19
Exposure to SARS-CoV-2
Oropharyngeal pain
SARS-CoV-2 test positive
Symptomtext
I was positive for COVID-19 on 06SEP2022, I had only a light sore throat nothing else. I only tested because my husband tested positive but I wasn't sick. I did speak to my doctor and prescribed me PAXLOVID, I started feeling better right away but it didn't make a difference because I wasn't sick.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Oropharyngeal pain
- Hospital-Tage
- -
- Labordaten
- 06SEP2022 COVID-19 test, positive
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- Diabetic; High cholesterol; Hypertension
- Andere Medikamente
- N/A
- Allergien
- Sulfa; latex
- Vorherige Impfungen
- -
- Staat
- OR
- Alter
- 64,0
- Geschlecht
- F
- Eingang
- 20.10.2022
- Impfdatum
- 18.04.2022
- Beginn
- 26.08.2022
- Tage bis Beginn
- 130,0
- Dosis
- 4
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
COVID-19
Cough
Fatigue
Pain
Respiratory tract congestion
Rhinorrhoea
SARS-CoV-2 test positive
Symptomtext
I had cough, congestion, achy, fatigue, and running nose. I tested positive for COVID-19 at home. I emailed my doctors office and was sent a prescription for Paxlovid.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Fatigue
- Hospital-Tage
- -
- Labordaten
- COVID-19, 08/27/2022, Positive
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- Hypertension
- Andere Medikamente
- Lisinopril; Metoprolol
- Allergien
- Penicillin
- Vorherige Impfungen
- COVID-19 1st and 2nd Moderna, Redness and Rash on arm, fatigue
- Staat
- MD
- Alter
- 76,0
- Geschlecht
- F
- Eingang
- 17.10.2022
- Impfdatum
- 13.04.2022
- Beginn
- 28.08.2022
- Tage bis Beginn
- 137,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Body temperature increased
COVID-19
Pain
SARS-CoV-2 test positive
Symptomtext
I did not have a reaction to the vaccine. I tested positive with a home test for COVID-19 on 08/28/2022. I had a temperature and felt achy. No congestion. I contacted my doctor and got the prescription for PAXLOVID.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pain
- Hospital-Tage
- -
- Labordaten
- 28AUG2022 COVID-19 test positive.
- Aktuelle Erkrankungen
- Urinary Tract Infection
- Vorgeschichte
- Myositis
- Andere Medikamente
- ZYRTEC; PEPCID; vitamin D; temazepam; AIRBORNE; TYLENOL
- Allergien
- Iodine; seafood
- Vorherige Impfungen
- -
- Staat
- NJ
- Alter
- 65,0
- Geschlecht
- M
- Eingang
- 10.09.2022
- Impfdatum
- 27.01.2022
- Beginn
- 01.01.2022
- Tage bis Beginn
- -
- Dosis
- 3
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Bone disorder
Pruritus
Rash
Sensitive skin
Symptomtext
Small bumps on forehead under the skin. Bumps on eyebrow bones Eyebrow bones becoming more pronounced at corners and sensitive to the touch , also itchy . Also, before this (1st booster) shot , I experienced itchy face and eyes for about 3 or 4 weeks up until the shot .
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pruritus
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- 1) Eczema around 4 years prior 2) earclog sin ce 2002
- Vorgeschichte
- N/A
- Andere Medikamente
- N/A
- Allergien
- Penicillin?
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 74,0
- Geschlecht
- M
- Eingang
- 10.08.2022
- Impfdatum
- 04.02.2022
- Beginn
- 04.08.2022
- Tage bis Beginn
- 181,0
- Dosis
- 3
- Route/Site
- UN / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: ja
COVID-19
Pain
Pyrexia
SARS-CoV-2 test positive
Vaccine breakthrough infection
Symptomtext
Breakthrough COVID infection. Generalized body aches and fever with unsure onset. Tested positive 08/04/2022.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pain
- Hospital-Tage
- 4,0
- Labordaten
- Positive SARS-COV-2 (COVID-19) by NAA on 08/04/2022
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- End stage renal disease, type 2 diabetes mellitus, hypertension
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 25,0
- Geschlecht
- M
- Eingang
- 05.08.2022
- Impfdatum
- 04.01.2022
- Beginn
- 30.07.2022
- Tage bis Beginn
- 207,0
- Dosis
- 2
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: ja
Asthenia
COVID-19
Computerised tomogram thorax normal
Fatigue
Inflammatory marker increased
Malaise
Pyrexia
SARS-CoV-2 test positive
Ultrasound Doppler normal
Symptomtext
7/30--8/3 25 yo gentleman with history of obesity, mitral regurgitation admitted with fever, malaise, fatigue, weakness and hoome test positive for COVID 19. Currently on room air. Non-hypoxic. Elevated inflammatory markers. Patient mid to the hospital seen by infectious disease placed in COVID isolation received IV Decadron remained stable and continued to improve had lower extremity venous Doppler CT of the chest negative for pulmonary embolism or DVT continue to improve was felt to be stable for discharge
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Fatigue
- Hospital-Tage
- 4,0
- Labordaten
- 7/30 -- SARS-CoV-2 by NAA, detected
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 69,0
- Geschlecht
- F
- Eingang
- 03.08.2022
- Impfdatum
- 01.02.2022
- Beginn
- 01.07.2022
- Tage bis Beginn
- 150,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
COVID-19
Chest discomfort
Cough
Hyposmia
Nasopharyngitis
Oropharyngeal pain
Pyrexia
Respiratory tract congestion
SARS-CoV-2 test positive
Symptomtext
7/1/2022 sore throat, felt like I was coming down with a cold. After dinner there was a tightness of the chest felt. 7/2 fever of 99.9, tested with at home COVID 19 test, negative. Symptoms were worse that day with more congestion and some light coughing. 7/3 fever 101.6, and tested with at home COVID 19 test, positive. Went to urgent care clinic and saw doctor. They prescribed PAXLOVID. 7/4 felt nauseous but coughing subsided. Sense of smell very diminished but sense of taste remained. 7/5 fever broken, generally felt better. Felt at about 80%. 7/7 felt nearly 100% but still had some chest tightness. 7/9 tested with at home COVID 19 test, negative.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Oropharyngeal pain
- Hospital-Tage
- -
- Labordaten
- 7/2 tested with at home COVID 19 test, negative. 7/3 tested with at home COVID 19 test, positive. 7/9 tested with at home COVID 19 test, negative.
- Aktuelle Erkrankungen
- No
- Vorgeschichte
- Asthma; High Cholesterol; Arthritis; Acid Reflux
- Andere Medikamente
- NAC; magnesium; vitamin K2; turmeric; omega oil; glucosamine sulfate; olive leaf extract; selenium; seriphos; gaba plus; omeprazole; ZYRTEC; SINGULAIR; ZOCOR; CELEBREX; FUSENRA
- Allergien
- Seasonal
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 72,0
- Geschlecht
- F
- Eingang
- 28.07.2022
- Impfdatum
- 27.04.2022
- Beginn
- 07.07.2022
- Tage bis Beginn
- 71,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
COVID-19
Cough
Headache
Nasal congestion
Pain
Pulmonary pain
SARS-CoV-2 test positive
Symptomtext
7/7/22 in the evening I started coughing a deep cough with pain in left lung. 7/8 Stuffy nose, deep cough, headache, and body aches progressed through 7/10. Took an at home Rapid COVID 19 test, strongly positive 7/09. Televisit with doctor on 7/10. Symptoms varied from very mild to moderate for about 2 weeks. One way was mild, and the next the symptoms were moderate. This lasted until 7/25, but symptoms are improving. Feeling better but still have a cough and stuffy nose, but mild.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Headache
- Hospital-Tage
- -
- Labordaten
- At home rapid COVID 19 test, strongly positive 7/09.
- Aktuelle Erkrankungen
- Cataract Surgery
- Vorgeschichte
- Gout; Asthma; COPD
- Andere Medikamente
- ENALAPRIL; metformin; metoprolol; aspirin; EXCEDRIN; BRONKAID; SUDAFED.
- Allergien
- CYRIL; BACTRIM
- Vorherige Impfungen
- -
- Staat
- NY
- Alter
- 68,0
- Geschlecht
- F
- Eingang
- 27.07.2022
- Impfdatum
- 26.04.2022
- Beginn
- 11.07.2022
- Tage bis Beginn
- 76,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
COVID-19
Cough
Nausea
Rhinorrhoea
SARS-CoV-2 test positive
Throat irritation
Vomiting
Symptomtext
Runny nose and scratchy throat on July 11, 2022. Positive home antigen test on July 11, 2022. Nausea with vomiting and cough on July 12, 2022. Started 5 day course of Paxlovid on July 12, 2022. Symptoms improved but then worsened again on July 21, 2022. Home antigen test was positive on July 21, 2022. Did NOT take more Paxlovid. Cough. Home test today, July 27, 2022, was very faintly positive.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Nausea
- Hospital-Tage
- -
- Labordaten
- Just home antigen tests. I can?t remember the name of the initial test. Subsequent tests were on/go.
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Acid reflux High cholesterol
- Andere Medikamente
- Rosuvastatin, 10mg/day; Famotidine, 40 mg/day; fluticasone nasal spray; azelastine nasal spray; multi vitamin; aspirin, 81 mg/day
- Allergien
- Penicillin
- Vorherige Impfungen
- -
- Staat
- PA
- Alter
- 28,0
- Geschlecht
- F
- Eingang
- 23.07.2022
- Impfdatum
- 30.01.2022
- Beginn
- 18.02.2022
- Tage bis Beginn
- 19,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Acne
Amenorrhoea
Diarrhoea
Vaginal discharge
Symptomtext
After the second dose in the initial series, I experienced amenorrhea for the subsequent menstrual cycle, which is extremely unusual. Instead of a normal bleeding, there was no blood and only strange gray discharge. I also experienced a strange acne-like rash on my face for months after both doses of the vaccine, which eventually faded. I also had loose stools starting after the first moderna dose that worsened after the second dose and went on for months until I started taking a probiotic. The menstrual cycle went back to normal the next month (March) and has remained normal. I have yet to get my booster. I do not take any form of birth control and never have. I really wish that women could be given the expectation that there may be menstrual (and other) disruption as a result of these vaccines, even if temporary. This experience has made me lose confidence in these vaccines and their safety. If women could at least be told that the vax may cause hormonal/menstrual disruption, then they could at least be saved the worry and stress brought on by then wondering whether they could have a gynecological condition or be pregnant. It truly is like the vaccine makers don't care about people who menstruate or have fluctuating hormones and how they may be affected, despite the fact that this is a large segment of the population.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Diarrhoea
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- Lyme disease.
- Vorgeschichte
- -
- Andere Medikamente
- Zinc, 25 mg every 1-3 days. Vitamin D, 1000 IU daily.
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- VA
- Alter
- 56,0
- Geschlecht
- F
- Eingang
- 05.07.2022
- Impfdatum
- 04.04.2022
- Beginn
- 03.06.2022
- Tage bis Beginn
- 60,0
- Dosis
- 4
- Route/Site
- SYR / AR
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
COVID-19
Cold sweat
Diarrhoea
Malaise
Nasal congestion
Nausea
Pyrexia
SARS-CoV-2 test positive
Vomiting
Symptomtext
Starting 06/03/2022, I was traveling and that morning I tested negative with a rapid antigen test. Later that day, I started getting very sick: nausea and diarrhea and vomiting. I spent the next 12 hours being sick but due to testing negative I didn't think it was COVID-19 so I went on a plane. On 06/05/2022, I tested myself at home and was positive. I called my doctor that day, but due to it being Sunday, we set up a virtual visit for 06/06/2022. I had lots of nasal congestion starting on 06/03/2022 starting after the nausea stopped and I started feeling clammy/feverish at this time but I did not take my temperature. On 06/06/2022, at the virtual visit, I was prescribed PAXLOVID which I started the same day and within 2 days I started feeling better and by the end of the week I was feeling much better.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Diarrhoea
- Hospital-Tage
- -
- Labordaten
- At-home COVID-19 test (06/05/2022): positive; At-home COVID-19 test (06/16/2022): negative.
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- Atorvastatin; FLONASE; PROAIR; multivitamin; vitamin D; calcium; fish oil; turmeric; ibuprofen
- Allergien
- Cephalosporin; cashews; pistachios; macadamia; animal hair and dander; feathers
- Vorherige Impfungen
- -
- Staat
- NC
- Alter
- 27,0
- Geschlecht
- M
- Eingang
- 29.06.2022
- Impfdatum
- 24.03.2022
- Beginn
- 31.03.2022
- Tage bis Beginn
- 7,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Blood pressure decreased
Fatigue
Feeling abnormal
Pain
Symptomtext
He got his vaccine, everything that generally comes with it, brain fog, fatigue, soreness, all the general side effect. Within the week of the vaccine his blood pressure dropped where he was taking two medicines for it, this happened after the 2nd vaccine and then happened again. It is now 100/60 which is how it typically runs now and there is not much he can do to get it up. This happened last year after the 2nd vaccine, and did not come up until the week of September 15th, almost 6 months after the vaccine. He has a feeling that this is going to be the same way around this time. He is on a transplant list trying to get a kidney transplant and he keeps getting cancelled due to his BP being so low. He has spoken with his nephrologist who thinks that it is a good BP and wants to keep it low.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Fatigue
- Hospital-Tage
- -
- Labordaten
- None.
- Aktuelle Erkrankungen
- None.
- Vorgeschichte
- Kidney disease.
- Andere Medikamente
- Renvela, Pantoprazole, Sensipar, PhosLo.
- Allergien
- Latex, Tegaderm, Cefazolin and it's family, contrast dye, Epogen.
- Vorherige Impfungen
- -
- Staat
- SC
- Alter
- 52,0
- Geschlecht
- F
- Eingang
- 15.06.2022
- Impfdatum
- 28.01.2022
- Beginn
- 12.06.2022
- Tage bis Beginn
- 135,0
- Dosis
- 3
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Abdominal pain
Abdominal pain upper
COVID-19
Chills
Cough
Decreased appetite
Diarrhoea
Ear discomfort
Fatigue
Headache
Hyperhidrosis
Hypersomnia
Malaise
Nausea
Ocular discomfort
Pain
Paranasal sinus discomfort
Pyrexia
Symptomtext
On 6/12/2022, I woke up with a pounding, severe headache. I also had pressure in the ears and behind the eyes, congestion, body aches, and fever. I didn't take my temperature, but I'm certain that I had a fever, since I had chills and was sweating. I was extremely fatigued and slept until noon; this is unusual for me, since I'm usually up at 6 AM. On 6/13/2022, I had nausea with diarrhea. I never threw up, however, and I took an anti-nausea pill. My throat also felt scratchy and I would sometimes cough, but the cough wasn't constant. I also had no appetite, and at the time of this writing, I have not had an appetite since 6/12/2022. On the morning of 6/12/2022, I took a home test for COVID, and the result was positive. Later that afternoon, I took a PCR test at pharmacy, and it also yielded a positive result. I called my doctor's office on 6/13/2022 to notify him of my diagnosis via the receptionist, and I have not heard back from him. On the afternoon of 6/13/2022, I experienced an increase in head pressure, an increase in nausea, a constantly runny nose; at the time of this writing, the symptoms have continued in conjunction with diarrhea and fatigue. I have not vomited at any point, however. On 6/14/2022, I had abdominal pain, which consisted of sharp stomach pains. In 2019, I had a gastric sleeve surgically inserted; I don't know if this is in any way related to the abdominal pain, but I mention it, as I had never experienced the pain until I was infected with COVID. At 4 AM on 6/15/2022, I woke up with a dry cough. From 4 AM to about 5 AM, the cough was constant. After I took Tylenol, though, it became intermittent. Since I have been sick, I have taken Tylenol every 4-5 hours and anti-nausea medicine. The Tylenol helps reduce the head pain and pressure, though it doesn't completely alleviate it. The Tylenol alleviated much of the cough. It also made the body aches much less intense. I only take the anti-nausea medicine PRN, so I have only taken two doses: once on 6/13/2022 and once on 6/14/2022. It provided immediate relief for the nausea, though it didn't help the abdominal pain.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Abdominal pain
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- None.
- Vorgeschichte
- Chronic sinus infections, hypothyroidism, anxiety, depression.
- Andere Medikamente
- Wellbutrin, Synthroid, women's multivitamin, Zyrtec, Mucinex.
- Allergien
- Sesame seeds, Tramadol.
- Vorherige Impfungen
- -
- Staat
- IL
- Alter
- 34,0
- Geschlecht
- F
- Eingang
- 14.06.2022
- Impfdatum
- 25.01.2022
- Beginn
- 26.01.2022
- Tage bis Beginn
- 1,0
- Dosis
- 3
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Dizziness
Ear discomfort
Head discomfort
Headache
Nausea
Tinnitus
Vertigo
Symptomtext
I have been experiencing vertigo, dizziness, pressure in head, headaches, nausea, pressure, ringing, popping, cracking in ears post Covid vaccine and booster.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dizziness
- Hospital-Tage
- -
- Labordaten
- Currently awaiting appointment with ENT & Allergists who are booked up for months in my area due to an increase in tinnitus cases and fluid in ears.
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- Wellbutrin
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- OR
- Alter
- 72,0
- Geschlecht
- M
- Eingang
- 07.06.2022
- Impfdatum
- 25.04.2022
- Beginn
- 26.04.2022
- Tage bis Beginn
- 1,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Abdominal pain
Blood test abnormal
Diarrhoea
Hypophagia
Symptomtext
On 4/25/2022, I received my second Moderna booster against COVID-19. On 4/26/2022, I began to have abdominal cramping and frequent watery diarrhea. Ever since then, I have been unable to eat as much in one sitting or in general as I was before the second booster. I also still have abdominal pains and frequent watery diarrhea. I went to an urgent care clinic that is run through the hospital system a week or two after receiving the shot, and a number of blood tests were ordered. I received news via email that I was diagnosed with eosinophilic gastroenteritis. On 6/7/2022, I saw my PCP for a follow-up. My doctor recommended a course of budesonide. However, as of now I am holding off on doing this. While I was at my doctor's office, I underwent more blood tests, and we're going to see if there have been any changes since my first blood test.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Abdominal pain
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Lymphocytic colitis; eosinophilic gastroenteritis; arteriosclerosis; high cholesterol (under control); hypertension (under control)
- Andere Medikamente
- Metoprolol, diltiazem, atorvastatin, terazosin, Ativan, aspirin, fish oil, vitamin B12, vitamin D, vitamin C, vitamin B6, folic acid, iron, magnesium, calcium.
- Allergien
- Penicillin; sulfa drugs; cat dander; seasonal allergies; dust
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 58,0
- Geschlecht
- F
- Eingang
- 31.05.2022
- Impfdatum
- 15.04.2022
- Beginn
- 27.05.2022
- Tage bis Beginn
- 42,0
- Dosis
- 4
- Route/Site
- SYR / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
COVID-19
Fatigue
Headache
Influenza like illness
Malaise
Nausea
Pain
Pyrexia
Rhinorrhoea
SARS-CoV-2 test positive
Symptomtext
My husband developed symptoms on Monday, May 24th, we both were with our son on the weekend of the 21st. He tested positive on the 22nd, and also tested positive on Friday, the 27th after having tested negative on the 25th. That night of the 27th, I started with mild symptoms and by the 29th my symptoms were more severe of headache, runny nose, fever, achy, and I tested positive. My doctor started me yesterday on Paxlovid. But overall my symptoms are more like a flu and less of a cold. No cough, just nausea, fatigue, aches, etc.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Fatigue
- Hospital-Tage
- -
- Labordaten
- Covid test, positive result.
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- High Blood Pressure; Diverticulitis; High Cholesterol
- Andere Medikamente
- Atorvastatin; pantoprazole; losartan; curcumin; magnesium; coQ10; vitamin D3
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- NY
- Alter
- 23,0
- Geschlecht
- F
- Eingang
- 24.05.2022
- Impfdatum
- 27.02.2022
- Beginn
- 11.03.2022
- Tage bis Beginn
- 12,0
- Dosis
- 3
- Route/Site
- SYR / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Erythema
Mechanical urticaria
Pruritus
Urticaria
Symptomtext
12 days after receiving Moderna booster I have had daily itchy skin, hives, and red lines all over my body. Were told the red lines are called dermatographia. Despite being on several different medications (prednisone, Pepcid, and daily high dose 4x a day prescription Allegra, and seeing several allergists and dermatologists) I still have the hives and dermatographia daily.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Mechanical urticaria
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- None
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- AL
- Alter
- 34,0
- Geschlecht
- F
- Eingang
- 23.05.2022
- Impfdatum
- 17.02.2022
- Beginn
- 23.05.2022
- Tage bis Beginn
- 95,0
- Dosis
- 3
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Arthralgia
Blood test
COVID-19
Chills
Cough
Ear pain
Fatigue
Feeling abnormal
Headache
Nasal congestion
Oropharyngeal pain
Pain
Polymerase chain reaction
Rhinorrhoea
SARS-CoV-2 test positive
Streptococcus test
Urine analysis
Vaccine breakthrough infection
Symptomtext
I was tested positive for breakthrough COVID today 05/23/2022. My symptom are moderate, I have a headache, chills, body ache, joint ache, sore throat and ears, fatigue, stuffing & running nose and a cough. I have been feeling bad. My doctor called me in something but I haven't went to pick it up as of yet.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Arthralgia
- Hospital-Tage
- -
- Labordaten
- PCR, urine, blood panel, and strep test.
- Aktuelle Erkrankungen
- No
- Vorgeschichte
- AST; Chron's
- Andere Medikamente
- No
- Allergien
- Banana; metformin
- Vorherige Impfungen
- -
- Staat
- MT
- Alter
- 70,0
- Geschlecht
- M
- Eingang
- 14.05.2022
- Impfdatum
- 22.03.2022
- Beginn
- 23.03.2022
- Tage bis Beginn
- 1,0
- Dosis
- 4
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Heart rate increased
Lethargy
Malaise
Pyrexia
Symptomtext
101? Fever, High Pulse Rate ~ 110, Malaise & Lethargy x 4 Days. Symptoms Lasted x 4Days Not Experienced With Other Doses
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Malaise
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- NKA
- Vorherige Impfungen
- -
- Staat
- MA
- Alter
- 73,0
- Geschlecht
- F
- Eingang
- 12.05.2022
- Impfdatum
- 09.02.2022
- Beginn
- 18.04.2022
- Tage bis Beginn
- 68,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
COVID-19
Fatigue
Hypersensitivity
Interchange of vaccine products
Oropharyngeal pain
Pain
SARS-CoV-2 test positive
Symptomtext
My first 3 doses were of Pfizer. I had allergies 2 weeks prior. Then, I started getting symptoms of achiness, tiredness, and sore throat. The next day I was more tired. I did a home COVID-19 test which was positive. I contacted my doctor and was prescribed Paxlovid due to being immune compromised. Within 24 hours, I was feeling better. It took a week to test negative. The only symptom that lingered more was the fatigue.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Fatigue
- Hospital-Tage
- -
- Labordaten
- COVID-19 test
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Hip replacement surgery 12/2021, Arthritis, Immune Compromised due to medication Orencia and methotrexate medications
- Andere Medikamente
- Orencia, Methotrexate, Serevent, Flovent, Fluticasone nasal spray, Vitamin D3, Calcium, Aspirin 81mg, Folic acid, Propranolol
- Allergien
- Penicillin, Darvon, Some nsaids, Statins, Mites, mildew, molds
- Vorherige Impfungen
- Pfizer 1st dose - Tiredness for 2 days
- Staat
- CA
- Alter
- 53,0
- Geschlecht
- F
- Eingang
- 06.05.2022
- Impfdatum
- 07.01.2021
- Beginn
- 04.02.2021
- Tage bis Beginn
- 28,0
- Dosis
- UNK
- Route/Site
- - / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Antibody test
Arthralgia
Blood test
COVID-19
Computerised tomogram
Headache
Inflammation
Joint swelling
Myalgia
Red blood cell sedimentation rate
Tinnitus
Symptomtext
Severe joint pain, swollen joints & Covid not hardly move. Severe inflammation Internally swollen, Headaches, Severe Tinnitus in both ears, ringing in both ears. Muscle aches (false (+) lupus)
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Arthralgia
- Hospital-Tage
- -
- Labordaten
- Blood work, sed rates, Antibodies testing, Ct Scans
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Psoriatic Arthritis/Gluten
- Andere Medikamente
- toporol xl 25, lasix 20. asprin 80 tumeric
- Allergien
- Gluten, Sulfa
- Vorherige Impfungen
- -
- Staat
- DE
- Alter
- 83,0
- Geschlecht
- F
- Eingang
- 28.04.2022
- Impfdatum
- 05.04.2022
- Beginn
- 08.04.2022
- Tage bis Beginn
- 3,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
Cerebral disorder
Diplopia
Eye pain
Magnetic resonance imaging head abnormal
Meningioma
Vision blurred
Symptomtext
on 4/8 pt reports double vision and was admitted to the hospital that day for concern of 3rd cranial nerve palsy. Neurology to follow for improvement in 4-6 weeks states this is likely a chronic condition. per H&P to the hospital patient had been complaining of right eye pain/ blurry vision for 1 week
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Eye pain
- Hospital-Tage
- 2,0
- Labordaten
- MRI: demonstrated chronic microvascular ischemic disease and meningioma which is known.
- Aktuelle Erkrankungen
- seen at PCP same day for right eye pain, sinus pain, and increased forgetfulness
- Vorgeschichte
- Raynaud's COPD HTN type 2 diabetes meningioma CAD
- Andere Medikamente
- atorvastatin cholecalciferol furosemide nifedipine losartan loratadine- pseudoephedrine
- Allergien
- sulfa drug ezetimibe
- Vorherige Impfungen
- -
- Staat
- ID
- Alter
- 52,0
- Geschlecht
- F
- Eingang
- 27.04.2022
- Impfdatum
- 26.04.2022
- Beginn
- 26.04.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Injection site erythema
Injection site induration
Injection site reaction
Injection site warmth
Pain
Symptomtext
Site reaction with possible palpations. Palpations lasted a couple hours, resolved this am when seen. Right deltoid is hard and warm to touch with erythema. This area measures 12 cm x 8 cm. --Do not recommend she receive any further Moderna COVID shots. -To apply ice to the area x24 hours and then may rotate heat and ice. 2 ice packs given in clinic. -Naproxen 500 mg tablet. Take 1 tablet twice a day for pain. Take with food in stomach to prevent GI upset. Encouraged to take for at least 3 days routinely. After 3 days she can change taking naproxen to as needed. -Benadryl 25 mg capsule. 1 capsule every 4-6 hours as needed. May cause drowsiness. Explained that I do not think it is necessary that she take Benadryl at this point. But will provide it to her to use at her discretion. It will cause drowsiness.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site erythema
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- Obesity HTN DM type 2 hyperlipidemia Depression
- Andere Medikamente
- Fish-oil Metformin lisinopril
- Allergien
- PCN
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 68,0
- Geschlecht
- F
- Eingang
- 26.04.2022
- Impfdatum
- 19.04.2022
- Beginn
- 19.04.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Feeling abnormal
Lethargy
Pharyngitis streptococcal
Rash
Streptococcus test positive
Symptomtext
PATIENT STATES THAT ON 4/19/22 SHE WENT OUT TO EAT WITH FRIENDS AND BEGAN"FEELING FUNNY". SHE STATES THAT SHE DID NOT EAT AND RETURNED HOME. ON 4/20/22 SHE BEGAN FEELING "LETHARGIC" THAT CONTINUED THROUGHTOUT THE DAY. IN THE AFTERNOON OF 4/20/22 SHE STARTED TO GET "BUMPS" ON HER HAND AND BY 4/21/22 THE "BUMPS" CONTINUED TO SPREAD THROUGHOUT HER ENTIRE BODY. ON 4/22/22 THE "BUMPS WERE SIGNIFICANTLY WORSE" AND SHE SOUGHT TREATMENT AT LOCAL CARE WHERE SHE WAS DIAGNOSED WITH STREP THROAT AND TOLD TO REPORT HER REACTION TO THE LOCAL HEALTH DEPARTMENT. SHE STATES THAT SHE WAS GIVEN ANTIBIOTICS AND "ANOTHER MEDICATION" AND THAT SHE IS IMPROVING.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Rash
- Hospital-Tage
- -
- Labordaten
- PER PATIENT, SHE WAS DIAGNOSED WITH STREP THROAT ON 4/22/22.
- Aktuelle Erkrankungen
- DIAGNOSED WITH STREP THROAT ON 4/22/2022 CANCER
- Vorgeschichte
- HTN HYPERLIPIDEMIA RECENTLY DX WITH BREAST CANCER
- Andere Medikamente
- Simvastatin, Trimetazidine, Amlodipine, Fenofibrate
- Allergien
- NKA
- Vorherige Impfungen
- -
- Staat
- NY
- Alter
- 78,0
- Geschlecht
- M
- Eingang
- 22.04.2022
- Impfdatum
- 13.04.2022
- Beginn
- 15.04.2022
- Tage bis Beginn
- 2,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Injection site pruritus
Injection site swelling
Symptomtext
Swelling below the injection site that was raised and about the size of a softball and quite itchy. 4/15/22 Swelling and raised area had decreased in size but still visible 4/19/22
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site pruritus
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Type 2 Diabetes
- Andere Medikamente
- Janumet XR 50/1000 Olopatadine Opthalmic solution Clopidogrel 75mg Potassium Citrate ER 10mEq Gemtesa 75mg Metoprolol ER 50mg Atorvastatin 80mg Fluticasone NS 50mcg Stiolto Respimat Albuterol HFA 90mcg inhaler Glimepiride 4mg Losartan 100
- Allergien
- NKA
- Vorherige Impfungen
- -
- Staat
- VA
- Alter
- 75,0
- Geschlecht
- M
- Eingang
- 22.04.2022
- Impfdatum
- 30.03.2022
- Beginn
- 07.04.2022
- Tage bis Beginn
- 8,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Feeling abnormal
Pyrexia
Symptomtext
Foggy head starting 4 days after injection, low grade fever - 99.3 - one week after for one evening
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pyrexia
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- metoprolol, atorvastatin, Vit D3, omeprazole, Zyrtec
- Allergien
- Penicillin
- Vorherige Impfungen
- -
- Staat
- IL
- Alter
- 57,0
- Geschlecht
- F
- Eingang
- 19.04.2022
- Impfdatum
- 18.04.2022
- Beginn
- 18.04.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Chills
Cold sweat
Dysgeusia
Fatigue
Headache
Nausea
Pyrexia
Symptomtext
HEADACHE, CHILLS, FEVER, MATALLIC TASTE, NAUSEA, FATIGUE, AND COLD SWEATS.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Chills
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NY
- Alter
- 69,0
- Geschlecht
- F
- Eingang
- 18.04.2022
- Impfdatum
- 15.04.2022
- Beginn
- 17.04.2022
- Tage bis Beginn
- 2,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Injection site pruritus
Rash erythematous
Symptomtext
developed red rash and itching around injection site. used heat to site and sx were almost gone in the morning
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site pruritus
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- na
- Vorgeschichte
- diabetic HTN hyperchol OAB arthritis gerd
- Andere Medikamente
- atorvastatin (LIPITOR) 20 mg tablet cholecalciferol (D3 DOTS) 50 mcg (2,000 unit) tablet clobetasoL (TEMOVATE) 0.05 % ointment colesevelam (WELCHOL) 625 mg tablet cyanocobalamin, vitamin B-12, (Vitamin B-12) 1,000 mcg tablet extended re
- Allergien
- cortisone
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 35,0
- Geschlecht
- M
- Eingang
- 14.04.2022
- Impfdatum
- 29.03.2022
- Beginn
- 29.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
No adverse event
Pain in extremity
Symptomtext
Patient had no adverse reaction. He stated that he felt normal just a sore arm. Patient was advised to come to clinic if new symptoms appeared.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pain in extremity
- Hospital-Tage
- -
- Labordaten
- None needed.
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- none
- Andere Medikamente
- unknown
- Allergien
- No known allergies
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 78,0
- Geschlecht
- F
- Eingang
- 11.04.2022
- Impfdatum
- 07.04.2022
- Beginn
- 09.04.2022
- Tage bis Beginn
- 2,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Injection site erythema
Injection site swelling
Pyrexia
Vomiting
Symptomtext
Patient phoned us this morning, to notify us that she had a reaction after her vaccine. Beginning on Saturday the 9th she awoke with slight fever, a red and swollen arm at injection site and some vomiting episodes. She is feeling better now, but wanted to let us know what happened.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site erythema
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 84,0
- Geschlecht
- M
- Eingang
- 11.04.2022
- Impfdatum
- 07.04.2022
- Beginn
- 09.04.2022
- Tage bis Beginn
- 2,0
- Dosis
- 4
- Route/Site
- - / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Vomiting
Symptomtext
Patient phoned in to let us know they had vomiting episodes on the second day after their vaccine.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Vomiting
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 48,0
- Geschlecht
- M
- Eingang
- 03.04.2022
- Impfdatum
- 31.03.2022
- Beginn
- 31.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Burning sensation
Rash
Rash pruritic
Symptomtext
Patient noticed rash forming on both arms approximately 15 minutes after vaccination. Reported that rash was itchy and had a burning sensation. Provider recommended that patient go home and take diphenhydramine for the reaction and seek urgent care if SOB developed. Vital signs were normal.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Rash
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NY
- Alter
- 43,0
- Geschlecht
- M
- Eingang
- 28.03.2022
- Impfdatum
- 30.01.2022
- Beginn
- 22.02.2022
- Tage bis Beginn
- 23,0
- Dosis
- 3
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Allergy test
Rash
Urticaria
Symptomtext
Hives 3 weeks after administration of Moderna vaccine
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Rash
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- No
- Vorgeschichte
- -
- Andere Medikamente
- No
- Allergien
- No
- Vorherige Impfungen
- -
- Staat
- NY
- Alter
- 43,0
- Geschlecht
- M
- Eingang
- 28.03.2022
- Impfdatum
- 30.01.2022
- Beginn
- 22.02.2022
- Tage bis Beginn
- 23,0
- Dosis
- 3
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Allergy test
Rash
Urticaria
Symptomtext
Hives 3 weeks after administration of Moderna vaccine
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Rash
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- No
- Vorgeschichte
- -
- Andere Medikamente
- No
- Allergien
- No
- Vorherige Impfungen
- -
- Staat
- MS
- Alter
- 64,0
- Geschlecht
- F
- Eingang
- 22.03.2022
- Impfdatum
- 08.02.2022
- Beginn
- 08.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Laboratory test
Lymphadenopathy
Pruritus
Symptomtext
itching, swollen lymphnode lt side of neck
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pruritus
- Hospital-Tage
- -
- Labordaten
- lab
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- hydrothiachlorizide, losartan
- Allergien
- cedeine, tramadol,
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 36,0
- Geschlecht
- F
- Eingang
- 15.03.2022
- Impfdatum
- 11.03.2022
- Beginn
- 15.03.2022
- Tage bis Beginn
- 4,0
- Dosis
- 3
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Oedema peripheral
Pruritus
Symptomtext
Itchy hands and feet and swollen armpit. Treating with Benadryl and symptoms are stable.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pruritus
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- Lamictal, lexapro, gabapentin
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 30,0
- Geschlecht
- F
- Eingang
- 12.03.2022
- Impfdatum
- 11.02.2022
- Beginn
- 24.02.2022
- Tage bis Beginn
- 13,0
- Dosis
- 3
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Rash
SARS-CoV-2 test negative
Urticaria
Symptomtext
Delayed urticaria hive like rash, generalized over body. Lasting in certain spots from 30 minutes to an hour at a time. Symptom relief with antihistamines. Was placed on prednisone 60mg x 5 days. Steroids helped but symptoms came back after I stopped taking them. Currently still taking Zyrtec
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Rash
- Hospital-Tage
- -
- Labordaten
- Negative Covid test (2 March)
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- Multivitamin, oral birth control (nortrel)
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 45,0
- Geschlecht
- M
- Eingang
- 11.03.2022
- Impfdatum
- 03.02.2022
- Beginn
- 07.02.2022
- Tage bis Beginn
- 4,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Arthralgia
Burning sensation
Computerised tomogram
Laboratory test
Pain in extremity
X-ray
Symptomtext
Right-side shoulder pain, aching in shoulder and burning sensation.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Arthralgia
- Hospital-Tage
- -
- Labordaten
- CT, lab and x-ray.
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- Lisinopril, Fenofibrate
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NY
- Alter
- 56,0
- Geschlecht
- F
- Eingang
- 09.03.2022
- Impfdatum
- 21.01.2022
- Beginn
- 01.02.2022
- Tage bis Beginn
- 11,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Allergy test
Blood test
Rash
Vaccine positive rechallenge
Symptomtext
1st Dose 4/15/21 - Given post Covid - Rash on Forehead 2nd Dose 5/13/21 - Rash on Forehead worsened 3rd Dose 1/21/22 - (Booster) Rash covered entire face. Prednisone prescribed multiple times. Still getting rash as of 3/9/22
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Rash
- Hospital-Tage
- -
- Labordaten
- Dermatologist appointment on 2/10/22. Given Tacrolimus Ointment 0.03% 1x daily at night and Ketoconazole 2% cream 2x a day. Appointment 2/21/22 - Given 40 mg Prednisone daily for 7 days rash returned within 24 hours of ending treatment. General Practioner appointment 3/1/22. Given Prednisone 10 mg. 4 tabs per day decreasing by one tablet every third day. ( over 12 days) break through rash on day 7. Took Blood and tested for allergies. 3/9/22 ENT/Allergist appointment. Rash present. Sent for Autoimmune testing to rule everything else out. But believes due to timeline reaction is from shot.
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- None
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- IL
- Alter
- 68,0
- Geschlecht
- F
- Eingang
- 09.03.2022
- Impfdatum
- 07.03.2022
- Beginn
- 07.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- - / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Chills
Diarrhoea
Headache
Injection site pain
Neck pain
Pyrexia
Symptomtext
Fever, chills, headache, neck ache, injection site pain; diarrhea
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Chills
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Thyroid; high blood pressure: high cholesterol; macular degeneration in right eye and cataract starting in left eye
- Andere Medikamente
- Levothyroxine; Atorvadtatin; Deloxetine; Hydrochlorothiazide; Losartan; Loratadine tablets; D3 vitamin; B-12 vitamin; eye vitamins adults 50+; multivitamin
- Allergien
- Lisinoprl; Tylenol with codeine; Cefdinir 300mg; Vicodin; Neosporin
- Vorherige Impfungen
- -
- Staat
- SC
- Alter
- 44,0
- Geschlecht
- F
- Eingang
- 07.03.2022
- Impfdatum
- 01.03.2022
- Beginn
- 02.03.2022
- Tage bis Beginn
- 1,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Injection site cellulitis
Injection site erythema
Injection site induration
Injection site warmth
Symptomtext
I have developed cellulitis in and around the injection site my left arm is inflammed, I have a 7*7 wheal that is hard, red, raised and red streaks going down my arm. I called the doctors office, they never called me back. I had to report to Urgent Care for treatment, the prescribed Cephaxelin 500mg QID
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site cellulitis
- Hospital-Tage
- -
- Labordaten
- Assessment only so far, will follow up with PCP this week per urgent care suggestion.
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Low back pain
- Andere Medikamente
- Butrans transdermal Xanaflex Gabapentin Linzess Relistor Fish oil Multivitamin Lexapro
- Allergien
- ASA
- Vorherige Impfungen
- -
- Staat
- OR
- Alter
- 67,0
- Geschlecht
- M
- Eingang
- 05.03.2022
- Impfdatum
- 31.01.2022
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 1
- Route/Site
- OT / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Chills
Pain in extremity
Pyrexia
Symptomtext
Arm hurt; Chills; Fever; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm hurt), CHILLS (Chills) and PYREXIA (Fever) in an elderly male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 vaccination. Concomitant products included LORAZEPAM for an unknown indication. On 31-Jan-2022, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Arm hurt), CHILLS (Chills) and PYREXIA (Fever). At the time of the report, PAIN IN EXTREMITY (Arm hurt), CHILLS (Chills) and PYREXIA (Fever) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No medical history was provided by the reporter. No treatment information was reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Chills
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- LORAZEPAM
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MD
- Alter
- 78,0
- Geschlecht
- F
- Eingang
- 03.03.2022
- Impfdatum
- 25.02.2022
- Beginn
- 25.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Blood glucose increased
Decreased appetite
Fatigue
Feeding disorder
Gait inability
Malaise
Symptomtext
On Day 6 Post Vaccination of Booster dose Moderna, patient reports still feeling extremely fatigues, lack of appetite, unable to eat, elevated blood sugar level, unable to walk, and general feeling of being unwell. On Day 6, she is just starting to be able to eat small amounts of food. Patient advised to seek medical attention if symptoms persist. **Note--patient reported that with the previous dose her vaccinated arm not only hurt, but it swelled up x 6 weeks.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Fatigue
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- Mobility issues/ chair bound.
- Vorgeschichte
- Obesity, Mostly chair bound.
- Andere Medikamente
- Unknown
- Allergien
- Wasp allergy as a child, had anaphylactic reaction to wasp sting as a child
- Vorherige Impfungen
- With dose #2 of Moderna, patient reports her vaccinated arm swelled x 6 weeks.
- Staat
- NJ
- Alter
- 38,0
- Geschlecht
- F
- Eingang
- 03.03.2022
- Impfdatum
- 03.02.2022
- Beginn
- 07.02.2022
- Tage bis Beginn
- 4,0
- Dosis
- 3
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Dry skin
Pruritus
Scratch
Sensitive skin
Symptomtext
It started with random itching, my scalp, my back, my neck so I wasn't sure if my skin was dry and it was patches all over my body. this past weekend at night I had a tremendous itching all over my body. Ever since then I notice that if I don't take Benadryl or Zyrtec I start itching right away, It doe gets worse at the evening and at night it keeps me up. There is nothing that I can do to get rid of it. within the next couple of days I notice that I have a deep scratch and I have lines, I've never been sensitive with my skin. I have an appointment on 03/09/2022 with Dr. which he is an allergist. I have met someone that has experience the same exact symptom after our booster, the pictures are identical.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pruritus
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- 02/23/2021 COVID-19 Positive, coughing
- Vorgeschichte
- N/A
- Andere Medikamente
- Adderall 10MG 1 a day.
- Allergien
- N/A
- Vorherige Impfungen
- -
- Staat
- PR
- Alter
- 43,0
- Geschlecht
- F
- Eingang
- 28.02.2022
- Impfdatum
- 28.02.2022
- Beginn
- 28.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Hypoaesthesia
Injection site hypoaesthesia
Symptomtext
Patient reports that when vaccinated she feels numbness in her left arm and on the left side of her neck.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site hypoaesthesia
- Hospital-Tage
- -
- Labordaten
- n/a
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Polycystic ovarian syndrome, sinusitis, hypoglycemia, hypertension.
- Andere Medikamente
- n/a
- Allergien
- n/a
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 49,0
- Geschlecht
- F
- Eingang
- 25.02.2022
- Impfdatum
- 25.02.2022
- Beginn
- 25.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Flushing
Pruritus
Skin warm
Urticaria
Symptomtext
Patient c/o feeling warm and itching, VSS at 136/89, 02 97% with mask, HR 88. Flushing noted to chest and patient scratching UE bilateral. Dr. notified and gave orders for 8omg/ml x 1 dose and send patient to ED if symptoms do not resolve. Patient monitored 1 on 1 for 60 minutes, hives on chest resolving, scratching stopped. Patient had no SOB, no difficulty breathing, no sweating, N/V noted. VSS, family member, with patient and will go to nearest ED or call 911 if symptoms worsen. NP evaluated the patient prior to D/C.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pruritus
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Type 2 DM
- Andere Medikamente
- Norvasc, Metformin, Vitamin D, Atorvastatin, Prozac.
- Allergien
- None
- Vorherige Impfungen
- Moderna, same thing hives and itching.
- Staat
- PR
- Alter
- 41,0
- Geschlecht
- M
- Eingang
- 22.02.2022
- Impfdatum
- 22.02.2022
- Beginn
- 22.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Dizziness
Symptomtext
patient reports feeling dizzy.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dizziness
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Clonazepam
- Andere Medikamente
- Yes, Cannabis
- Allergien
- NKA
- Vorherige Impfungen
- -
- Staat
- NY
- Alter
- 36,0
- Geschlecht
- F
- Eingang
- 21.02.2022
- Impfdatum
- 21.01.2022
- Beginn
- 23.01.2022
- Tage bis Beginn
- 2,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Eye swelling
Mouth swelling
Pruritus
Rash
Rash pruritic
Swelling face
Swelling of eyelid
Swollen tongue
Type IV hypersensitivity reaction
Symptomtext
Systemic: Allergic: Itch (specify: facial area, extremeties)-Severe, Systemic: Allergic: Itch Generalized-Severe, Systemic: Allergic: Rash (specify: facial area, extremeties)-Severe, Systemic: Allergic: Rash Generalized-Severe, Systemic: Allergic: Swelling of Face / Eyes / Mouth / Tongue-Medium, Additional Details: Delayed allergic reaction. Itchy rash on chest, neck and eyelid. Eyelids moderately swollen.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pruritus
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MD
- Alter
- 49,0
- Geschlecht
- F
- Eingang
- 20.02.2022
- Impfdatum
- 14.02.2022
- Beginn
- 14.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Burning sensation
Chills
Diarrhoea
Dizziness
Headache
Pain
Rash
Symptomtext
On 2/14/22, burning sensation started an hour after injection. Also. rashes on both arms and legs. The burning sensation began in the left arm and spread to my chest, right arm and both legs. The strong burning sensation was without a fever and it continued until 2/17 along with body aches, headaches, chills. On 2/18/22, the aches went away with daily naproxen. The burning sensation subsided expect for a slight burning sensation on my legs. However, the rashes continued to spread on both arms and legs. Additionally, I became very dizzy and had diarrhea. Which made me go to my local Urgent care.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Chills
- Hospital-Tage
- -
- Labordaten
- On 2/18/2022, I went to the Urgent care where the doctor examined me and prescribed a cortisone cream and Hydroxyzine.
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- Vitamin D3
- Allergien
- None known
- Vorherige Impfungen
- -
- Staat
- AZ
- Alter
- 37,0
- Geschlecht
- F
- Eingang
- 19.02.2022
- Impfdatum
- 18.02.2022
- Beginn
- 19.02.2022
- Tage bis Beginn
- 1,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Fatigue
Headache
Lymphadenopathy
Nausea
Pain
Pyrexia
Symptomtext
Swelling of the L arm pit lymph node. Fever fatigue body aches headache nausea
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Fatigue
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- NA
- Vorgeschichte
- NA
- Andere Medikamente
- Ibuprofen
- Allergien
- NA
- Vorherige Impfungen
- Covid vaccine moderna
- Staat
- NH
- Alter
- 33,0
- Geschlecht
- F
- Eingang
- 18.02.2022
- Impfdatum
- 03.02.2022
- Beginn
- 03.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Rash
Rash pruritic
Symptomtext
patient developed an extremely itchy rash all over her body and was prescribed prednisone to treat
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Rash
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- none
- Andere Medikamente
- lorazepam 0.5mg
- Allergien
- no known allergies
- Vorherige Impfungen
- -
- Staat
- NJ
- Alter
- 45,0
- Geschlecht
- F
- Eingang
- 15.02.2022
- Impfdatum
- 30.01.2022
- Beginn
- 02.02.2022
- Tage bis Beginn
- 3,0
- Dosis
- UNK
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Blood test
Hyperhidrosis
Hypersensitivity
Pyrexia
Skin discolouration
Symptomtext
-1/30 (Sun): I had a low-grade fever and was sweating 12 hours after receiving my booster shot (at 2:15 Pm), but these symptoms were similar to the ones I experienced when I got the first 2 doses. These symptoms lasted for approx. 24 hours. - 2/2 (Wed): I started seeing skin discoloration on my left leg that did not disappear after a day. - 2/5 (Sat): I started noticing visible blood vessels on my chest and my face - 2/6 (Sun): I started seeing skin discoloration on my face - 2/16 (Wed): I started seeing skin discoloration on my chest
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pyrexia
- Hospital-Tage
- -
- Labordaten
- -2/12 (Sat): I saw my PCP, who said my condition resembled something similar to Livedo reticularis, but this opinion conflicts with that of other doctors I saw. They took 5 blood samples and I am waiting on these results. -2/15 (Tues): I saw a dermatologist who believes these symptoms are the result of an allergic reaction. She prescribed an antihistamine and vitamin C.
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- None
- Allergien
- Occasionally I?m allergic to shellfish
- Vorherige Impfungen
- 1st Shot : No adverse event (44 Years, Covid19 (Moderna), Moderna) 2nd Shot: I had a high fever and chills, and I was sweating 1
- Staat
- IL
- Alter
- 80,0
- Geschlecht
- F
- Eingang
- 15.02.2022
- Impfdatum
- 08.02.2022
- Beginn
- 09.02.2022
- Tage bis Beginn
- 1,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: ja
Asthenia
Confusional state
Pyrexia
Symptomtext
Reporting what I was told. The patient had a low grade fever of 100.4 F, weakness and confusion. Her assisted living facility sent her to the ER where they observed her for less than 24 hours for a discharge date of 2/10/22
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pyrexia
- Hospital-Tage
- 1,0
- Labordaten
- Unknown to pharmacy
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Anxiety, hypertension,
- Andere Medikamente
- Clonazepam, Carvedilol, Topiramate, Fluoxetine, Bupropion XL
- Allergien
- Penicillamine, sulfa
- Vorherige Impfungen
- -
- Staat
- NC
- Alter
- 24,0
- Geschlecht
- F
- Eingang
- 12.02.2022
- Impfdatum
- 10.02.2022
- Beginn
- 11.02.2022
- Tage bis Beginn
- 1,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Injection site reaction
Rash erythematous
Rash pruritic
Symptomtext
After showering the day after receiving the booster a red rash appeared below the injection site (2/11/22 10 pm). It is still there with few changes in size or color (2/12/22 11 am) and itches frequently.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site reaction
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- Birth control
- Allergien
- Wasps
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 22,0
- Geschlecht
- F
- Eingang
- 12.02.2022
- Impfdatum
- 11.02.2022
- Beginn
- 11.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: ja
Dizziness
Flushing
Hyperhidrosis
Symptomtext
Systemic: Dizziness / Lightheadness-Mild, Systemic: Flushed / Sweating-Mild
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dizziness
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- IA
- Alter
- 46,0
- Geschlecht
- F
- Eingang
- 11.02.2022
- Impfdatum
- 01.02.2022
- Beginn
- 04.02.2022
- Tage bis Beginn
- 3,0
- Dosis
- 2
- Route/Site
- SYR / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
COVID-19
Cough
Head discomfort
Malaise
SARS-CoV-2 test positive
Symptomtext
I got sick w cough & stuffy head the same day . Kept getting sicker went to dr & was covid 19 positive
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Malaise
- Hospital-Tage
- -
- Labordaten
- Dr took covid test
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- Amitriptyline25, myrbetriq50, cetirizine10, ropinirole 2, top-rated 50, desvenlafaxine 50
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- NY
- Alter
- 32,0
- Geschlecht
- F
- Eingang
- 11.02.2022
- Impfdatum
- 10.02.2022
- Beginn
- 10.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Chills
Headache
Pain
Petechiae
Symptomtext
Petechiae on left arm below injection site and on right shoulder blade about 4 hours after injection. Continued petechiae in the same locations, headache, chills and full body aches the next morning (about 12 hours after injection), lasting all day. 1000mg PO Tylenol taken at 09:30am. All symptoms continued throughout the day.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Chills
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Hypothyroidism, mild asthma, eczema
- Andere Medikamente
- 50mcg PO Synthroid daily
- Allergien
- None
- Vorherige Impfungen
- Headache and chills with second Moderna vaccination in March of 2021 (patient was 31 years old). Patient also contracted COVID 1
- Staat
- NY
- Alter
- 59,0
- Geschlecht
- F
- Eingang
- 10.02.2022
- Impfdatum
- 25.01.2022
- Beginn
- 26.01.2022
- Tage bis Beginn
- 1,0
- Dosis
- 3
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Allergy test positive
Blood test normal
Discomfort
Erythema
Hypersensitivity
Pain in extremity
Pruritus
Rash
Rash erythematous
Rash morbilliform
Rash pruritic
Symptomtext
Very sore arm beginning night of booster injection. Next day left flank became itchy. About a day later right flank became itchy. Thought it was dry winter skin. Over next few days redness with intermittent itching developed. Then a red, angry, bumpy measle type rash appeared on both sides. Then thought it was shingles. Went to General Practioner Friday 2/4/22. He diagnosed as possible contact dermatitis. Prescribed course of Prednisone and Cortosteroid topical cream. Monday 2/7 rash was no better and extremely uncomfortable and itchy. I have not changed any lotions soaps etc. I have never had a rash like this in my life. Called my dermatologist Dr and was able to get in that day. She diagnosed as allergic reaction to something.! Continue with Prednisone and changed topical to stronger one called Clobetasol. It is now a little over 2 weeks and I still have the rash on both sides. It might seem to be getting a bit better. Follow up with dermatologist in 3 weeks.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pain in extremity
- Hospital-Tage
- -
- Labordaten
- Food and respiratory blood panel. 0 Food allergies. Mild allergy to grass and Maple trees.
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- slight high blood pressure panic attacks Restless Leg Syndrome
- Andere Medikamente
- Paxil 20 mg. Toporol 10 mg Ropinirol 2 mg
- Allergien
- Penicillin Sulfur CAT scan dye
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 54,0
- Geschlecht
- M
- Eingang
- 09.02.2022
- Impfdatum
- 07.02.2022
- Beginn
- 08.02.2022
- Tage bis Beginn
- 1,0
- Dosis
- 3
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Axillary pain
Chills
Injection site pain
Oedema peripheral
Pyrexia
Rash
Symptomtext
rash and swollen left armpit. Armpit slightly painful. Injection site sore, chills and fever for one night.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Axillary pain
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- none
- Andere Medikamente
- Rosuvastatin 5mg
- Allergien
- no
- Vorherige Impfungen
- Moderna 2nd dose, had rash, chills, fever
- Staat
- PR
- Alter
- 42,0
- Geschlecht
- F
- Eingang
- 08.02.2022
- Impfdatum
- 08.02.2022
- Beginn
- 08.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Erythema
Pruritus
Symptomtext
PATIENT REFERS ITCHY SKIN AND REDNESS
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pruritus
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- none
- Andere Medikamente
- NONE
- Allergien
- Benadryl Septra Watermellon Cherry
- Vorherige Impfungen
- MODERNA VACCINE FOR COVID, RASH, HIPERTENSION
- Staat
- NY
- Alter
- 46,0
- Geschlecht
- F
- Eingang
- 08.02.2022
- Impfdatum
- 03.02.2022
- Beginn
- 06.02.2022
- Tage bis Beginn
- 3,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Injection site erythema
Injection site pain
Injection site pruritus
Symptomtext
Site: Itching at Injection Site-Medium, Site: Pain at Injection Site-Mild, Site: Redness at Injection Site-Medium
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site erythema
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 20,0
- Geschlecht
- F
- Eingang
- 07.02.2022
- Impfdatum
- 07.02.2022
- Beginn
- 07.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- - / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Dizziness
Heart rate increased
Hypopnoea
Nausea
Symptomtext
Pt first experience dizziness and increase heart rate. Patient observed to have shallowing breaths. pt also stated that she was experiencing nausea. First patient was advised to have her head down to help with the feeling of faint. after the shallow breaths did not resolve, rph called 911 to request paramedic assistance. Epi-pen was on stand by but did not have to be used.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dizziness
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- Not known.
- Vorgeschichte
- None.
- Andere Medikamente
- Not known.
- Allergien
- Stated allergic to previous pfizer vaccines.
- Vorherige Impfungen
- Pfizer covid vaccine.
- Staat
- KS
- Alter
- 37,0
- Geschlecht
- F
- Eingang
- 07.02.2022
- Impfdatum
- 04.02.2022
- Beginn
- 05.02.2022
- Tage bis Beginn
- 1,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Inflammation
Lymph node pain
Mass
Oral pain
Pain in extremity
Stomatitis
Symptomtext
Orange size, painful, inflammed mass in axilla lymph node following day after receiving vaccination. Extremely sore entire arm for 2 days following injection- worst in life with vaccinations. Open and painful sore in roof of mouth also noted within 24 hours of receiving shot
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Lymph node pain
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Psoriatic Arthritis
- Andere Medikamente
- Remicade, prednisone, Arava, Cymbalta
- Allergien
- Sulfa, Wheat dust, Shellfish
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 47,0
- Geschlecht
- M
- Eingang
- 07.02.2022
- Impfdatum
- 30.01.2022
- Beginn
- 31.01.2022
- Tage bis Beginn
- 1,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Arthritis
Chills
Ear swelling
Erythema
Fatigue
Hyperhidrosis
Joint swelling
Musculoskeletal stiffness
Nausea
Night sweats
Pruritus
Skin warm
Symptomtext
Vaccine given 1/30/22. On 1/31/22, he developed chills and nausea and fatigue. That night, he developed profuse night sweats. Felt tired 2/1/22 and had night sweats again that night. On 2/1/22, he developed right medial ankle redness and swelling and pruritis (itchiness there), which improved some by the next day. On 2/2/22 as his right ankle was improving, he developed left thumb arthritis (swelling, redness, stiffness), which started improving by the next day. On 2/3/22, he developed right ear (pinna) swelling, redness and warmth, which started improving by the next day. On 2/4/22, he developed left ear (pinna) swelling, redness and warmth, which started improving by the next day. He started taking naproxen about 1-2 tabs (220 mg each) about 1-2 times a day starting around 2/1/22 and continued through Friday 2/4/22. He was feeling overall better by 2/5/22.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Chills
- Hospital-Tage
- -
- Labordaten
- none done
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Psoriasis (chronic)
- Andere Medikamente
- none
- Allergien
- none
- Vorherige Impfungen
- Was tired after 2nd Moderna COVID vaccine for about 1 day (vaccine given around April 2021)
- Staat
- NY
- Alter
- 37,0
- Geschlecht
- F
- Eingang
- 06.02.2022
- Impfdatum
- 03.02.2022
- Beginn
- 04.02.2022
- Tage bis Beginn
- 1,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Injection site erythema
Injection site pain
Injection site pruritus
Injection site swelling
Symptomtext
Site: Itching at Injection Site-Severe, Site: Pain at Injection Site-Medium, Site: Redness at Injection Site-Medium, Site: Swelling at Injection Site-Medium, Additional Details: Informed patient if worsened, call back or call physician. Patient informed to take ibuprofen, Benadryl and apply hydrocortisone.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site erythema
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- SC
- Alter
- 65,0
- Geschlecht
- F
- Eingang
- 04.02.2022
- Impfdatum
- 01.02.2022
- Beginn
- 02.02.2022
- Tage bis Beginn
- 1,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Injection site erythema
Injection site swelling
Symptomtext
Site: Redness at Injection Site-Medium, Site: Swelling at Injection Site-Medium.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site erythema
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 43,0
- Geschlecht
- F
- Eingang
- 04.02.2022
- Impfdatum
- 01.02.2022
- Beginn
- 02.02.2022
- Tage bis Beginn
- 1,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Fatigue
Flushing
Injection site erythema
Injection site pain
Injection site pruritus
Injection site swelling
Lethargy
Local reaction
Malaise
Pain
Pruritus
Pyrexia
Symptomtext
Site: Itching at Injection Site-Medium, Site: Pain at Injection Site-Medium, Site: Redness at Injection Site-Medium, Site: Swelling at Injection Site-Medium, Systemic: Allergic: Itch Generalized-Medium, Systemic: Body Aches Generalized-Medium, Systemic: Exhaustion / Lethargy-Medium, Systemic: Fever-Medium, Additional Details: Pt came into the pharmacy after receiving the vaccine on 2/1 with a localized reaction. Itching, swollen area about 2 inches below the injeciton site. Pt is flushed, has fatigue, fever and does not feel well. I instructed her to ice the area, take benadryl and ibuprofen and to monitor area for worsening of symptoms. Also to seek medical attention if airway is compromised.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Fatigue
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NJ
- Alter
- 54,0
- Geschlecht
- M
- Eingang
- 04.02.2022
- Impfdatum
- 31.01.2022
- Beginn
- 02.02.2022
- Tage bis Beginn
- 2,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Injection site bruising
Injection site erythema
Injection site pain
Injection site swelling
Symptomtext
Site: Bruising at Injection Site-Medium, Site: Pain at Injection Site-Medium, Site: Redness at Injection Site-Medium, Site: Swelling at Injection Site-Medium
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site bruising
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 35,0
- Geschlecht
- M
- Eingang
- 04.02.2022
- Impfdatum
- 03.02.2022
- Beginn
- 03.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Pruritus
Symptomtext
Systemic: Allergic: Itch Generalized-Mild, Additional Details: mild itching, benadryl was given and patient was completely fine after 30minutes
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pruritus
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MD
- Alter
- 60,0
- Geschlecht
- F
- Eingang
- 03.02.2022
- Impfdatum
- 02.02.2022
- Beginn
- 02.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Injection site pain
Injection site swelling
Symptomtext
Site: Pain at Injection Site-Mild, Site: Swelling at Injection Site-Mild
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site pain
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- DE
- Alter
- 63,0
- Geschlecht
- M
- Eingang
- 01.02.2022
- Impfdatum
- 04.01.2022
- Beginn
- 16.01.2022
- Tage bis Beginn
- 12,0
- Dosis
- UNK
- Route/Site
- - / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Chills
Diarrhoea
Pyrexia
Symptomtext
Fever, chills, and diarhea...self-treated with Tylenol and plenty of fluids. Effects lasted for 2 days.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Chills
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- None.
- Vorgeschichte
- Refer to medications section in Item #9.
- Andere Medikamente
- Implanted pacemaker (bradycardia), Olmasartan (high blood pressure), Atorvorastatin (high cholesterol), Jardiance (borderline diabetic), Eliquis (blood thinner), Metoprolol (tachacardia).
- Allergien
- Penicillin causes swelling and rash in legs, as of 18 yrs old result of double viral pneumonia - hospitalized for 12 days.
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 31,0
- Geschlecht
- F
- Eingang
- 31.01.2022
- Impfdatum
- 29.01.2022
- Beginn
- 29.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Dizziness
Feeling of body temperature change
Injection site erythema
Injection site pain
Injection site swelling
Injection site warmth
Lymphadenopathy
Pain of skin
Sensitive skin
Sinus headache
Sinus pain
Symptomtext
Raised red skin at injection site measuring 2.75" x 1.57" and increasing slowly. Painful, warm to touch. No itching. Have drawn circle around to validate start of size. Skin sensitivity on arms, legs, back, buttocks (similar to mild sunburn sensation), still ongoing. Scalp sensitivity/tenderness for 24 hours (has stopped). Sinus headache/pain when coughing only or bending over. Swollen lymph nodes in left armpit area, still ongoing. Feelings of hot/cold but no fever ongoing. Dizziness started approx. 25 min. while moving head too quickly or standing too quickly and continued approx. until 36 hours. Treating with Tylenol, ice, vitamins.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dizziness
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- Birth control- JUNEL FE 1 MG-20MCG Tablet
- Allergien
- NKA
- Vorherige Impfungen
- 1st Dose Moderna Covid19 on 07/20/21, age 30, lot# 041C21A. Dizzy within 20 minutes of vaccine lasting 4 hours. Waited 45 minute
- Staat
- CA
- Alter
- 32,0
- Geschlecht
- F
- Eingang
- 30.01.2022
- Impfdatum
- 28.01.2022
- Beginn
- 29.01.2022
- Tage bis Beginn
- 1,0
- Dosis
- UNK
- Route/Site
- - / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Axillary pain
Symptomtext
My right armpit hurts
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Axillary pain
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- No
- Vorherige Impfungen
- -
- Staat
- NY
- Alter
- 59,0
- Geschlecht
- F
- Eingang
- 29.01.2022
- Impfdatum
- 23.01.2022
- Beginn
- 27.01.2022
- Tage bis Beginn
- 4,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Chills
Injection site rash
Pain
Pyrexia
Symptomtext
Systemic: Allergic: Rash (specify: facial area, extremeties)-Mild, Systemic: Body Aches Generalized-Mild, Systemic: Chills-Mild, Systemic: Fever-Mild, Additional Details: patient said she had chills,fever and body ache within first 24-48 hours of receiving vaccine then on 01/27/2022 noticed a 2-4 inch rash on her left arm at vaccine site. she feels fine otherwise.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Chills
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WA
- Alter
- 65,0
- Geschlecht
- F
- Eingang
- 28.01.2022
- Impfdatum
- 26.01.2022
- Beginn
- 26.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Body temperature increased
Chills
Diarrhoea
Headache
Night sweats
Vomiting
Symptomtext
Violent chills for over 6 hours, then a temperature that spiked up to 104, followed by vomiting and diarrhea for 12 hours and then night sweats and a severe headache. Remained in bed for over 30 hours.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Chills
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Fibromyalgia Osteoarthritis
- Andere Medikamente
- Multi vitamin, Diclonifec, Elderberry
- Allergien
- Peniciilin, Tetracyclin, Sulfa, Codeine, Demerol, Trulicity, eggs, gluten, toothpaste and shampoo ingrediants
- Vorherige Impfungen
- Moderna vax 1 and 2. Agec64, same results as dose 3 with exception did not spike fever over 101. All were Moderna.
- Staat
- NY
- Alter
- 61,0
- Geschlecht
- M
- Eingang
- 28.01.2022
- Impfdatum
- 25.01.2022
- Beginn
- 26.01.2022
- Tage bis Beginn
- 1,0
- Dosis
- 3
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Injection site pain
Pyrexia
Symptomtext
Fever. (Also, muscle soreness at site of injection.) [ caused to miss a day of work ]
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site pain
- Hospital-Tage
- -
- Labordaten
- January 27, 2022: 7:5xAM: 100.0 F fever (oral thermometer); January 27, 2022: 7:0xPM: 100.4 F fever (oral thermometer);
- Aktuelle Erkrankungen
- possible covid or 'low level' covid;
- Vorgeschichte
- none (except for hypothyroid)
- Andere Medikamente
- synthroid
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- VA
- Alter
- 25,0
- Geschlecht
- F
- Eingang
- 26.01.2022
- Impfdatum
- 25.01.2022
- Beginn
- 26.01.2022
- Tage bis Beginn
- 1,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Diarrhoea
Pyrexia
Vomiting
Symptomtext
5:30pm 1/25/2022 received vaccination 4:00am 1/26/2022 woke up with fever, took 1000mg acetaminophen 5:30am 1/26/2022 had diarrhea & threw up 6:30am 1/26/2022 drank a few sips of Sprite, ate a few saltine crackers. Fever 100 Fahrenheit 10:00am 1/26/2022 had diarrhea & threw up 10:30am 1/26/2022 took 50mg Dramamine. Ate a few spoons of apple sauce, drank a few sips of ginger ale, drank a few sips of Gatorade. Fever 101 Fahrenheit 12:30pm 1/26/2022 had diarrhea & threw up 2:00pm 1/26/2022 drank a few sips of Gatorade, reported reaction to pharmacy, fever 102 Fahrenheit
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Diarrhoea
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- Sinus infection 12/20/2021 - 1/15/2022. Antibiotics taken 1/6/2022-1/15/2022.
- Vorgeschichte
- Hemophilia A mild Childhood asthma, stopped around age 8
- Andere Medikamente
- Sronyx birth control I also took acetaminophen at 4:00am 1/26/22 and Dramamine at 11:00am 1/26/22
- Allergien
- Penicillin
- Vorherige Impfungen
- -
- Staat
- KS
- Alter
- 31,0
- Geschlecht
- M
- Eingang
- 25.01.2022
- Impfdatum
- 22.01.2022
- Beginn
- 23.01.2022
- Tage bis Beginn
- 1,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Injection site warmth
Peripheral swelling
Rash
Symptomtext
Started to break out in a rash on his wrist, hands feet and a little on his back. At the injection sight it is 102 degrees. Both hands have started to swell.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site warmth
- Hospital-Tage
- -
- Labordaten
- no
- Aktuelle Erkrankungen
- no
- Vorgeschichte
- no
- Andere Medikamente
- no
- Allergien
- penicillin, sulfa drugs and nickel
- Vorherige Impfungen
- -
- Staat
- NY
- Alter
- 70,0
- Geschlecht
- F
- Eingang
- 23.01.2022
- Impfdatum
- 22.01.2022
- Beginn
- 22.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Dizziness
Symptomtext
Systemic: Dizziness / Lightheadness-Mild, Additional Details: Lightheaded. Had patient sit with head down forward. Resolved within 15 minutes.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dizziness
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NY
- Alter
- 65,0
- Geschlecht
- F
- Eingang
- 23.01.2022
- Impfdatum
- 19.01.2022
- Beginn
- 20.01.2022
- Tage bis Beginn
- 1,0
- Dosis
- 3
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Injection site erythema
Injection site pain
Injection site pruritus
Injection site swelling
Vaccination site reaction
Symptomtext
Site: Itching at Injection Site-Medium, Site: Pain at Injection Site-Medium, Site: Redness at Injection Site-Medium, Site: Swelling at Injection Site-Medium, Additional Details: Possible COVID arm
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site erythema
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- IN
- Alter
- 30,0
- Geschlecht
- F
- Eingang
- 16.01.2022
- Impfdatum
- 15.01.2022
- Beginn
- 16.01.2022
- Tage bis Beginn
- 1,0
- Dosis
- 3
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Axillary pain
Injection site pain
Malaise
Oedema peripheral
Pain
Pyrexia
Symptomtext
Fever, body aches, severe pain in the injection site for over 24 hours, axillary pain and swelling and general malaise
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Axillary pain
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- Wellbutrin, Junel birth control, and Allegra
- Allergien
- Azithromycin, codeine, sulfa
- Vorherige Impfungen
- -
- Staat
- NY
- Alter
- 24,0
- Geschlecht
- M
- Eingang
- 25.10.2023
- Impfdatum
- 28.01.2022
- Beginn
- 11.03.2022
- Tage bis Beginn
- 42,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: ja
ER: ja
Erholt: nein
Antiacetylcholine receptor antibody
Antibody test negative
Asthenia
Blood folate normal
CSF cell count normal
CSF protein normal
CSF test normal
Cerebral atrophy
Computerised tomogram head abnormal
Decubitus ulcer
Dysphagia
Electromyogram abnormal
Failure to thrive
Flow cytometry
Gastrostomy
Infected skin ulcer
Magnetic resonance imaging head normal
Magnetic resonance imaging spinal abnormal
Symptomtext
26 y.o. male with spastic quadriplegic cerebral palsy, previously high-functioning and self-sufficient prior to decline in 2022, that 6 weeks after covid vaccination, developed global weakness, dysphagia (to point that required new PEG tube), with secondary weight loss of 100lbs, pressure ulcers complicated by infection, and overall failure to thrive.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Antiacetylcholine receptor antibody
- Hospital-Tage
- -
- Labordaten
- - LP CSF studies (neg): flow cytometry, protein, cell counts, culture, paraneoplastic panel - AChR Abs (neg) - CT head 8/5/22 mild diffuse atrophy - MRI brain w/o 8/6/22 normal - MRI C spine w/o 8/8/22 minor foraminal narrowing C6-C7 - B12, folate, thiamine normal - EMG/NCS 1/31/23: "Overall, these findings support the presence of a severe left ulnar neuropathy at the elbow, and mild chronic neurogenic process affecting C6-8 innervated left arm muscles. no clear evidence of progressive motor neuron disease "
- Aktuelle Erkrankungen
- no
- Vorgeschichte
- Spastic quadriplegia from cerebral palsy
- Andere Medikamente
- Aripiprazole, Baclofen, buspirone, omeprazole, propranolol, scopolamine, sertraline
- Allergien
- morphine
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 50,0
- Geschlecht
- M
- Eingang
- 11.07.2023
- Impfdatum
- 13.04.2022
- Beginn
- 07.07.2023
- Tage bis Beginn
- 450,0
- Dosis
- 4
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
Unevaluable event
Symptomtext
HOSPITALIZATION
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Unevaluable event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 38,0
- Geschlecht
- F
- Eingang
- 10.07.2023
- Impfdatum
- 01.02.2022
- Beginn
- 19.04.2023
- Tage bis Beginn
- 442,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
Obstructive sleep apnoea syndrome
Symptomtext
ADULT OBSTRUCTIVE SLEEP APNEA, MODERATE 4/3/2023 BMI 45-49.9 ADULT
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Obstructive sleep apnoea syndrome
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 98,0
- Geschlecht
- F
- Eingang
- 02.06.2023
- Impfdatum
- 06.02.2022
- Beginn
- 31.10.2022
- Tage bis Beginn
- 267,0
- Dosis
- 3
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
COVID-19
SARS-CoV-2 test positive
Vaccine breakthrough infection
Symptomtext
Breakthrough case admission after 3 vaccines Moderna 6/13/21 lot# 047C21A; Moderna 7/11/21 lot# 053C21A; Moderna 2/16/22 Lot# 042J21A
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- COVID-19
- Hospital-Tage
- -
- Labordaten
- COVID +
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 75,0
- Geschlecht
- F
- Eingang
- 26.05.2023
- Impfdatum
- 08.02.2022
- Beginn
- 21.09.2022
- Tage bis Beginn
- 225,0
- Dosis
- 3
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Myocardial ischaemia
Symptomtext
PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE DEMAND ISCHEMIA
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Myocardial ischaemia
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 54,0
- Geschlecht
- F
- Eingang
- 23.05.2023
- Impfdatum
- 24.01.2022
- Beginn
- 01.12.2022
- Tage bis Beginn
- 311,0
- Dosis
- 2
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Neuropathy peripheral
Symptomtext
PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE PERIPHERAL NEUROPATHY
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Neuropathy peripheral
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 81,0
- Geschlecht
- F
- Eingang
- 09.05.2023
- Impfdatum
- 17.02.2022
- Beginn
- 06.01.2023
- Tage bis Beginn
- 323,0
- Dosis
- 3
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
COVID-19
SARS-CoV-2 test positive
Vaccine breakthrough infection
Symptomtext
Breakthrough case admission after 3 vaccines Moderna 3/18/21 Lot# 002B21A; Moderna 4/15/21 Lot# 025B21A; Moderna 2/17/22 Lot# 042J21A
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- COVID-19
- Hospital-Tage
- -
- Labordaten
- COVID +
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 30,0
- Geschlecht
- M
- Eingang
- 19.04.2023
- Impfdatum
- 11.02.2022
- Beginn
- 29.07.2022
- Tage bis Beginn
- 168,0
- Dosis
- 2
- Route/Site
- - / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Hypersensitivity
Symptomtext
PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE ALLERGIC REACTION, INIT
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Hypersensitivity
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 58,0
- Geschlecht
- M
- Eingang
- 15.03.2023
- Impfdatum
- 13.03.2023
- Beginn
- 13.03.2023
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
No adverse event
Product storage error
Symptomtext
Pfizer-BioNTech Bivalent COVID-19 Vaccine EUA: case resulting in invalid dose given Patient has previously received Moderna Vaccines on 3/4/2021, 4/1/2021, and 1/28/2022. Patient received Pfizer-BioNTech Bivalent vaccine on 3/13/2023 at 08:45AM. Pt inadvertently received vaccine from vial opened on 03/10/2023 since 15:30PM. Error was found while documenting on 3/13/2023. No harm came to patient. Patient has been contacted, is doing well, and will return for revaccination per Pfizer and CDC recommendations.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- DM2, HLD, HTN, Obesity, OSA on CPAP, urinary frequency
- Andere Medikamente
- aspirin, dapagliflozin, fenofibrate, lisinopril, metformin, metoprolol, pravastatin
- Allergien
- NKDA
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 70,0
- Geschlecht
- M
- Eingang
- 28.02.2023
- Impfdatum
- 21.03.2022
- Beginn
- 09.11.2022
- Tage bis Beginn
- 233,0
- Dosis
- 3
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
COVID-19
SARS-CoV-2 test positive
Vaccine breakthrough infection
Symptomtext
Breakthrough case admission after 3 vaccines Moderna 4/13/21 Lot# 025B21A; Moderna 5/27/21 Lot# 033C21A; Modena 3/21/222 Lot# 042J21A
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- COVID-19
- Hospital-Tage
- -
- Labordaten
- COVID +
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MO
- Alter
- 67,0
- Geschlecht
- F
- Eingang
- 22.02.2023
- Impfdatum
- 17.02.2022
- Beginn
- 14.01.2023
- Tage bis Beginn
- 331,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Decreased appetite
Gastrointestinal disorder
Nasal congestion
Parosmia
Respiratory symptom
Taste disorder
Symptomtext
Upper respiratory symptoms nasal congestion bowel problems ill taste for food lack of appetite food smelled like ammonia.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Decreased appetite
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Chronic hip and lower back pain
- Andere Medikamente
- Gabapentin
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 78,0
- Geschlecht
- F
- Eingang
- 08.02.2023
- Impfdatum
- 14.11.2022
- Beginn
- 29.12.2022
- Tage bis Beginn
- 45,0
- Dosis
- 3
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: ja
Acute kidney injury
COVID-19
Encephalopathy
Hypernatraemia
Influenza
Mental status changes
SARS-CoV-2 test positive
Screaming
Sedation
Somnolence
Symptomtext
"Patient with history of COVID vaccines who admitted to hospital with COVID detected PCR. Provider d/c note: ""78-year-old female with dementia who presents with acute encephalopathy, somnolence. Suspect influenza with over-sedation. Wean down psychotropic medications. Her mental status improved although she did have outbreaks of yelling. Tamiflu x5 days. Hypernatremia and AKI resolved with IV fluids and was stable without IV fluids. Recommend outpatient neuropsych testing and psychiatric consultation. I suspect progression of patient's dementia is causing many of her symptoms. Incidentally tested positive for COVID on day of discharge, was negative on admission. Question if false positive as she had no change in her respiratory status."""
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute kidney injury
- Hospital-Tage
- 5,0
- Labordaten
- Covid PCR dectected on 01/03/2023
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Cardiovascular High blood pressure Hyperlipidemia Bilateral pulmonary embolism (HCC) Hypotension Endocrine Type 2 diabetes mellitus with stable proliferative retinopathy of both eyes, without long-term current use of insulin (HCC) Psychological Late onset Alzheimer's dementia with behavioral disturbance (HCC) Respiratory Influenza A Acute respiratory failure with hypoxia (HCC) Urinary AKI (acute kidney injury) (HCC) Other Retinopathy, hypertensive, right eye Obesity (BMI 30.0-34.9) Benign familial tremor Osteoporosis Weakness Chronic midline low back pain without sciatica Hypernatremia Viral sepsis (HCC) Toxic metabolic encephalopathy
- Andere Medikamente
- acetaminophen (TYLENOL) 500 MG tablet Take 1 tablet by mouth every 4 (four) hours as needed for Pain. aluminum-magnesium hydroxide-simethicone (MAALOX) 200-200-20 mg/5 mL suspension Take 30 mLs by mouth every 4 (four) hours as needed for I
- Allergien
- No Know Allergies
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 65,0
- Geschlecht
- M
- Eingang
- 31.01.2023
- Impfdatum
- 23.02.2022
- Beginn
- 23.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
No adverse event; Vaccine administered on 22-Feb-2022 after 30 days BUD date which was 17-Feb-2022; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine administered on 22-Feb-2022 after 30 days BUD date which was 17-Feb-2022) and NO ADVERSE EVENT (No adverse event) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 prophylaxis. No Medical History information was reported. On 23-Feb-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Feb-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine administered on 22-Feb-2022 after 30 days BUD date which was 17-Feb-2022). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine administered on 22-Feb-2022 after 30 days BUD date which was 17-Feb-2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Vaccine administered on 22-Feb-2022 after 30 days BUD date which was 17-Feb-2022). No concomitant product reported by reporter. More or less 170 - monovalent and 20 bivalent doses had been administered which were beyond the 30 day beyond use date. Vaccine administered on 23-Feb-2022 with lot number 042J21A after 30 days BUD date which was 17-Feb-2022. No treatment medication reported by reporter. This case was linked to US-MODERNATX, INC.-MOD-2023-704416 ( Linked Report). Most recent FOLLOW-UP information incorporated above includes: On 24-Jan-2023: Live significant follow-up received. Narrative updated.; Sender's Comments: US-MODERNATX, INC.-MOD-2023-704416:Master case
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 27,0
- Geschlecht
- M
- Eingang
- 31.01.2023
- Impfdatum
- 22.02.2022
- Beginn
- 22.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
No adverse event; Vaccine administered on 22-Feb-2022 after 30 days BUD date which was 17-Feb-2022; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine administered on 22-Feb-2022 after 30 days BUD date which was 17-Feb-2022) and NO ADVERSE EVENT (No adverse event) in a 27-year-old male patient who received mRNA-1273 (Spikevax) (batch no. 042J21A) for COVID-19 prophylaxis. No Medical History information was reported. On 22-Feb-2022, the patient received second dose of mRNA-1273 (Spikevax) (Intramuscular) 1 dosage form. On 22-Feb-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine administered on 22-Feb-2022 after 30 days BUD date which was 17-Feb-2022). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine administered on 22-Feb-2022 after 30 days BUD date which was 17-Feb-2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Spikevax) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Vaccine administered on 22-Feb-2022 after 30 days BUD date which was 17-Feb-2022). No concomitant product reported by reporter. More or less 170 - monovalent and 20 bivalent doses had been administered which were beyond the 30 day beyond use date. Vaccine administered on 22-Feb-2022 with lot number 042J21A after 30 days BUD date which was 17-Feb-2022. No treatment medication reported by reporter. This case was linked to US-MODERNATX, INC.-MOD-2023-704416 (Linked Report). Most recent FOLLOW-UP information incorporated above includes: On 24-Jan-2023: Live significant follow-up received. Patient information added. Product details added. Narrative updated.; Sender's Comments: US-MODERNATX, INC.-MOD-2023-704416:Master case
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 58,0
- Geschlecht
- F
- Eingang
- 31.01.2023
- Impfdatum
- 22.02.2022
- Beginn
- 22.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
No adverse event; Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date) and NO ADVERSE EVENT (No adverse event) in a 58-year-old female patient who received mRNA-1273 (Spikevax) (batch no. 042J21A) for COVID-19 prophylaxis. No Medical History information was reported. On 22-Feb-2022, the patient received second dose of mRNA-1273 (Spikevax) (Intramuscular) 1 dosage form. On 22-Feb-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Spikevax) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date). Concomitant product use was not provided by the reporter. More or less 170 - monovalent and 20 bivalent doses had been administered which were beyond the 30 day beyond use date. Vaccine administered on 23-Feb-2022 with lot number 042J21A after 30 days BUD date which was 17-Feb-2022. Treatment information was not provided. This case was linked to US-MODERNATX, INC.-MOD-2023-704416 (Linked Report). Most recent FOLLOW-UP information incorporated above includes: On 24-Jan-2023: Non significant Follow up Appended; Sender's Comments: US-MODERNATX, INC.-MOD-2023-704416:Master case
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 63,0
- Geschlecht
- M
- Eingang
- 31.01.2023
- Impfdatum
- 22.02.2022
- Beginn
- 22.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
No adverse event; Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date) and NO ADVERSE EVENT (No adverse event) in a 63-year-old male patient who received mRNA-1273 (Spikevax) (batch no. 042J21A) for COVID-19 prophylaxis. No Medical History information was reported. On 22-Feb-2022, the patient received second dose of mRNA-1273 (Spikevax) (Intramuscular) 1 dosage form. On 22-Feb-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Spikevax) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date). Concomitant product use was not provided by the reporter. More or less 170 - monovalent and 20 bivalent doses had been administered which were beyond the 30 day beyond use date. Vaccine administered on 23-Feb-2022 with lot number 042J21A after 30 days BUD date which was 17-Feb-2022. Treatment information was not provided. This case was linked to US-MODERNATX, INC.-MOD-2023-704416 (E2B Linked Report). Most recent FOLLOW-UP information incorporated above includes: On 24-Jan-2023: Live follow up has been appended.; Sender's Comments: US-MODERNATX, INC.-MOD-2023-704416:Master case
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WA
- Alter
- 65,0
- Geschlecht
- M
- Eingang
- 31.01.2023
- Impfdatum
- 22.02.2022
- Beginn
- 22.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
No adverse event; Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date) and NO ADVERSE EVENT (No adverse event) in a 65-year-old male patient who received mRNA-1273 (Spikevax) (batch no. 042J21A) for COVID-19 prophylaxis. No Medical History information was reported. On 22-Feb-2022, the patient received second dose of mRNA-1273 (Spikevax) (Intramuscular) 1 dosage form. On 22-Feb-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Spikevax) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date). Concomitant product use was not provided by the reporter. More or less 170 - monovalent and 20 bivalent doses had been administered which were beyond the 30 day beyond use date. Vaccine administered on 23-Feb-2022 with lot number 042J21A after 30 days BUD date which was 17-Feb-2022. Treatment information was not provided. This case was linked to US-MODERNATX, INC.-MOD-2023-704416 (Linked Report). Most recent FOLLOW-UP information incorporated above includes: On 24-Jan-2023: Live follow up has been appended.; Sender's Comments: US-MODERNATX, INC.-MOD-2023-704416:Master case
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 44,0
- Geschlecht
- M
- Eingang
- 31.01.2023
- Impfdatum
- 22.02.2022
- Beginn
- 22.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
No adverse event; Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date) and NO ADVERSE EVENT (No adverse event) in a 44-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 prophylaxis. No Medical History information was reported. On 22-Feb-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Feb-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date). Concomitant product use was not provided by the reporter. More or less 170 - monovalent and 20 bivalent doses had been administered which were beyond the 30 day beyond use date. Vaccine administered on 23-Feb-2022 with lot number 042J21A after 30 days BUD date which was 17-Feb-2022 Treatment information was not provided. This case was linked to US-MODERNATX, INC.-MOD-2023-704416 (Linked Report).; Sender's Comments: US-MODERNATX, INC.-MOD-2023-704416:Master case
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 25,0
- Geschlecht
- F
- Eingang
- 31.01.2023
- Impfdatum
- 18.02.2022
- Beginn
- 18.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
No adverse event; Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date) and NO ADVERSE EVENT (No adverse event) in a 25-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 prophylaxis. No Medical History information was reported. On 18-Feb-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Feb-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date). Concomitant Medication use information was not provided by reporter. Pharmacist reports that the more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 monovalent and 20 bivalent) which were beyond the 30 day beyond use date. Patient received vaccine at Pharmacy. The lot 042J21A beyond use date of the vaccine was reported as 17 February 2022. NDC number was reported. Treatment Medication use information was not provided by reporter. This case was linked to US-MODERNATX, INC.-MOD-2023-704416 (E2B Linked Report). Most recent FOLLOW-UP information incorporated above includes: On 24-Jan-2023: Follow up received that contains significant information includes updated patient details, suspect product details and updated narrative.; Sender's Comments: US-MODERNATX, INC.-MOD-2023-704416:Master case
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 62,0
- Geschlecht
- M
- Eingang
- 31.01.2023
- Impfdatum
- 18.02.2022
- Beginn
- 18.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Product storage error
Symptomtext
Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date; No adverse event; Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date), PRODUCT STORAGE ERROR (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date) and NO ADVERSE EVENT (No adverse event) in a 62-year-old male patient who received mRNA-1273 (Spikevax) (batch no. 042J21A) for COVID-19 prophylaxis. No Medical History information was reported. On 18-Feb-2022, the patient received second dose of mRNA-1273 (Spikevax) (Intramuscular) 1 dosage form. On 18-Feb-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date), PRODUCT STORAGE ERROR (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Spikevax) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date) and PRODUCT STORAGE ERROR (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date). Concomitant products were not provided. Treatment medication were not reported. It was reported that there was a mistake given during phone call regarding lot 012H21B. That lot was not affected, but lot 042J21A should have been reported with a BUD of Feb 17, 2022. This case was linked to US-MODERNATX, INC.-MOD-2023-704416 (Linked Report). Most recent FOLLOW-UP information incorporated above includes: On 24-Jan-2023: Follow-up contains no new information.; Sender's Comments: US-MODERNATX, INC.-MOD-2023-704416:Master case
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 59,0
- Geschlecht
- F
- Eingang
- 31.01.2023
- Impfdatum
- 18.02.2022
- Beginn
- 18.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Product storage error
Symptomtext
Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date; No adverse event; Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date), PRODUCT STORAGE ERROR (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date) and NO ADVERSE EVENT (No adverse event) in a 59-year-old female patient who received mRNA-1273 (Spikevax) (batch no. 042J21A) for COVID-19 prophylaxis. No Medical History information was reported. On 18-Feb-2022, the patient received second dose of mRNA-1273 (Spikevax) (Intramuscular) 1 dosage form. On 18-Feb-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date), PRODUCT STORAGE ERROR (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Spikevax) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date) and PRODUCT STORAGE ERROR (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date). Concomitant products were not provided. Treatment medication were not reported. It was reported that there was a mistake given during phone call regarding lot 012H21B. That lot was not affected, but lot 042J21A should have been reported with a BUD of Feb 17, 2022. This case was linked to US-MODERNATX, INC.-MOD-2023-704416 (E2B Linked Report). Most recent FOLLOW-UP information incorporated above includes: On 24-Jan-2023: Follow-up contains no new information.; Sender's Comments: US-MODERNATX, INC.-MOD-2023-704416:Master case
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 40,0
- Geschlecht
- M
- Eingang
- 31.01.2023
- Impfdatum
- 10.03.2022
- Beginn
- 10.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
No adverse event; Expired vaccine used; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) and NO ADVERSE EVENT (No adverse event) in a 40-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 prophylaxis. No Medical History information was reported. On 10-Mar-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). No concomitant medication information provided. Patient age was 40 years 2 months. Pharmacist reported that they have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30 day beyond use date. Before use date reported was 17-Feb-2022. No treatment information provided. This case was linked to US-MODERNATX, INC.-MOD-2023-704416 (E2B Linked Report). Most recent FOLLOW-UP information incorporated above includes: On 24-Jan-2023: Live Significant follow up received: Patient information and vaccination details updated.; Sender's Comments: US-MODERNATX, INC.-MOD-2023-704416:Master case
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 22,0
- Geschlecht
- M
- Eingang
- 31.01.2023
- Impfdatum
- 08.03.2022
- Beginn
- 08.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patients had been administered with the Moderna vaccine which were beyond the 30 day beyond use date) and NO ADVERSE EVENT (No adverse event) in a 22-year-old male patient who received mRNA-1273 (Spikevax) (batch no. 042J21A) for COVID-19 prophylaxis. No Medical History information was reported. On 08-Mar-2022, the patient received second dose of mRNA-1273 (Spikevax) (Intramuscular) 1 dosage form. On 08-Mar-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patients had been administered with the Moderna vaccine which were beyond the 30 day beyond use date). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patients had been administered with the Moderna vaccine which were beyond the 30 day beyond use date) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Spikevax) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Patients had been administered with the Moderna vaccine which were beyond the 30 day beyond use date). No concomitant medication was reported. Patient received vaccine from lot 042J21A with a BUD of 17-Feb-2022. The time for expiry date was reported as 12 am. No treatment medication was reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 54,0
- Geschlecht
- M
- Eingang
- 31.01.2023
- Impfdatum
- 08.03.2022
- Beginn
- 08.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
No adverse event; Patients had been administered with the Moderna vaccine which were beyond the 30 day beyond use date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patients had been administered with the Moderna vaccine which were beyond the 30 day beyond use date) and NO ADVERSE EVENT (No adverse event) in a 54-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 prophylaxis. No Medical History information was reported. On 08-Mar-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Mar-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patients had been administered with the Moderna vaccine which were beyond the 30 day beyond use date). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patients had been administered with the Moderna vaccine which were beyond the 30 day beyond use date) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Patients had been administered with the Moderna vaccine which were beyond the 30 day beyond use date). No concomitant medication was reported. Patient received vaccine from lot 042J21A with a BUD of 17-Feb-2022. The time for expiry date was reported as 12 am. No treatment medication was reported. This case was linked to US-MODERNATX, INC.-MOD-2023-704416 (Linked Report). Most recent FOLLOW-UP information incorporated above includes: On 24-Jan-2023: Live follow Up contains updated narrative.; Sender's Comments: US-MODERNATX, INC.-MOD-2023-704416:Master case
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 36,0
- Geschlecht
- M
- Eingang
- 31.01.2023
- Impfdatum
- 09.03.2022
- Beginn
- 09.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
No adverse event; Patient had been administered with the Moderna vaccine which were beyond the 30day beyond use date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient had been administered with the Moderna vaccine which were beyond the 30day beyond use date) and NO ADVERSE EVENT (No adverse event) in a 36-year-old male patient who received mRNA-1273 (Spikevax) (batch no. 042J21A) for COVID-19 prophylaxis. No Medical History information was reported. On 09-Mar-2022, the patient received second dose of mRNA-1273 (Spikevax) (Intramuscular) 1 dosage form. On 09-Mar-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient had been administered with the Moderna vaccine which were beyond the 30day beyond use date). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient had been administered with the Moderna vaccine which were beyond the 30day beyond use date) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Spikevax) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Patient had been administered with the Moderna vaccine which were beyond the 30day beyond use date). No concomitant medication was reported. No treatment medication was reported. This case was linked to US-MODERNATX, INC.-MOD-2023-704416 (E2B Linked Report). Most recent FOLLOW-UP information incorporated above includes: On 24-Jan-2023: Non significant Live Follow up; Sender's Comments: US-MODERNATX, INC.-MOD-2023-704416:Master case
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- AZ
- Alter
- 61,0
- Geschlecht
- M
- Eingang
- 31.01.2023
- Impfdatum
- 04.03.2022
- Beginn
- 04.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
No adverse event; Patients had been administered with the Moderna vaccine which were beyond the 30 day beyond use date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patients had been administered with the Moderna vaccine which were beyond the 30 day beyond use date) and NO ADVERSE EVENT (No adverse event) in a 61-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 prophylaxis. No Medical History information was reported. On 04-Mar-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patients had been administered with the Moderna vaccine which were beyond the 30 day beyond use date). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patients had been administered with the Moderna vaccine which were beyond the 30 day beyond use date) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Patients had been administered with the Moderna vaccine which were beyond the 30 day beyond use date). No concomitant medication was reported. Patient received vaccine from lot 042J21A with a BUD of 17-Feb-2022. The time for expiry date was reported as 12 am. No treatment medication was reported. This case was linked to US-MODERNATX, INC.-MOD-2023-704416 (Linked Report). Most recent FOLLOW-UP information incorporated above includes: On 24-Jan-2023: Live followup received contains updated narrative.; Sender's Comments: US-MODERNATX, INC.-MOD-2023-704416:Master case
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 32,0
- Geschlecht
- M
- Eingang
- 31.01.2023
- Impfdatum
- 09.03.2022
- Beginn
- 09.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
no adverse event; vaccine used which were beyond the 30-Day beyond use date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (vaccine used which were beyond the 30-Day beyond use date) and NO ADVERSE EVENT (no adverse event) in a 32-year-old male patient who received mRNA-1273 (Spikevax) (batch no. 042J21A) for COVID-19 prophylaxis. No Medical History information was reported. On 09-Mar-2022, the patient received second dose of mRNA-1273 (Spikevax) (Intramuscular) 1 dosage form. On 09-Mar-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (vaccine used which were beyond the 30-Day beyond use date). On an unknown date, the patient experienced NO ADVERSE EVENT (no adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (vaccine used which were beyond the 30-Day beyond use date) and NO ADVERSE EVENT (no adverse event) outcome was unknown. For mRNA-1273 (Spikevax) (Intramuscular), the reporter considered NO ADVERSE EVENT (no adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (vaccine used which were beyond the 30-Day beyond use date). Concomitant products were not reported. It was reported that patient received monovalent dose that was administered beyond 30 day beyond use date. The use by date of lot 042J21A was reported as 17-Feb-2022. Treatment medications were not reported. This case was linked to US-MODERNATX, INC.-MOD-2023-704416 (Linked Report). Most recent FOLLOW-UP information incorporated above includes: On 24-Jan-2023: Significant Live Follow up received narrative updated.; Sender's Comments: US-MODERNATX, INC.-MOD-2023-704416:Master case
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- -
- Geschlecht
- M
- Eingang
- 31.01.2023
- Impfdatum
- 09.03.2022
- Beginn
- 09.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
no adverse event; vaccine used which were beyond the 30-Day beyond use date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (vaccine used which were beyond the 30-Day beyond use date) and NO ADVERSE EVENT (no adverse event) in a 46-year-old male patient who received mRNA-1273 (Spikevax) (batch no. 042J21A) for COVID-19 prophylaxis. No Medical History information was reported. On 09-Mar-2022, the patient received second dose of mRNA-1273 (Spikevax) (Intramuscular) 1 dosage form. On 09-Mar-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (vaccine used which were beyond the 30-Day beyond use date). On an unknown date, the patient experienced NO ADVERSE EVENT (no adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (vaccine used which were beyond the 30-Day beyond use date) and NO ADVERSE EVENT (no adverse event) outcome was unknown. For mRNA-1273 (Spikevax) (Intramuscular), the reporter considered NO ADVERSE EVENT (no adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (vaccine used which were beyond the 30-Day beyond use date). Concomitant products were not reported. It was reported that patient received monovalent dose that was administered beyond 30 day beyond use date. The use by date of lot 042J21A was reported as 17-Feb-2022. Treatment medications were not reported. This case was linked to US-MODERNATX, INC.-MOD-2023-704416 (E2B Linked Report). Most recent FOLLOW-UP information incorporated above includes: On 24-Jan-2023: Significant Live Follow up received narrative updated.; Sender's Comments: US-MODERNATX, INC.-MOD-2023-704416:Master case
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 53,0
- Geschlecht
- M
- Eingang
- 31.01.2023
- Impfdatum
- 04.03.2022
- Beginn
- 04.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
No adverse event; Expired vaccine used; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) and NO ADVERSE EVENT (No adverse event) in a 53-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 prophylaxis. No Medical History information was reported. On 04-Mar-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). No concomitant medication information was provided. Patient age was 53 years 4 months. Beyond use date was reported as 17-Feb-2022. Pharmacist reported that they have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30 days beyond use date. No treatment medications were provided. This case was linked to US-MODERNATX, INC.-MOD-2023-704416 (Linked Report). Most recent FOLLOW-UP information incorporated above includes: On 24-Jan-2023: Live Significant follow up received: Patient information and vaccination details updated.; Sender's Comments: US-MODERNATX, INC.-MOD-2023-704416:Master case
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 43,0
- Geschlecht
- M
- Eingang
- 31.01.2023
- Impfdatum
- 09.03.2022
- Beginn
- 09.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
no adverse event; vaccine used which were beyond the 30-Day beyond use date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (vaccine used which were beyond the 30-Day beyond use date) and NO ADVERSE EVENT (no adverse event) in a 43-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 prophylaxis. No Medical History information was reported. On 09-Mar-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (vaccine used which were beyond the 30-Day beyond use date). On an unknown date, the patient experienced NO ADVERSE EVENT (no adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (vaccine used which were beyond the 30-Day beyond use date) and NO ADVERSE EVENT (no adverse event) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered NO ADVERSE EVENT (no adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (vaccine used which were beyond the 30-Day beyond use date). Concomitant products were not reported. It was reported that patient received monovalent dose that was administered beyond 30 day beyond use date. The use by date of lot 042J21A was reported as 17-Feb-2022. Treatment medications were not reported. This case was linked to US-MODERNATX, INC.-MOD-2023-704416 (Linked Report). Most recent FOLLOW-UP information incorporated above includes: On 24-Jan-2023: Significant Live Follow up received narrative updated.; Sender's Comments: US-MODERNATX, INC.-MOD-2023-704416:Master case
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 56,0
- Geschlecht
- F
- Eingang
- 31.01.2023
- Impfdatum
- 04.03.2022
- Beginn
- 04.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
No adverse event; Expired vaccine used; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) and NO ADVERSE EVENT (No adverse event) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 prophylaxis. No Medical History information was reported. On 04-Mar-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). No concomitant medication information was provided. Beyond use date was reported as 17-Feb-2022. Pharmacist reported that they have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30 days beyond use date. No treatment medications were provided. This case was linked to US-MODERNATX, INC.-MOD-2023-704416 (Linked Report). Most recent FOLLOW-UP information incorporated above includes: On 24-Jan-2023: Live Non Significant follow Up; Sender's Comments: US-MODERNATX, INC.-MOD-2023-704416:Master case
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 23,0
- Geschlecht
- F
- Eingang
- 31.01.2023
- Impfdatum
- 04.03.2022
- Beginn
- 04.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
No adverse event; Expired vaccine used; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) and NO ADVERSE EVENT (No adverse event) in a 23-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 prophylaxis. No Medical History information was reported. On 04-Mar-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). No concomitant medication information was provided. Beyond use date was reported as 17-Feb-2022. Pharmacist reported that they have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30 days beyond use date. No treatment medications were provided. This case was linked to US-MODERNATX, INC.-MOD-2023-704416 (Linked Report). Most recent FOLLOW-UP information incorporated above includes: On 24-Jan-2023: Live Significant follow up received: Patient information and vaccination details updated.; Sender's Comments: US-MODERNATX, INC.-MOD-2023-704416:Master case
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- AZ
- Alter
- 44,0
- Geschlecht
- M
- Eingang
- 31.01.2023
- Impfdatum
- 09.03.2022
- Beginn
- 09.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
no adverse event; vaccine used which were beyond the 30-Day beyond use date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (vaccine used which were beyond the 30-Day beyond use date) and NO ADVERSE EVENT (no adverse event) in a 44-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 prophylaxis. No Medical History information was reported. On 09-Mar-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (vaccine used which were beyond the 30-Day beyond use date). On an unknown date, the patient experienced NO ADVERSE EVENT (no adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (vaccine used which were beyond the 30-Day beyond use date) and NO ADVERSE EVENT (no adverse event) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered NO ADVERSE EVENT (no adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (vaccine used which were beyond the 30-Day beyond use date). Concomitant products were not reported. It was reported that patient received monovalent dose that was administered beyond 30 day beyond use date. The use by date of lot 042J21A was reported as 17-Feb-2022. Treatment medications were not reported. This case was linked to US-MODERNATX, INC.-MOD-2023-704416 (E2B Linked Report). Most recent FOLLOW-UP information incorporated above includes: On 24-Jan-2023: Significant Live Follow up received narrative updated.; Sender's Comments: US-MODERNATX, INC.-MOD-2023-704416:Master case
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 52,0
- Geschlecht
- F
- Eingang
- 31.01.2023
- Impfdatum
- 09.03.2022
- Beginn
- 09.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
no adverse event; vaccine used which were beyond the 30-Day beyond use date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (vaccine used which were beyond the 30-Day beyond use date) and NO ADVERSE EVENT (no adverse event) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 prophylaxis. No Medical History information was reported. On 09-Mar-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (vaccine used which were beyond the 30-Day beyond use date). On an unknown date, the patient experienced NO ADVERSE EVENT (no adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (vaccine used which were beyond the 30-Day beyond use date) and NO ADVERSE EVENT (no adverse event) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered NO ADVERSE EVENT (no adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (vaccine used which were beyond the 30-Day beyond use date). Concomitant products were not reported. It was reported that patient received monovalent dose that was administered beyond 30 day beyond use date. The use by date of lot 042J21A was reported as 17-Feb-2022. Treatment medications were not reported. This case was linked to US-MODERNATX, INC.-MOD-2023-704416 (E2B Linked Report). Most recent FOLLOW-UP information incorporated above includes: On 24-Jan-2023: Significant Live Follow up received use by date of the vaccine was added.; Sender's Comments: US-MODERNATX, INC.-MOD-2023-704416:Master case
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 56,0
- Geschlecht
- F
- Eingang
- 31.01.2023
- Impfdatum
- 18.02.2022
- Beginn
- 18.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
No adverse event; BUD was reported as 18-Feb-2022 and vaccine was administered on 23-Dec-2021; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (BUD was reported as 18-Feb-2022 and vaccine was administered on 23-Dec-2021) and NO ADVERSE EVENT (No adverse event) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 prophylaxis. No Medical History information was reported. On 18-Feb-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Feb-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (BUD was reported as 18-Feb-2022 and vaccine was administered on 23-Dec-2021). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (BUD was reported as 18-Feb-2022 and vaccine was administered on 23-Dec-2021) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (BUD was reported as 18-Feb-2022 and vaccine was administered on 23-Dec-2021). Concomitant product use was not provided by the reporter. Treatment information was not provided. This case was linked to US-MODERNATX, INC.-MOD-2023-704416 (E2B Linked Report). Most recent FOLLOW-UP information incorporated above includes: On 24-Jan-2023: Follow-up received contains additional no new information was received.; Sender's Comments: US-MODERNATX, INC.-MOD-2023-704416:master case
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 47,0
- Geschlecht
- F
- Eingang
- 31.01.2023
- Impfdatum
- 09.03.2022
- Beginn
- 09.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
No adverse event; BUD was reported as 23-Dec-2021 and vaccine was administered on 09-Mar-2022; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (BUD was reported as 23-Dec-2021 and vaccine was administered on 09-Mar-2022) and NO ADVERSE EVENT (No adverse event) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 prophylaxis. No Medical History information was reported. On 09-Mar-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (BUD was reported as 23-Dec-2021 and vaccine was administered on 09-Mar-2022). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (BUD was reported as 23-Dec-2021 and vaccine was administered on 09-Mar-2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (BUD was reported as 23-Dec-2021 and vaccine was administered on 09-Mar-2022). Concomitant product use was not provided by the reporter. Treatment information was not provided. This case was linked to US-MODERNATX, INC.-MOD-2023-704416 (E2B Linked Report). Most recent FOLLOW-UP information incorporated above includes: On 24-Jan-2023: Follow-up received contains additional no new information was received.; Sender's Comments: US-MODERNATX, INC.-MOD-2023-704416:Master case
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 54,0
- Geschlecht
- F
- Eingang
- 31.01.2023
- Impfdatum
- 09.03.2022
- Beginn
- 09.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (BUD was reported as 23-Dec-2021 and vaccine was administered on 09-Mar-2022) and NO ADVERSE EVENT (No adverse event) in a 54-year-old female patient who received mRNA-1273 (Spikevax) (batch no. 042J21A) for COVID-19 prophylaxis. No Medical History information was reported. On 09-Mar-2022, the patient received dose of mRNA-1273 (Spikevax) (Intramuscular) 1 dosage form. On 09-Mar-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (BUD was reported as 23-Dec-2021 and vaccine was administered on 09-Mar-2022). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (BUD was reported as 23-Dec-2021 and vaccine was administered on 09-Mar-2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Spikevax) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (BUD was reported as 23-Dec-2021 and vaccine was administered on 09-Mar-2022). Concomitant product use was not provided by the reporter. Treatment information was not provided.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 56,0
- Geschlecht
- F
- Eingang
- 31.01.2023
- Impfdatum
- 28.02.2022
- Beginn
- 28.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
No adverse event; Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date) and NO ADVERSE EVENT (No adverse event) in a 56-year-old female patient who received mRNA-1273 (Spikevax) (batch no. 042J21A) for COVID-19 prophylaxis. No Medical History information was reported. On 28-Feb-2022, the patient received second dose of mRNA-1273 (Spikevax) (Intramuscular) 1 dosage form. On 28-Feb-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Spikevax) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date). No concomitant information was reported. BUD reported as 17Feb2022. No treatment information was reported. This case was linked to US-MODERNATX, INC.-MOD-2023-704416 (Linked Report). Most recent FOLLOW-UP information incorporated above includes: On 24-Jan-2023: Live non-significant follow-up; Sender's Comments: US-MODERNATX, INC.-MOD-2023-704416:Master case
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 71,0
- Geschlecht
- M
- Eingang
- 31.01.2023
- Impfdatum
- 28.02.2022
- Beginn
- 28.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
No adverse event; Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date) and NO ADVERSE EVENT (No adverse event) in a 71-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 prophylaxis. No Medical History information was reported. On 28-Feb-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Feb-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date). No concomitant information was reported. BUD reported as 17Feb2022. No treatment information was reported. Most recent FOLLOW-UP information incorporated above includes: On 24-Jan-2023: Live non significant FU
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- AZ
- Alter
- 73,0
- Geschlecht
- M
- Eingang
- 31.01.2023
- Impfdatum
- 09.03.2022
- Beginn
- 09.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
No adverse event; Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date) and NO ADVERSE EVENT (No adverse event) in a 73-year-old male patient who received mRNA-1273 (Spikevax) (batch no. 042J21A) for COVID-19 prophylaxis. No Medical History information was reported. On 09-Mar-2022, the patient received second dose of mRNA-1273 (Spikevax) (Intramuscular) 1 dosage form. On 09-Mar-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Spikevax) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date). No concomitant information was reported. BUD reported as 17Feb2022. No treatment information was reported. This case was linked to US-MODERNATX, INC.-MOD-2023-704416 (Linked Report). Most recent FOLLOW-UP information incorporated above includes: On 24-Jan-2023: Non significant Live Follow up; Sender's Comments: US-MODERNATX, INC.-MOD-2023-704416:Master case
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 22,0
- Geschlecht
- M
- Eingang
- 31.01.2023
- Impfdatum
- 04.03.2022
- Beginn
- 04.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
No adverse event; Expired vaccine used; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) and NO ADVERSE EVENT (No adverse event) in a 22-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 prophylaxis. No Medical History information was reported. On 04-Mar-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). No concomitant medication information was provided. Patient age was 22 years and 6 months. Beyond use date was reported as 17-Feb-2022. Pharmacist reported that they have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30 days beyond use date. No treatment medications were provided. This case was linked to US-MODERNATX, INC.-MOD-2023-704416 (Linked Report). Most recent FOLLOW-UP information incorporated above includes: On 24-Jan-2023: Live Significant follow up received: Patient information and vaccination details updated.; Sender's Comments: US-MODERNATX, INC.-MOD-2023-704416:Master case
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 58,0
- Geschlecht
- M
- Eingang
- 31.01.2023
- Impfdatum
- 04.03.2022
- Beginn
- 04.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
no ad; Expired vaccine used; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) and NO ADVERSE EVENT (no ad) in a 58-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 prophylaxis. No Medical History information was reported. On 04-Mar-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On an unknown date, the patient experienced NO ADVERSE EVENT (no ad). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) and NO ADVERSE EVENT (no ad) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered NO ADVERSE EVENT (no ad) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). No concomitant medications were reported. Patient received Moderna vaccine beyond the 30 days beyond use date. Beyond use date for lot was 17-Feb-2022 and patient received vaccine on 04-Mar-2022. No treatment medications were reported. This case was linked to US-MODERNATX, INC.-MOD-2023-704416 (Linked Report). Most recent FOLLOW-UP information incorporated above includes: On 24-Jan-2023: Live Non Significant follow Up received.; Sender's Comments: US-MODERNATX, INC.-MOD-2023-704416:Master case
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 37,0
- Geschlecht
- M
- Eingang
- 31.01.2023
- Impfdatum
- 04.03.2022
- Beginn
- 04.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) and NO ADVERSE EVENT (no adverse event) in a 37-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 prophylaxis. No Medical History information was reported. On 04-Mar-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On an unknown date, the patient experienced NO ADVERSE EVENT (no adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) and NO ADVERSE EVENT (no adverse event) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered NO ADVERSE EVENT (no adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). No concomitant medications were reported. Patient received Moderna vaccine beyond the 30 day beyond use date. Beyond use date for lot was 17-Feb-2022 and patient received vaccine on 04-Mar-2022.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- OR
- Alter
- -
- Geschlecht
- M
- Eingang
- 31.01.2023
- Impfdatum
- 04.03.2022
- Beginn
- 04.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
no ad; Expired vaccine used; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) and NO ADVERSE EVENT (no ad) in an 83-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 prophylaxis. No Medical History information was reported. On 04-Mar-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On an unknown date, the patient experienced NO ADVERSE EVENT (no ad). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) and NO ADVERSE EVENT (no ad) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered NO ADVERSE EVENT (no ad) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). No concomitant medications were reported. Patient received Moderna vaccine beyond the 30 day beyond use date. Beyond use date for lot was 17-Feb-2022 and patient received vaccine on 04-Apr-2022. No treatment medications were reported. This case was linked to US-MODERNATX, INC.-MOD-2023-704416 (E2B Linked Report). Most recent FOLLOW-UP information incorporated above includes: On 24-Jan-2023: Live Non Significant follow Up received.; Sender's Comments: US-MODERNATX, INC.-MOD-2023-704416:Master case
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- OR
- Alter
- -
- Geschlecht
- F
- Eingang
- 31.01.2023
- Impfdatum
- 04.03.2022
- Beginn
- 04.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
no adverse event; Expired vaccine used; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) and NO ADVERSE EVENT (no adverse event) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 prophylaxis. No Medical History information was reported. On 04-Mar-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On an unknown date, the patient experienced NO ADVERSE EVENT (no adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) and NO ADVERSE EVENT (no adverse event) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered NO ADVERSE EVENT (no adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). No concomitant medications were reported. Patient received Moderna vaccine beyond the 30 day beyond use date. Beyond use date for lot was 17-Feb-2022 and patient received vaccine on 04-Mar-2022. No treatment medications were reported. This case was linked to US-MODERNATX, INC.-MOD-2023-704416 (Linked Report). Most recent FOLLOW-UP information incorporated above includes: On 24-Jan-2023: Live Non Significant follow Up; Sender's Comments: US-MODERNATX, INC.-MOD-2023-704416:Master case
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 39,0
- Geschlecht
- F
- Eingang
- 31.01.2023
- Impfdatum
- 03.03.2022
- Beginn
- 03.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
no ad; Expired vaccine used; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) and NO ADVERSE EVENT (no ad) in a 39-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 prophylaxis. No Medical History information was reported. On 03-Mar-2022, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On an unknown date, the patient experienced NO ADVERSE EVENT (no ad). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) and NO ADVERSE EVENT (no ad) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered NO ADVERSE EVENT (no ad) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). No concomitant medications were reported. Patient received Moderna vaccine beyond the 30 day beyond use date. Beyond use date for lot was 17-Feb-2022 and patient received vaccine on 03-Mar-2022. No treatment medications were reported. This case was linked to US-MODERNATX, INC.-MOD-2023-704416 (Linked Report). Most recent FOLLOW-UP information incorporated above includes: On 24-Jan-2023: Non Significant follow Up received; Sender's Comments: US-MODERNATX, INC.-MOD-2023-704416:Master case
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 51,0
- Geschlecht
- F
- Eingang
- 31.01.2023
- Impfdatum
- 03.03.2022
- Beginn
- 03.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
No adverse event; Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date) and NO ADVERSE EVENT (No adverse event) in a 51-year-old female patient who received mRNA-1273 (Spikevax) (batch no. 042J21A) for COVID-19 prophylaxis. No Medical History information was reported. On 03-Mar-2022, the patient received first dose of mRNA-1273 (Spikevax) (Intramuscular) 1 dosage form. On 03-Mar-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Spikevax) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date). Patient received the vaccine at a Pharmacy. No concomitant medication reported. No treatment medication reported. This case was linked to US-MODERNATX, INC.-MOD-2023-704416 (Linked Report). Most recent FOLLOW-UP information incorporated above includes: On 24-Jan-2023: Follow-up document received on 24-Jan-2023 no new significant information.; Sender's Comments: US-MODERNATX, INC.-MOD-2023-704416:Master case
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 65,0
- Geschlecht
- M
- Eingang
- 31.01.2023
- Impfdatum
- 03.03.2022
- Beginn
- 03.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
No adverse event; Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date) and NO ADVERSE EVENT (No adverse event) in a 65-year-old male patient who received mRNA-1273 (Spikevax) (batch no. 042J21A) for COVID-19 prophylaxis. No Medical History information was reported. On 03-Mar-2022, the patient received second dose of mRNA-1273 (Spikevax) (Intramuscular) 1 dosage form. On 03-Mar-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Spikevax) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date). No concomitant medication was reported. No treatment medication was reported. Patients had been administered with the Moderna vaccine which were beyond the 30 day beyond use date. Patient received dose from lot 042J21A with a BUD of 17-Feb-2022. This case was linked to US-MODERNATX, INC.-MOD-2023-704416 (Linked Report). Most recent FOLLOW-UP information incorporated above includes: On 24-Jan-2023: Live follow-up received: Narrative was updated.; Sender's Comments: US-MODERNATX, INC.-MOD-2023-704416:Master case
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 55,0
- Geschlecht
- M
- Eingang
- 31.01.2023
- Impfdatum
- 25.02.2022
- Beginn
- 25.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
No adverse event; Patients had been administered with the Moderna vaccine which were beyond the 30 day beyond use date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patients had been administered with the Moderna vaccine which were beyond the 30 day beyond use date) and NO ADVERSE EVENT (No adverse event) in a 55-year-old male patient who received mRNA-1273 (Spikevax) (batch no. 042J21A) for COVID-19 prophylaxis. No Medical History information was reported. On 25-Feb-2022, the patient received second dose of mRNA-1273 (Spikevax) (Intramuscular) 1 dosage form. On 25-Feb-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patients had been administered with the Moderna vaccine which were beyond the 30 day beyond use date). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patients had been administered with the Moderna vaccine which were beyond the 30 day beyond use date) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Spikevax) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Patients had been administered with the Moderna vaccine which were beyond the 30 day beyond use date). No concomitant medication was reported. No treatment medication was reported. Patient was administered with Moderna vaccine which were beyond the 30 day beyond use date. Patient received vaccine from lot 042J21A with a BUD of 17-Feb-2022. This case was linked to US-MODERNATX, INC.-MOD-2023-704416 (Linked Report). Most recent FOLLOW-UP information incorporated above includes: On 24-Jan-2023: Live follow-up received: Narrative was updated.; Sender's Comments: US-MODERNATX, INC.-MOD-2023-704416:Master case
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 65,0
- Geschlecht
- F
- Eingang
- 31.01.2023
- Impfdatum
- 25.02.2022
- Beginn
- 25.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
No adverse event; Patients had been administered with the Moderna vaccine which were beyond the 30 day beyond use date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patients had been administered with the Moderna vaccine which were beyond the 30 day beyond use date) and NO ADVERSE EVENT (No adverse event) in a 65-year-old female patient who received mRNA-1273 (Spikevax) (batch no. 042J21A) for COVID-19 prophylaxis. No Medical History information was reported. On 25-Feb-2022, the patient received second dose of mRNA-1273 (Spikevax) (Intramuscular) 1 dosage form. On 25-Feb-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patients had been administered with the Moderna vaccine which were beyond the 30 day beyond use date). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patients had been administered with the Moderna vaccine which were beyond the 30 day beyond use date) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Spikevax) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Patients had been administered with the Moderna vaccine which were beyond the 30 day beyond use date). No concomitant medication was reported. No treatment medication was reported. Patient was administered with Moderna vaccine which were beyond the 30 day beyond use date. Patient received vaccine from lot 042J21A with a BUD of 17-Feb-2022. This case was linked to US-MODERNATX, INC.-MOD-2023-704416 (Linked Report). Most recent FOLLOW-UP information incorporated above includes: On 24-Jan-2023: Live follow-up received: Narrative was updated.; Sender's Comments: US-MODERNATX, INC.-MOD-2023-704416:Master case
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 63,0
- Geschlecht
- M
- Eingang
- 31.01.2023
- Impfdatum
- 02.03.2022
- Beginn
- 02.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient had been administered with the Moderna vaccine which were beyond the 30day beyond use date) and NO ADVERSE EVENT (No adverse event) in a 63-year-old male patient who received mRNA-1273 (Spikevax) (batch no. 042J21A) for COVID-19 prophylaxis. No Medical History information was reported. On 02-Mar-2022, the patient received third dose of mRNA-1273 (Spikevax) (Intramuscular) 1 dosage form. On 02-Mar-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient had been administered with the Moderna vaccine which were beyond the 30day beyond use date). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient had been administered with the Moderna vaccine which were beyond the 30day beyond use date) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Spikevax) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Patient had been administered with the Moderna vaccine which were beyond the 30day beyond use date). No concomitant medication was reported. No treatment medication was reported. Most recent FOLLOW-UP information incorporated above includes:
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 38,0
- Geschlecht
- M
- Eingang
- 31.01.2023
- Impfdatum
- 25.02.2022
- Beginn
- 25.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
No adverse event; Patient had been administered with the Moderna vaccine which were beyond the 30day beyond use date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient had been administered with the Moderna vaccine which were beyond the 30day beyond use date) and NO ADVERSE EVENT (No adverse event) in a 38-year-old male patient who received mRNA-1273 (Spikevax) (batch no. 042J21A) for COVID-19 prophylaxis. No Medical History information was reported. On 25-Feb-2022, the patient received third dose of mRNA-1273 (Spikevax) (Intramuscular) 1 dosage form. On 25-Feb-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient had been administered with the Moderna vaccine which were beyond the 30day beyond use date). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient had been administered with the Moderna vaccine which were beyond the 30day beyond use date) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Spikevax) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Patient had been administered with the Moderna vaccine which were beyond the 30day beyond use date). No concomitant medication was reported. No treatment medication was reported. This case was linked to US-MODERNATX, INC.-MOD-2023-704416 (Linked Report). Most recent FOLLOW-UP information incorporated above includes: On 24-Jan-2023: Live non significant Follow up received.; Sender's Comments: US-MODERNATX, INC.-MOD-2023-704416:Master case
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 57,0
- Geschlecht
- F
- Eingang
- 31.01.2023
- Impfdatum
- 25.02.2022
- Beginn
- 25.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
No adverse event; Patient had been administered with the Moderna vaccine which were beyond the 30day beyond use date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient had been administered with the Moderna vaccine which were beyond the 30day beyond use date) and NO ADVERSE EVENT (No adverse event) in a 57-year-old female patient who received mRNA-1273 (Spikevax) (batch no. 042J21A) for COVID-19 prophylaxis. No Medical History information was reported. On 25-Feb-2022, the patient received third dose of mRNA-1273 (Spikevax) (Intramuscular) 1 dosage form. On 25-Feb-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient had been administered with the Moderna vaccine which were beyond the 30day beyond use date). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient had been administered with the Moderna vaccine which were beyond the 30day beyond use date) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Spikevax) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Patient had been administered with the Moderna vaccine which were beyond the 30day beyond use date). No concomitant medication was reported. No treatment medication was reported. This case was linked to US-MODERNATX, INC.-MOD-2023-704416 (Linked Report). Most recent FOLLOW-UP information incorporated above includes: On 24-Jan-2023: Live non significant Follow up received; Sender's Comments: US-MODERNATX, INC.-MOD-2023-704416:Master case
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 36,0
- Geschlecht
- F
- Eingang
- 31.01.2023
- Impfdatum
- 02.03.2022
- Beginn
- 02.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
No adverse event; Expired vaccine used; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) and NO ADVERSE EVENT (No adverse event) in a 36-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 prophylaxis. No Medical History information was reported. On 02-Mar-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Mar-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). No concomitant medications details were reported. Patient received vaccine at Pharmacy. Beyond use date of the vaccine was 17-Feb-2022. No treatment medications details were reported. NDC number was reported as 80777-273-10. This case was linked to US-MODERNATX, INC.-MOD-2023-704416 (Linked Report). Most recent FOLLOW-UP information incorporated above includes: On 24-Jan-2023: Follow-up received wherein patient and vaccination details added.; Sender's Comments: US-MODERNATX, INC.-MOD-2023-704416:Master case
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 59,0
- Geschlecht
- M
- Eingang
- 31.01.2023
- Impfdatum
- 25.02.2022
- Beginn
- 25.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
No adverse event; Expired vaccine used; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) and NO ADVERSE EVENT (No adverse event) in a 59-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 prophylaxis. No Medical History information was reported. On 25-Feb-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Feb-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). No concomitant medications details were reported. Patient received vaccine at Pharmacy. Beyond use date of the vaccine was 17-Feb-2022. No treatment medications details were reported. NDC number was reported as 80777-273-10. This case was linked to US-MODERNATX, INC.-MOD-2023-704416 (Linked Report). Most recent FOLLOW-UP information incorporated above includes: On 24-Jan-2023: Follow-up received wherein patient and vaccination details added; Sender's Comments: US-MODERNATX, INC.-MOD-2023-704416:Master case
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 54,0
- Geschlecht
- M
- Eingang
- 31.01.2023
- Impfdatum
- 02.03.2022
- Beginn
- 02.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
No adverse event; Expired vaccine used; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) and NO ADVERSE EVENT (No adverse event) in a 54-year-old male patient who received mRNA-1273 (Spikevax) (batch no. 042J21A) for COVID-19 prophylaxis. No Medical History information was reported. On 02-Mar-2022, the patient received second dose of mRNA-1273 (Spikevax) (Intramuscular) 1 dosage form. On 02-Mar-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Spikevax) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). No concomitant medications details were reported. Patient received vaccine at Pharmacy. Beyond use date of the vaccine was 17-Feb-2022. No treatment medications details were reported. NDC number was reported as 80777-273-10. This case was linked to US-MODERNATX, INC.-MOD-2023-704416 (Linked Report). Most recent FOLLOW-UP information incorporated above includes: On 24-Jan-2023: Follow-up received wherein patient and vaccination details added.; Sender's Comments: US-MODERNATX, INC.-MOD-2023-704416:Master case
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 24,0
- Geschlecht
- F
- Eingang
- 31.01.2023
- Impfdatum
- 01.03.2022
- Beginn
- 01.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
No adverse event; Expired vaccine used; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) and NO ADVERSE EVENT (No adverse event) in a 24-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 prophylaxis. No Medical History information was reported. On 01-Mar-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Mar-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). No concomitant medications details were reported. Patient received vaccine at Pharmacy. Beyond use date of the vaccine was 17-Feb-2022. No treatment medications details were reported. NDC number was reported as 80777-273-10. This case was linked to US-MODERNATX, INC.-MOD-2023-704416 (Linked Report). Most recent FOLLOW-UP information incorporated above includes: On 24-Jan-2023: Follow-up received wherein patient and vaccination details added.; Sender's Comments: US-MODERNATX, INC.-MOD-2023-704416:master case
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 57,0
- Geschlecht
- F
- Eingang
- 31.01.2023
- Impfdatum
- 01.03.2022
- Beginn
- 01.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
No adverse event; Expired vaccine used; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) and NO ADVERSE EVENT (No adverse event) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 prophylaxis. No Medical History information was reported. On 01-Mar-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Mar-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). No concomitant medications details were reported. Patient received vaccine at Pharmacy. Beyond use date of the vaccine was 17-Feb-2022. No treatment medications details were reported. NDC number was reported as 80777-273-10. This case was linked to US-MODERNATX, INC.-MOD-2023-704416 (Linked Report). Most recent FOLLOW-UP information incorporated above includes: On 24-Jan-2023: Follow-up received wherein patient and vaccination details added. Case narrative updated.; Sender's Comments: US-MODERNATX, INC.-MOD-2023-704416:Master case
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- AZ
- Alter
- 59,0
- Geschlecht
- F
- Eingang
- 31.01.2023
- Impfdatum
- 01.03.2022
- Beginn
- 01.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
No adverse event; They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.) and NO ADVERSE EVENT (No adverse event) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 prophylaxis. No Medical History information was reported. On 01-Mar-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Mar-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.). No concomitant medicine were reported. No treatment medicine were reported. lot 042J21A should have been reported with a BUD of 17-Feb-2022. This case was linked to US-MODERNATX, INC.-MOD-2023-704416 (E2B Linked Report). Most recent FOLLOW-UP information incorporated above includes: On 24-Jan-2023: Non-significant follow-up; Sender's Comments: US-MODERNATX, INC.-MOD-2023-704416:Master case
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 67,0
- Geschlecht
- F
- Eingang
- 31.01.2023
- Impfdatum
- 01.03.2022
- Beginn
- 01.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
No adverse event; They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.) and NO ADVERSE EVENT (No adverse event) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 prophylaxis. No Medical History information was reported. On 01-Mar-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Mar-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.). No concomitant medicine were reported. No treatment medicine were reported. lot 042J21A should have been reported with a BUD of 17-Feb-2022. This case was linked to US-MODERNATX, INC.-MOD-2023-704416 (Linked Report). Most recent FOLLOW-UP information incorporated above includes: On 24-Jan-2023: Non-significant follow-up; Sender's Comments: US-MODERNATX, INC.-MOD-2023-704416:Master case
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 60,0
- Geschlecht
- F
- Eingang
- 31.01.2023
- Impfdatum
- 01.03.2022
- Beginn
- 01.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
No adverse event; They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.) and NO ADVERSE EVENT (No adverse event) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 prophylaxis. No Medical History information was reported. On 01-Mar-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Mar-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.). No concomitant medicine were reported. No treatment medicine were reported. lot 042J21A should have been reported with a BUD of 17-Feb-2022. This case was linked to US-MODERNATX, INC.-MOD-2023-704416 (Linked Report). Most recent FOLLOW-UP information incorporated above includes: On 24-Jan-2023: Non-significant follow-up; Sender's Comments: US-MODERNATX, INC.-MOD-2023-704416:Master case
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 33,0
- Geschlecht
- M
- Eingang
- 31.01.2023
- Impfdatum
- 28.02.2022
- Beginn
- 28.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
No adverse event; lot 042J21A should have been reported with a BUD of Feb 17, 2022.; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (lot 042J21A should have been reported with a BUD of Feb 17, 2022.) and NO ADVERSE EVENT (No adverse event) in a 33-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 prophylaxis. No Medical History information was reported. On 28-Feb-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Feb-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (lot 042J21A should have been reported with a BUD of Feb 17, 2022.). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (lot 042J21A should have been reported with a BUD of Feb 17, 2022.) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (lot 042J21A should have been reported with a BUD of Feb 17, 2022.). No concomitant medication was provided by reporter. No treatment information was provided by the reporter. NDC- 0777-273-10 This case was linked to US-MODERNATX, INC.-MOD-2023-704416 (Linked Report). Most recent FOLLOW-UP information incorporated above includes: On 24-Jan-2023: Non-significant follow-up; Sender's Comments: US-MODERNATX, INC.-MOD-2023-704416:Master case
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 51,0
- Geschlecht
- F
- Eingang
- 31.01.2023
- Impfdatum
- 28.02.2022
- Beginn
- 28.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
No adverse event; They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.) and NO ADVERSE EVENT (No adverse event) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 prophylaxis. No Medical History information was reported. On 28-Feb-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Feb-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.). No concomitant medicine were reported. lot 042J21A should have been reported with a BUD of 17-Feb-2022. No treatment medicine were reported. This case was linked to US-MODERNATX, INC.-MOD-2023-704416 (Linked Report). Most recent FOLLOW-UP information incorporated above includes: On 24-Jan-2023: Follow-up received contains no new information.; Sender's Comments: US-MODERNATX, INC.-MOD-2023-704416:Master case
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 82,0
- Geschlecht
- F
- Eingang
- 31.01.2023
- Impfdatum
- 25.02.2022
- Beginn
- 25.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
No adverse event; They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.) and NO ADVERSE EVENT (No adverse event) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 prophylaxis. No Medical History information was reported. On 25-Feb-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Feb-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.). No concomitant medicine were reported. lot 042J21A should have been reported with a BUD of 17-Feb-2022. No treatment medicine were reported. This case was linked to US-MODERNATX, INC.-MOD-2023-704416 (Linked Report). Most recent FOLLOW-UP information incorporated above includes: On 24-Jan-2023: Live follow up consists of non significant information.; Sender's Comments: US-MODERNATX, INC.-MOD-2023-704416:Master case
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 59,0
- Geschlecht
- M
- Eingang
- 31.01.2023
- Impfdatum
- 23.02.2022
- Beginn
- 23.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
No adverse event; They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.) and NO ADVERSE EVENT (No adverse event) in a 59-year-old male patient who received mRNA-1273 (Spikevax) (batch no. 042J21A) for COVID-19 prophylaxis. No Medical History information was reported. On 23-Feb-2022, the patient received second dose of mRNA-1273 (Spikevax) (Intramuscular) 1 dosage form. On 23-Feb-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Spikevax) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.). No concomitant medicine were reported. lot 042J21A should have been reported with a BUD of 17-Feb-2022. No treatment medicine were reported. This case was linked to US-MODERNATX, INC.-MOD-2023-704416 (E2B Linked Report). Most recent FOLLOW-UP information incorporated above includes: On 24-Jan-2023: Live FU consists of non significant information.; Sender's Comments: US-MODERNATX, INC.-MOD-2023-704416:Master case
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 35,0
- Geschlecht
- M
- Eingang
- 31.01.2023
- Impfdatum
- 23.02.2022
- Beginn
- 23.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
No adverse event; Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date) and NO ADVERSE EVENT (No adverse event) in a 35-year-old male patient who received mRNA-1273 (Spikevax) (batch no. 042J21A) for COVID-19 prophylaxis. No Medical History information was reported. On 23-Feb-2022, the patient received second dose of mRNA-1273 (Spikevax) (Intramuscular) 1 dosage form. On 23-Feb-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Spikevax) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date). Concomitant product use was not provided by the reporter. Pharmacist reported that they have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 days beyond use date. The lot number for the monovalent vaccines with their corresponding BUD dates were 027C21A (BUD - 21-May-2021), 053C21A (BUD - 01-Jul-2021), 939902 (BUD - 02-Sep-2021), 011F21A (BUD - 04-Nov-2021), 012H21B (BUD - 23-Dec-2021), 056M21A (BUD - 12-May-2022), 082B22A (BUD - 08-Sep-2022). The lot numbers for the bivalent vaccines with their corresponding BUD dates and the interval period of administration. 052D22A (BUD - 17-Nov-2022), dates of administration 18-Nov-2022 to 28-Nov-2022, 023H22A, (BUD - 15-Dec-2022), dates of administration 16-Dec-2022 to 20-Dec-2022. Treatment information was not provided. This case was linked to US-MODERNATX, INC.-MOD-2023-704416 (Linked Report). Most recent FOLLOW-UP information incorporated above includes: On 24-Jan-2023: Live follow-up information received contains non-significant information.; Sender's Comments: US-MODERNATX, INC.-MOD-2023-704416:Master case
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 62,0
- Geschlecht
- F
- Eingang
- 31.01.2023
- Impfdatum
- 23.02.2022
- Beginn
- 23.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
no ad; Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date) and NO ADVERSE EVENT (no ad) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 prophylaxis. No Medical History information was reported. On 23-Feb-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Feb-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date). On an unknown date, the patient experienced NO ADVERSE EVENT (no ad). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date) and NO ADVERSE EVENT (no ad) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered NO ADVERSE EVENT (no ad) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date). Concomitant product use was not provided by the reporter. Pharmacist reported that they have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 days beyond use date. The lot number for the monovalent vaccines with their corresponding BUD dates were 027C21A (BUD - 21-May-2021), 053C21A (BUD - 01-Jul-2021), 939902 (BUD - 02-Sep-2021), 011F21A (BUD - 04-Nov-2021), 012H21B (BUD - 23-Dec-2021), 056M21A (BUD - 12-May-2022), 082B22A (BUD - 08-Sep-2022). The lot numbers for the bivalent vaccines with their corresponding BUD dates and the interval period of administration. 052D22A (BUD - 17-Nov-2022), dates of administration 18-Nov-2022 to 28-Nov-2022, 023H22A, (BUD - 15-Dec-2022), dates of administration 16-Dec-2022 to 20-Dec-2022. Treatment information was not provided. This case was linked to US-MODERNATX, INC.-MOD-2023-704416 (Linked Report). Most recent FOLLOW-UP information incorporated above includes: On 24-Jan-2023: Live follow-up information received contains non-significant information.; Sender's Comments: US-MODERNATX, INC.-MOD-2023-704416:Master case
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 30,0
- Geschlecht
- M
- Eingang
- 31.01.2023
- Impfdatum
- 28.02.2022
- Beginn
- 28.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
No adverse event; Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date) and NO ADVERSE EVENT (No adverse event) in a 30-year-old male patient who received mRNA-1273 (Spikevax) (batch no. 042J21A) for COVID-19 prophylaxis. No Medical History information was reported. On 28-Feb-2022, the patient received first dose of mRNA-1273 (Spikevax) (Intramuscular) 1 dosage form. On 28-Feb-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Spikevax) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date). Concomitant product use was not provided by the reporter. Pharmacist reported that they have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 days beyond use date. The lot number for the monovalent vaccines with their corresponding BUD dates were 027C21A (BUD - 21-May-2021), 053C21A (BUD - 01-Jul-2021), 939902 (BUD - 02-Sep-2021), 011F21A (BUD - 04-Nov-2021), 012H21B (BUD - 23-Dec-2021), 056M21A (BUD - 12-May-2022), 082B22A (BUD - 08-Sep-2022). The lot numbers for the bivalent vaccines with their corresponding BUD dates and the interval period of administration. 052D22A (BUD - 17-Nov-2022), dates of administration 18-Nov-2022 to 28-Nov-2022, 023H22A, (BUD - 15-Dec-2022), dates of administration 16-Dec-2022 to 20-Dec-2022. Treatment information was not provided. This case was linked to US-MODERNATX, INC.-MOD-2023-704416 (E2B Linked Report). Most recent FOLLOW-UP information incorporated above includes: On 24-Jan-2023: Live ollow-up information received contains non-significant information.; Sender's Comments: US-MODERNATX, INC.-MOD-2023-704416:Master Case
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 61,0
- Geschlecht
- M
- Eingang
- 31.01.2023
- Impfdatum
- 23.02.2022
- Beginn
- 23.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
No adverse event; They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30 day beyond use date.; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30 day beyond use date.) and NO ADVERSE EVENT (No adverse event) in a 61-year-old male patient who received mRNA-1273 (Spikevax) (batch no. 042J21A) for COVID-19 prophylaxis. No Medical History information was reported. On 23-Feb-2022, the patient received second dose of mRNA-1273 (Spikevax) (Intramuscular) 1 dosage form. On 23-Feb-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30 day beyond use date.). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30 day beyond use date.) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Spikevax) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30 day beyond use date.). No concomitant medications were provided. Lot 042J21A should have been reported with a BUD of 17-Feb-2022. No treatment medication was provided. This case was linked to US-MODERNATX, INC.-MOD-2023-704416 (E2B Linked Report). Most recent FOLLOW-UP information incorporated above includes: On 24-Jan-2023: Live follow up received with Updated narrative.; Sender's Comments: US-MODERNATX, INC.-MOD-2023-704416:MASTER CASE
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- AZ
- Alter
- 56,0
- Geschlecht
- F
- Eingang
- 31.01.2023
- Impfdatum
- 28.02.2022
- Beginn
- 23.02.2022
- Tage bis Beginn
- -
- Dosis
- 1
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
No adverse event; Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date) and NO ADVERSE EVENT (No adverse event) in a 56-year-old female patient who received mRNA-1273 (Spikevax) (batch no. 042J21A) for COVID-19 prophylaxis. No Medical History information was reported. On 28-Feb-2022, the patient received first dose of mRNA-1273 (Spikevax) (Intramuscular) 1 dosage form. On 23-Feb-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Spikevax) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date). Concomitant product use was not provided by the reporter. Pharmacist reported that they have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 days beyond use date. The lot number for the monovalent vaccines with their corresponding BUD dates were 027C21A (BUD - 21-May-2021), 053C21A (BUD - 01-Jul-2021), 939902 (BUD - 02-Sep-2021), 011F21A (BUD - 04-Nov-2021), 012H21B (BUD - 23-Dec-2021), 056M21A (BUD - 12-May-2022), 082B22A (BUD - 08-Sep-2022). The lot numbers for the bivalent vaccines with their corresponding BUD dates and the interval period of administration. 052D22A (BUD - 17-Nov-2022), dates of administration 18-Nov-2022 to 28-Nov-2022, 023H22A, (BUD - 15-Dec-2022), dates of administration 16-Dec-2022 to 20-Dec-2022. Treatment information was not provided. [an_linked_ref_type] Most recent FOLLOW-UP information incorporated above includes: On 24-Jan-2023: Live follow-up information received contains Patient information added. On 24-Jan-2023: Live follow-up information received contains non-significant information.; Sender's Comments: US-MODERNATX, INC.-MOD-2023-704664:Master case US-MODERNATX, INC.-MOD-2023-704558:Master case US-MODERNATX, INC.-MOD-2023-704441:Master case US-MODERNATX, INC.-MOD-2023-704560:master case US-MODERNATX, INC.-MOD-2023-704653:Master case US-MODERNATX, INC.-MOD-2023-704494:Master case US-MODERNATX, INC.-MOD-2023-704473:Master case US-MODERNATX, INC.-MOD-2023-704620:Master case US-MODERNATX, INC.-MOD-2023-704648:Master case US-MODERNATX, INC.-MOD-2023-704450:MASTER CASE US-MODERNATX, INC.-MOD-2023-704698:Master case US-MODERNATX, INC.-MOD-2023-704685:Master case US-MODERNATX, INC.-MOD-2023-704707:Master case US-MODERNATX, INC.-MOD-2023-704713:Master case US-MODERNATX, INC.-MOD-2023-704472:Master case US-MODERNATX, INC.-MOD-2023-704715:Master case US-MODERNATX, INC.-MOD-2023-704475:Master case US-MODERNATX, INC.-MOD-2023-704694:Master case US-MODERNATX, INC.-MOD-2023-704478:Master case US-MODERNATX, INC.-MOD-2023-704719:Master case US-MODERNATX, INC.-MOD-2023-704724:Master case US-MODERNATX, INC.-MOD-2023-704725:Master case US-MODERNATX, INC.-MOD-2023-704709:Master case US-MODERNATX, INC.-MOD-2023-704481:Master case US-MODERNATX, INC.-MOD-2023-704476:Master case US-MODERNATX, INC.-MOD-2023-704543:Master case US-MODERNATX, INC.-MOD-2023-704669:Master case US-MODERNATX, INC.-MOD-2023-704580:Master case US-MODERNATX, INC.-MOD-2023-704569:Master case US-MODERNATX, INC.-MOD-2023-704588:Master case US-MODERNATX, INC.-MOD-2023-704668:Master case US-MODERNATX, INC.-MOD-2023-704585:Master case US-MODERNATX, INC.-MOD-2023-704561:Master case US-MODERNATX, INC.-MOD-2023-704714:Master case US-MODERNATX, INC.-MOD-2023-704562:Master case US-MODERNATX, INC.-MOD-2023-704496:Master case US-MODERNATX, INC.-MOD-2023-704591:Master case US-MODERNATX, INC.-MOD-2023-704662:Master case US-MODERNATX, INC.-MOD-2023-704502:Master case US-MODERNATX, INC.-MOD-2023-704618:Master case US-MODERNATX, INC.-MOD-2023-704586:Master case US-MODERNATX, INC.-MOD-2023-704680:Master case US-MODERNATX, INC.-MOD-2023-704733:Master case US-MODERNATX, INC.-MOD-2023-704469:Master case US-MODERNATX, INC.-MOD-2023-704483:Master case US-MODERNATX, INC.-MOD-2023-704509:Master case US-MODERNATX, INC.-MOD-2023-704522:Master case US-MODERNATX, INC.-MOD-2023-704540:Master case US-MODERNATX, INC.-MOD-2023-704587:Master case US-MODERNATX, INC.-MOD-2023-704706:Master case US-MODERNATX, INC.-MOD-2023-704689:Master case US-MODERNATX, INC.-MOD-2023-704734:Master case US-MODERNATX, INC.-MOD-2023-704671:master case US-MODERNATX, INC.-MOD-2023-704722:Master case US-MODERNATX, INC.-MOD-2023-704727:Master case US-MODERNATX, INC.-MOD-2023-704672:Master Case US-MODERNATX, INC.-MOD-2023-704486:Master case US-MODERNATX, INC.-MOD-2023-704712:Master case US-MODERNATX, INC.-MOD-2023-704565:Master case US-MODERNATX, INC.-MOD-2023-704482:Master case US-MODERNATX, INC.-MOD-2023-704581:Master case US-MODERNATX, INC.-MOD-2023-704583:Master case US-MODERNATX, INC.-MOD-2023-704710:Master case US-MODERNATX, INC.-MOD-2023-704691:Master case US-MODERNATX, INC.-MOD-2023-704696:Master case US-MODERNATX, INC.-MOD-2023-704700:Master case US-MODERNATX, INC.-MOD-2023-704754:Master case US-MODERNATX, INC.-MOD-2023-704728:Master case US-MODERNATX, INC.-MOD-2023-704731:Master case US-MODERNATX, INC.-MOD-2023-704670:Master Case US-MODERNATX, INC.-MOD-2023-704717:Master case US-MODERNATX, INC.-MOD-2023-704705:Master case US-MODERNATX, INC.-MOD-2023-704546:Master case US-MODERNATX, INC.-MOD-2023-704621:Master case US-MODERNATX, INC.-MOD-2023-704678:master case US-MODERNATX, INC.-MOD-2023-704629:Master case US-MODERNATX, INC.-MOD-2023-704606:Master case US-MODERNATX, INC.-MOD-2023-704651:Master case US-MODERNATX, INC.-MOD-2023-704637:Master case US-MODERNATX, INC.-MOD-2023-704649:master case US-MODERNATX, INC.-MOD-2023-704657:Master case US-MODERNATX, INC.-MOD-2023-704573:Master case US-MODERNATX, INC.-MOD-2023-704708:Master case US-MODERNATX, INC.-MOD-2023-704667:Master case US-MODERNATX, INC.-MOD-2023-704721:Master case US-MODERNATX, INC.-MOD-2023-704695:Master case US-MODERNATX, INC.-MOD-2023-704723:Master case US-MODERNATX, INC.-MOD-2023-704589:Master case US-MODERNATX, INC.-MOD-2023-704704:Master case US-MODERNATX, INC.-MOD-2023-704711:Master case US-MODERNATX, INC.-MOD-2023-704497:Master Case US-MODERNATX, INC.-MOD-2023-704559:Master case US-MODERNATX, INC.-MOD-2023-704638:Master case US-MODERNATX, INC.-MOD-2023-704505:Master case US-MODERNATX, INC.-MOD-2023-704484: US-MODERNATX, INC.-MOD-2023-704504:Master case US-MODERNATX, INC.-MOD-2023-704477:Master case US-MODERNATX, INC.-MOD-2023-704503:Master case US-MODERNATX, INC.-MOD-2023-704619:Master case US-MODERNATX, INC.-MOD-2023-704498:Master Case US-MODERNATX, INC.-MOD-2023-704611:Master case US-MODERNATX, INC.-MOD-2023-704674:Master case US-MODERNATX, INC.-MOD-2023-704732:Master case US-MODERNATX, INC.-MOD-2023-704625:Master case US-MODERNATX, INC.-MOD-2023-704676:Master case US-MODERNATX, INC.-MOD-2023-704735:Master case US-MODERNATX, INC.-MOD-2023-704843:Master Case US-MODERNATX, INC.-MOD-2023-704821:Master case US-MODERNATX, INC.-MOD-2023-704878:Master case US-MODERNATX, INC.-MOD-2023-704802:Master case US-MODERNATX, INC.-MOD-2023-704817:Master case US-MODERNATX, INC.-MOD-2023-704814:Master case US-MODERNATX, INC.-MOD-2023-704688:Master Case US-MODERNATX, INC.-MOD-2023-704931:Master case US-MODERNATX, INC.-MOD-2023-704842:Master case US-MODERNATX, INC.-MOD-2023-704840:Master Case US-MODERNATX, INC.-MOD-2023-704811:Master case US-MODERNATX, INC.-MOD-2023-704839:Master case US-MODERNATX, INC.-MOD-2023-704804:Master case US-MODERNATX, INC.-MOD-2023-704838:Master Case US-MODERNATX, INC.-MOD-2023-704718:Master case US-MODERNATX, INC.-MOD-2023-704738:Master case US-MODERNATX, INC.-MOD-2023-704683:Master case US-MODERNATX, INC.-MOD-2023-704624:Master case US-MODERNATX, INC.-MOD-2023-704823:Master case US-MODERNATX, INC.-MOD-2023-704826:Master case US-MODERNATX, INC.-MOD-2023-704824:Master case US-MODERNATX, INC.-MOD-2023-704825:Master case US-MODERNATX, INC.-MOD-2023-704938:Master case US-MODERNATX, INC.-MOD-2023-704890:Master case
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 78,0
- Geschlecht
- M
- Eingang
- 30.01.2023
- Impfdatum
- 16.02.2022
- Beginn
- 26.01.2023
- Tage bis Beginn
- 344,0
- Dosis
- 3
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
COVID-19
SARS-CoV-2 test positive
Vaccine breakthrough infection
Symptomtext
Breakthrough case admission after 3 Vaccines NO Manufacturer listed on any of the vaccines; Moderna listed on form only because form will be rejected if no manufacturer listed; DO NOT SEND FOLLOW UP REQUEST FOR MANUFACTURER; NOT LISTED IN STATE DATABASE 2/26/21 Lot# 001a21A; 3/26/21 Lot# 006B21A; 2/16/22 Lot# 042J21A
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- COVID-19
- Hospital-Tage
- -
- Labordaten
- covid +
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 84,0
- Geschlecht
- F
- Eingang
- 21.12.2022
- Impfdatum
- 07.01.2021
- Beginn
- 25.09.2022
- Tage bis Beginn
- 626,0
- Dosis
- 3
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: ja
Bacterial test negative
COVID-19
Chest X-ray abnormal
Computerised tomogram head normal
Computerised tomogram spine
Fall
Haemorrhage
Head injury
Lethargy
Lung opacity
SARS-CoV-2 test positive
Urine analysis normal
White blood cell count normal
Symptomtext
This is a 85y.o. female with PMH significant for dementia, alzheimers, depression, hypothyroidism who presents to hospital for fall and head injury. History gathered for paramedics and family. Patient from SKLD, baseline A&Ox1-2. Had unwitnessed fall with bleeding in the back of head. She was placed on C collar. During ED eval, COVID positive, placed in isolation. UA + WBC, negative for bacteria. Was started on IV rocephin in EC. Cervical CT showed no acute fracture. Chest xray showed left sided patchy opacity. Head CT showed no acute hemorrhage. Patient was RRT due to lethargy. And her night time risperidone dose was reduced with good improvement. Met with hospice and will follow up with community hospice needs. Patient also tested positive for COVID, was seen by ID, and no txt needed since respiratory status is stable. Discharged in a stable condition.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Bacterial test negative
- Hospital-Tage
- 5,0
- Labordaten
- 9/25 SARS-CoV-2 (COVID-19).
- Aktuelle Erkrankungen
- unknown
- Vorgeschichte
- unknown
- Andere Medikamente
- unknown
- Allergien
- unknown
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 75,0
- Geschlecht
- M
- Eingang
- 15.11.2022
- Impfdatum
- 25.10.2021
- Beginn
- 20.09.2022
- Tage bis Beginn
- 330,0
- Dosis
- 2
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
COVID-19
Mental status changes
SARS-CoV-2 test positive
Symptomtext
09/20/22 presents to ED for "AMS". PMHx of "HTN, CVA, AAA s/p repair, NSTEMI and heart murmur"
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- COVID-19
- Hospital-Tage
- -
- Labordaten
- 09/20/22 SARS-CoV-2 (COVID-19) detected
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 70,0
- Geschlecht
- M
- Eingang
- 28.10.2022
- Impfdatum
- 25.02.2022
- Beginn
- 27.10.2022
- Tage bis Beginn
- 244,0
- Dosis
- 4
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
COVID-19
SARS-CoV-2 test positive
Vaccine breakthrough infection
Symptomtext
COVID breakthrough case
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- COVID-19
- Hospital-Tage
- -
- Labordaten
- COVID positive test 10/27/22
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 56,0
- Geschlecht
- M
- Eingang
- 31.08.2022
- Impfdatum
- 01.08.2022
- Beginn
- 17.08.2022
- Tage bis Beginn
- 16,0
- Dosis
- 2
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
COVID-19
SARS-CoV-2 test positive
Symptomtext
Pt tested positive for COVID on 08/17/2022
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- COVID-19
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 65,0
- Geschlecht
- F
- Eingang
- 30.08.2022
- Impfdatum
- 22.03.2022
- Beginn
- 14.08.2022
- Tage bis Beginn
- 145,0
- Dosis
- 4
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
COVID-19
SARS-CoV-2 test positive
Symptomtext
Patient tested positive for COVID-19 on 08/14/2022.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- COVID-19
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 45,0
- Geschlecht
- F
- Eingang
- 24.08.2022
- Impfdatum
- 24.02.2022
- Beginn
- 01.02.2022
- Tage bis Beginn
- -
- Dosis
- 3
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Biopsy endometrium normal
Blood test
Heavy menstrual bleeding
Menstruation irregular
Polymenorrhoea
Post procedural haemorrhage
Thyroid disorder
Vaginal haemorrhage
Symptomtext
Just after my first booster in February I had a normal period and it was 7 days. It is normally 19-21 days in between. In March it was 28 days since last period. In April it was 13 days since last one and then I had a second cycle that lasted 7 days. In May it was 18 days since last one. In May I had blood work because of the issue with so many menstrual cycles. My thyroid numbers were under active. I had a biopsy in May and and the spotting began due to the biopsy and then I started my period and it was heavy at times. My biopsy was normal. Blood work was all normal except for thyroid numbers.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Biopsy endometrium normal
- Hospital-Tage
- -
- Labordaten
- Blood panel, thyroid abnormal; Endometrial Biopsy, normal.
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- Eczema; Hay fever
- Andere Medikamente
- CBD tincture
- Allergien
- Penicillin
- Vorherige Impfungen
- -
- Staat
- MO
- Alter
- 55,0
- Geschlecht
- F
- Eingang
- 16.08.2022
- Impfdatum
- 05.04.2022
- Beginn
- 15.07.2022
- Tage bis Beginn
- 101,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
Alcohol withdrawal syndrome
Anal incontinence
Confusional state
Hypovolaemia
Interchange of vaccine products
Rhabdomyolysis
Symptomtext
7/15/2022 patient presented to ER after children found her at home on the couch covered in feces. Admitted to the hospital for confusion, rhabdomyolysis, hypovelemia, and alcohol withdrawal.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Alcohol withdrawal syndrome
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- VA
- Alter
- 66,0
- Geschlecht
- F
- Eingang
- 02.08.2022
- Impfdatum
- 02.05.2022
- Beginn
- 30.07.2022
- Tage bis Beginn
- 89,0
- Dosis
- 4
- Route/Site
- - / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
COVID-19
SARS-CoV-2 test positive
Symptomtext
I contracted Covid on July 30, 2022 (a bit over 3 months after receiving my 4th Moderna inoculation)
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- COVID-19
- Hospital-Tage
- -
- Labordaten
- At home antigen test
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- Multi vitamin
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- OR
- Alter
- 65,0
- Geschlecht
- M
- Eingang
- 20.07.2022
- Impfdatum
- 19.04.2022
- Beginn
- 25.06.2022
- Tage bis Beginn
- 67,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
COVID-19
Cough
SARS-CoV-2 test positive
Symptomtext
06/25/2022 I caught Covid. Severe cough. 4 days. I also took PAXLOVID ( Renal lower dose)
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- COVID-19
- Hospital-Tage
- -
- Labordaten
- Positive Covid 06/25/22
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- HTN , DM2, Diabetic neuropathy, ortho arthritis
- Andere Medikamente
- Allopurinol, Alpha-Lipoic Acid, Amlodipine, Aspirin, Carvedilol, Duloxetine, Lisinpril
- Allergien
- NKA
- Vorherige Impfungen
- -
- Staat
- VA
- Alter
- 71,0
- Geschlecht
- F
- Eingang
- 15.07.2022
- Impfdatum
- 12.04.2022
- Beginn
- 23.05.2022
- Tage bis Beginn
- 41,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Computerised tomogram abnormal
Retinal detachment
Retinopexy
Surgery
Visual impairment
Vitreous floaters
Symptomtext
I have had a history of retinal issues. But this was different because it required immediate surgery. I had some floaters in my right eye but it wasn't major. On Monday May 23, 2022 I woke up and it was a blob coming from the inside corner of my right eye moving over. I had it for a couple of weeks first thing in the morning but it would go away. This day it got bigger and didn't go away. I was diagnosed with detached retina in my right eye and had surgery on the May 24, 2022. The surgery was successful and my eye healed. Then July 5, 2022, I had the curtain coming down from the top of my right eye. I was diagnosed with detached retina again in my right eye. I had surgery again to repair retina on July 6, 2022. As of today the surgery appears to be successful.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Computerised tomogram abnormal
- Hospital-Tage
- -
- Labordaten
- Physical Eye Exams; CAT scans on my eye
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- Asthma; Bronchiectasis; Cyst in Pancreas;
- Andere Medikamente
- Lipitor; Wixela Inhaler; Pro Biotic; Multi Vitamin; CoQ10; Phytoceramides
- Allergien
- N/A
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 62,0
- Geschlecht
- M
- Eingang
- 21.06.2022
- Impfdatum
- 17.06.2022
- Beginn
- 17.06.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Expired product administered
Symptomtext
Expired vaccine administered
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- none needed
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 62,0
- Geschlecht
- M
- Eingang
- 21.06.2022
- Impfdatum
- 17.06.2022
- Beginn
- 17.06.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Product storage error
Symptomtext
Dose administered after manufacturer date of expiry; Received expired first booster dose after manufacturer date of expiry; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Received expired first booster dose after manufacturer date of expiry) and PRODUCT STORAGE ERROR (Dose administered after manufacturer date of expiry) in a 62-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 prophylaxis. Previously administered products included for Product used for unknown indication: J&J COVID-19 Vaccine (First Dose) on 28-Oct-2021. Past adverse reactions to the above products included No adverse event with J&J COVID-19 Vaccine. On 17-Jun-2022, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Jun-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Received expired first booster dose after manufacturer date of expiry). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Dose administered after manufacturer date of expiry). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Received expired first booster dose after manufacturer date of expiry) and PRODUCT STORAGE ERROR (Dose administered after manufacturer date of expiry) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medication was reported. No treatment information was reported. On 17-Jun-2022, patient received expired first booster dose of Moderna COVID-19 vaccine. Vial was removed from freezer at 10AM on 17-Jun-2022. 1 dose / 1 dose administered after manufacturer date of expiry. The vial did not undergo any temperature excursions. Patient was on way back to the vaccination site to be re-vaccinated. Re-vaccination was kept on hold, until Tier 2 team reaches out for regarding the urgent case.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NY
- Alter
- -
- Geschlecht
- U
- Eingang
- 17.06.2022
- Impfdatum
- 12.05.2022
- Beginn
- 12.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Symptomtext
Patients received the vaccine after the expiry date; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patients received the vaccine after the expiry date) in a patient of an unknown age and gender who received mRNA-1273 (Spikevax) (batch no. 042J21A) for COVID-19 prophylaxis. No Medical History information was reported. On 12-May-2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 12-May-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patients received the vaccine after the expiry date). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patients received the vaccine after the expiry date) outcome was unknown. For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments. No concomitant medications were provided by the reporter. Reporter stated that the date on packing slip that comes with the vaccine was not a correct expiration date and reporter also used the CIR (City Immunization registry) portal, where they store their documentation inventory and find out that the date on the portal is also not accurate, after that reporter used the Look up tool on the Moderna website, the tools told her the vaccine was expired. Reporter wanted to know the lot number 042J21A have been extended and reporter thought the expiration date was 31-Dec-2069. The vial didn't undergone temperature excursions. No treatment information was provided.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- SC
- Alter
- 55,0
- Geschlecht
- F
- Eingang
- 09.06.2022
- Impfdatum
- 02.05.2022
- Beginn
- 02.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
Moderna vaccine was given after published expiration date. No adverse reaction. Vaccine was given on 05/02/2022. expiration 04/29/2022. No signs or symptoms noted at the time of vaccination, Patient was monitor for 15mins after administration and tolerated well.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- patient reported no illness at time of vaccination
- Vorgeschichte
- Prediabetes, hyperlipidemia
- Andere Medikamente
- none
- Allergien
- penicillin
- Vorherige Impfungen
- -
- Staat
- SC
- Alter
- 57,0
- Geschlecht
- F
- Eingang
- 09.06.2022
- Impfdatum
- 02.05.2022
- Beginn
- 02.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
Moderna vaccine was given after published expiration date. No adverse reaction. Vaccine was given on 05/02/2022. expiration 04/29/2022. No signs or symptoms noted at the time of vaccination, Patient was monitor for 15mins after administration and tolerated well.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- patient reported no illness at the time of vaccination
- Vorgeschichte
- COPD, Seizures, osteopenia, arthritis and anemia
- Andere Medikamente
- symbicort, proair, depakote, ferrous sulfate, folic acid, vitamin d, vitamin b12, omeprazole
- Allergien
- codeine, sulfacetamide, penicillin
- Vorherige Impfungen
- -
- Staat
- SC
- Alter
- 42,0
- Geschlecht
- F
- Eingang
- 09.06.2022
- Impfdatum
- 02.05.2022
- Beginn
- 02.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Product storage error
Symptomtext
Moderna vaccine was given after published expiration date. No adverse reaction. Vaccine was given on 05/02/2022. expiration 04/29/2022. No signs or symptoms noted at the time of vaccination, Patient was monitor for 15mins after administration and tolerated well.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- patient reported no illness at the time of vaccination
- Vorgeschichte
- Diabetes, Hyperlipidemia, HTN, anemia, schizophrenia, depression, anxiety
- Andere Medikamente
- Olanzapine ,bupropion ,sertraline, mirtazaprine, omega 3,meloxicam, Baclofen, Ferrous sulfate, Lisinopril, omeprazole, semglee, vitamin D, Gabapentin
- Allergien
- NKDA
- Vorherige Impfungen
- -
- Staat
- SC
- Alter
- 35,0
- Geschlecht
- M
- Eingang
- 09.06.2022
- Impfdatum
- 02.05.2022
- Beginn
- 02.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Product storage error
Symptomtext
Moderna vaccine expired 04/29/2022 and was given to patient on 05/02/2022. No adverse reaction at the time of vaccination or 15 min after administration. Vaccine was tolerated well.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- Patient reported no illness at the time of vaccination
- Vorgeschichte
- Autistic disorder, ADHD, Diabetes, Anxiety and obesity
- Andere Medikamente
- Fioricet, Metformin, welchol, lisinopril
- Allergien
- NKDA
- Vorherige Impfungen
- -
- Staat
- SC
- Alter
- 35,0
- Geschlecht
- M
- Eingang
- 09.06.2022
- Impfdatum
- 02.05.2022
- Beginn
- 02.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Product storage error
Symptomtext
Moderna vaccine expired 04/29/2022 and was given to patient on 05/02/2022. No adverse reaction at the time of vaccination or 15 min after administration. Vaccine was tolerated well.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- Patient reported no illness at the time of vaccination
- Vorgeschichte
- Autistic disorder, ADHD, Diabetes, Anxiety and obesity
- Andere Medikamente
- Fioricet, Metformin, welchol, lisinopril
- Allergien
- NKDA
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 60,0
- Geschlecht
- F
- Eingang
- 09.06.2022
- Impfdatum
- 02.05.2022
- Beginn
- 02.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Product storage error
Symptomtext
expired moderna vaccine was given. No adverse reaction. Vaccine was given on 05/02/2022. expiration 04/29/2022. No signs or symptoms noted at the time of vaccination, Patient was monitor for 15mins after administration and tolerated well.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- patient reported no illness at time of vaccination
- Vorgeschichte
- HTN, depression,hypothyroidism,diabetic neuropathy,visual impairment, ischemic optic neuropathy, gastroparesis
- Andere Medikamente
- Omeprazole,victoza,atorvastatin,metformin,miralax,levemir,humo
- Allergien
- NKDA
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 60,0
- Geschlecht
- F
- Eingang
- 09.06.2022
- Impfdatum
- 02.05.2022
- Beginn
- 02.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- OT / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Product storage error
Symptomtext
expired moderna vaccine was given. No adverse reaction. Vaccine was given on 05/02/2022. expiration 04/29/2022. No signs or symptoms noted at the time of vaccination, Patient was monitor for 15mins after administration and tolerated well.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- patient reported no illness at time of vaccination
- Vorgeschichte
- HTN, depression,hypothyroidism,diabetic neuropathy,visual impairment, ischemic optic neuropathy, gastroparesis
- Andere Medikamente
- Omeprazole,victoza,atorvastatin,metformin,miralax,levemir,humo
- Allergien
- NKDA
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 58,0
- Geschlecht
- M
- Eingang
- 09.06.2022
- Impfdatum
- 02.05.2022
- Beginn
- 02.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Product storage error
Symptomtext
expired moderna vaccine was given. No adverse reaction. Vaccine was given on 05/02/2022. expiration 04/29/2022. No signs or symptoms noted at the time of vaccination, Patient was monitor for 15mins after administration and tolerated well.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- NONE
- Aktuelle Erkrankungen
- PATIENT REPORTED NO ILLNESS AT TIME OF VISIT
- Vorgeschichte
- -
- Andere Medikamente
- zonisamide,vitamin d, tizanidine, lyrica,levetiracetam, omega
- Allergien
- NKDA
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 58,0
- Geschlecht
- M
- Eingang
- 09.06.2022
- Impfdatum
- 02.05.2022
- Beginn
- 02.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Product storage error
Symptomtext
expired moderna vaccine was given. No adverse reaction. Vaccine was given on 05/02/2022. expiration 04/29/2022. No signs or symptoms noted at the time of vaccination, Patient was monitor for 15mins after administration and tolerated well.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- NONE
- Aktuelle Erkrankungen
- PATIENT REPORTED NO ILLNESS AT TIME OF VISIT
- Vorgeschichte
- -
- Andere Medikamente
- zonisamide,vitamin d, tizanidine, lyrica,levetiracetam, omega
- Allergien
- NKDA
- Vorherige Impfungen
- -
- Staat
- SC
- Alter
- 82,0
- Geschlecht
- F
- Eingang
- 09.06.2022
- Impfdatum
- 02.05.2022
- Beginn
- 02.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Product storage error
Symptomtext
Moderna vaccine was given after published expiration date. No adverse reaction. Vaccine was given on 05/02/2022. expiration 04/29/2022. No signs or symptoms noted at the time of vaccination, Patient was monitor for 15mins after administration and tolerated well.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- Patient reported no illness at the time of vaccination
- Vorgeschichte
- anxiety, hypothroidism ,depression, seizures, renal insufficiency, neurosyphilis, neuropathy
- Andere Medikamente
- omeprazole ,levetiracetam, Vitamin D, Proair, omega3, magnesium, Levothyroxine, sertraline ,memantine, trazadone,
- Allergien
- Aspirin
- Vorherige Impfungen
- -
- Staat
- SC
- Alter
- 82,0
- Geschlecht
- F
- Eingang
- 09.06.2022
- Impfdatum
- 02.05.2022
- Beginn
- 02.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Product storage error
Symptomtext
Moderna vaccine was given after published expiration date. No adverse reaction. Vaccine was given on 05/02/2022. expiration 04/29/2022. No signs or symptoms noted at the time of vaccination, Patient was monitor for 15mins after administration and tolerated well.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- Patient reported no illness at the time of vaccination
- Vorgeschichte
- anxiety, hypothroidism ,depression, seizures, renal insufficiency, neurosyphilis, neuropathy
- Andere Medikamente
- omeprazole ,levetiracetam, Vitamin D, Proair, omega3, magnesium, Levothyroxine, sertraline ,memantine, trazadone,
- Allergien
- Aspirin
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 70,0
- Geschlecht
- M
- Eingang
- 08.06.2022
- Impfdatum
- 06.04.2022
- Beginn
- 01.06.2022
- Tage bis Beginn
- 56,0
- Dosis
- 4
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
COVID-19
SARS-CoV-2 test positive
Vaccine breakthrough infection
Symptomtext
Breakthrough case admission after 4 vaccines 3/13/21 Moderna Lot# 010A21A 4/10/21 Moderna Lot# 025B21A 12/1/21 Moderna Lot#067F21A 4/6/22 Moderna Lot#042J21A
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- COVID-19
- Hospital-Tage
- -
- Labordaten
- 6/1/22 COVID +
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- SC
- Alter
- 55,0
- Geschlecht
- F
- Eingang
- 07.06.2022
- Impfdatum
- 23.05.2022
- Beginn
- 23.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Product storage error
Symptomtext
2 vials were placed in the freezer on 18Jan2022, and was never stored in the refrigerated; Vaccine administered after date of expiry to 1 patient; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine administered after date of expiry to 1 patient) and PRODUCT STORAGE ERROR (2 vials were placed in the freezer on 18Jan2022, and was never stored in the refrigerated) in a 55-year-old female patient who received mRNA-1273 (Spikevax) (batch no. 042J21A) for COVID-19 vaccination. No Medical History information was reported. On 23-May-2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) .5 milliliter. On 23-May-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine administered after date of expiry to 1 patient). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (2 vials were placed in the freezer on 18Jan2022, and was never stored in the refrigerated). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine administered after date of expiry to 1 patient) and PRODUCT STORAGE ERROR (2 vials were placed in the freezer on 18Jan2022, and was never stored in the refrigerated) outcome was unknown. For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments. No concomitant information was reported. It was reported that the 2 vials were placed in the freezer on 18Jan2022, and was never stored in the refrigerated. The total number of vials were 2. The vial was not initially stored in the refrigerator. The vial did not undergo any temperature excursions. This case was linked to MOD-2022-582455, MOD-2022-582637, MOD-2022-582638, MOD-2022-582640, MOD-2022-582644 (Patient Link).
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- SC
- Alter
- 57,0
- Geschlecht
- F
- Eingang
- 07.06.2022
- Impfdatum
- 02.05.2022
- Beginn
- 02.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Product storage error
Symptomtext
vials were placed in the freezer on 18Jan2022, and was never stored in the refrigerated; Vaccine administered after date of expiry to patient; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine administered after date of expiry to patient) and PRODUCT STORAGE ERROR (vials were placed in the freezer on 18Jan2022, and was never stored in the refrigerated) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 vaccination. No Medical History information was reported. On 02-May-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 02-May-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine administered after date of expiry to patient). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (vials were placed in the freezer on 18Jan2022, and was never stored in the refrigerated). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine administered after date of expiry to patient) and PRODUCT STORAGE ERROR (vials were placed in the freezer on 18Jan2022, and was never stored in the refrigerated) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medications were reported. Vial was not initially stored in the refrigerator. Vial did not undergo any temperature excursions. No treatment information was provided.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 67,0
- Geschlecht
- F
- Eingang
- 04.06.2022
- Impfdatum
- 25.02.2022
- Beginn
- 29.05.2022
- Tage bis Beginn
- 93,0
- Dosis
- 3
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
COVID-19
SARS-CoV-2 test positive
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- COVID-19
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NY
- Alter
- 83,0
- Geschlecht
- M
- Eingang
- 03.06.2022
- Impfdatum
- 11.05.2022
- Beginn
- 11.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- OT / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
SARS-CoV-2 test
Symptomtext
The patient received the vaccine on 11-May-2022, which had got expired on the 29-Apr-2022.; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (The patient received the vaccine on 11-May-2022, which had got expired on the 29-Apr-2022.) in an 83-year-old male patient who received mRNA-1273 (Spikevax) (batch no. 042J21A) for COVID-19 vaccination. No Medical History information was reported. On 11-May-2022 at 2:18 PM, the patient received first dose of mRNA-1273 (Spikevax) (Intramuscular) .5 milliliter. On 11-May-2022 at 2:18 PM, the patient experienced EXPIRED PRODUCT ADMINISTERED (The patient received the vaccine on 11-May-2022, which had got expired on the 29-Apr-2022.). At the time of the report, EXPIRED PRODUCT ADMINISTERED (The patient received the vaccine on 11-May-2022, which had got expired on the 29-Apr-2022.) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 13-Dec-2020, SARS-CoV-2 test: positive (Positive) Positive. For mRNA-1273 (Spikevax) (Intramuscular), the reporter did not provide any causality assessments. Concomitant drugs were not reported. The patient had not taken any prescriptions, over the counter medication, dietary supplement or herbal remedies at the time of vaccination and also not had any acute illness at the time of vaccination and up to 1 month before. Hcp reported they administer a vaccine that expired on the 29Apr2022 to less 5 patients which was the dose administered after 30-day Use By Date or after manufacturer date of expiry. Number of vials and date the vial was initially stored in the refrigerator were unknown. The vial did not undergo any temperature excursions. The event does not caused the patient to seek the medical care. It was unknown if the event most likely caused by Mrna-1273 and the patient experienced a similar events in the past. Treatment details were not given. This case was linked to MOD-2022-573908 (Patient Link).
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- Test Date: 20201213; Test Name: Rapid COVID-19 test; Test Result: Positive ; Result Unstructured Data: Positive
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NY
- Alter
- 55,0
- Geschlecht
- F
- Eingang
- 03.06.2022
- Impfdatum
- 11.05.2022
- Beginn
- 11.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Symptomtext
Patient received the vaccine on 11-May-2022, which had got expired on the 29-Apr-2022; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient received the vaccine on 11-May-2022, which had got expired on the 29-Apr-2022) in a 55-year-old female patient who received mRNA-1273 (Spikevax) (batch no. 042j21a) for COVID-19 vaccination. It was unknown whether patient was diagnosed or had tested positive for Covid -19 It was unknown whether patient had acute illness at the time of vaccination and upto one month prior. It was unknown whether patient had chronic or long standing health conditions. On 11-May-2022 at 8:00 PM, the patient received first dose of mRNA-1273 (Spikevax) (Intramuscular) .5 milliliter. On 11-May-2022 at 8:00 PM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient received the vaccine on 11-May-2022, which had got expired on the 29-Apr-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient received the vaccine on 11-May-2022, which had got expired on the 29-Apr-2022) outcome was unknown. For mRNA-1273 (Spikevax) (Intramuscular), the reporter did not provide any causality assessments. Concomitant drugs were not reported. Hcp reported they administered a vaccine that expired on the 29Apr2022 to less 5 patients. It was unknown on which date the vial was initially stored in the refrigerator. The vial did not undergo any temperature excursions Treatment details were not given. This case was linked to MOD-2022-573908 (Patient Link).
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Comments: It was unknown whether patient was diagnosed or had tested positive for Covid -19. It was unknown whether patient had acute illness at the time of vaccination and up to one month prior. It was unknown whether patient had chronic or long standing health conditions.
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 57,0
- Geschlecht
- F
- Eingang
- 25.05.2022
- Impfdatum
- 17.05.2022
- Beginn
- 20.05.2022
- Tage bis Beginn
- 3,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Expired product administered
Symptomtext
PATIENT RECEIVED EXPIRED MODERNA VACCINE. NO ADVERSE EVENTS EXPERIENCED
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- NONE
- Aktuelle Erkrankungen
- NONE
- Vorgeschichte
- NONE
- Andere Medikamente
- NONE
- Allergien
- NKDA
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 63,0
- Geschlecht
- F
- Eingang
- 25.05.2022
- Impfdatum
- 17.05.2022
- Beginn
- 20.05.2022
- Tage bis Beginn
- 3,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Expired product administered
No adverse event
Symptomtext
PATIENT RECEIVED EXPIRED MODERNA VACCINE. NO ADVERSE EVENTS EXPERIENCED
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- NONE
- Aktuelle Erkrankungen
- NONE
- Vorgeschichte
- NONE
- Andere Medikamente
- NONE
- Allergien
- NKDA
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 66,0
- Geschlecht
- M
- Eingang
- 25.05.2022
- Impfdatum
- 17.05.2022
- Beginn
- 20.05.2022
- Tage bis Beginn
- 3,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Expired product administered
No adverse event
Symptomtext
PATIENT RECEIVED EXPIRED MODERNA VACCINE. NO ADVERSE EVENTS EXPERIENCED
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- NONE
- Aktuelle Erkrankungen
- NONE
- Vorgeschichte
- NONE
- Andere Medikamente
- NONE
- Allergien
- NKDA
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 53,0
- Geschlecht
- M
- Eingang
- 25.05.2022
- Impfdatum
- 16.05.2022
- Beginn
- 20.05.2022
- Tage bis Beginn
- 4,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Expired product administered
No adverse event
Symptomtext
PATIENT RECEIVED EXPIRED MODERNA VACCINE. NO ADVERSE EVENTS EXPERIENCED
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- NONE
- Aktuelle Erkrankungen
- NONE
- Vorgeschichte
- DIABETES AND HIGH BLOOD PRESSURE
- Andere Medikamente
- PATIENT IS TAKING MEDICATIONS FOR DIABETES AND HIGH BLOOD PRESSURE
- Allergien
- NKA
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 60,0
- Geschlecht
- F
- Eingang
- 25.05.2022
- Impfdatum
- 10.05.2022
- Beginn
- 20.05.2022
- Tage bis Beginn
- 10,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Expired product administered
No adverse event
Symptomtext
PATIENT RECEIVED EXPIRED MODERNA VACCINE. PATIENT EXPERIENCED NO ADVERSE SYMPTOMS
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- NONE
- Aktuelle Erkrankungen
- NONE
- Vorgeschichte
- HIGH BLOOD PRESSURE
- Andere Medikamente
- PATIENT IS TAKING MEDICATIONS FOR HIGH BLOOD PRESSURE, HYPERLIPIDEMIA, AND ANXIETY
- Allergien
- NKDA
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 33,0
- Geschlecht
- M
- Eingang
- 25.05.2022
- Impfdatum
- 26.05.2021
- Beginn
- 21.05.2022
- Tage bis Beginn
- 360,0
- Dosis
- 2
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
COVID-19
Localised infection
SARS-CoV-2 test positive
Symptomtext
5/20 34y.o. male with past medical history most significant for IVDU presents with chief complaint of left toe infection
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- COVID-19
- Hospital-Tage
- -
- Labordaten
- 5/20 SARS-CoV-2 by NAA, Detected
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 57,0
- Geschlecht
- M
- Eingang
- 24.05.2022
- Impfdatum
- 10.05.2022
- Beginn
- 20.05.2022
- Tage bis Beginn
- 10,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Expired product administered
Symptomtext
PATIENT RECEIVED VACCINE THAT'S EXPIRED
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- NONE
- Aktuelle Erkrankungen
- NONE
- Vorgeschichte
- HYPOTHYROIDISM, HYPERLIPEDEMIA
- Andere Medikamente
- N/A
- Allergien
- NKDA
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 55,0
- Geschlecht
- F
- Eingang
- 24.05.2022
- Impfdatum
- 10.05.2022
- Beginn
- 20.05.2022
- Tage bis Beginn
- 10,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Expired product administered
No adverse event
Symptomtext
PATIENT RECEIVED VACCINE THAT'S EXPIRED - NO ADVERSE EFFECTS REPORTED
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- NONE
- Aktuelle Erkrankungen
- NONE
- Vorgeschichte
- HEALTHY
- Andere Medikamente
- NONE
- Allergien
- NKDA
- Vorherige Impfungen
- -
- Staat
- NC
- Alter
- 67,0
- Geschlecht
- F
- Eingang
- 24.05.2022
- Impfdatum
- 03.05.2022
- Beginn
- 03.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Expired product administered
Product expiration date issue
Symptomtext
Moderna vaccine vial expired on 04/29/22, expiration located on box not vial. Nurse pulled and discarded vial. Contacted Moderna and report made and lot analysis sent. Analysis of involved lot # maintained activity necessary to protect against the SARS-COV-2 (Covid-19) virus at the time of administration. RN and FNP made aware. Not necessary to notify patient or repeat dose.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 50,0
- Geschlecht
- M
- Eingang
- 20.05.2022
- Impfdatum
- 01.05.2022
- Beginn
- 01.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Product storage error
Symptomtext
Expired dose stored in refrigerator/ administered expired dose to the patient; Patient received expired dose of Moderna vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient received expired dose of Moderna vaccine) and PRODUCT STORAGE ERROR (Expired dose stored in refrigerator/ administered expired dose to the patient) in a 50-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 vaccination. The previous history of COVID-19 vaccination was unavailable. In May 2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. In May 2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient received expired dose of Moderna vaccine). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Expired dose stored in refrigerator/ administered expired dose to the patient). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient received expired dose of Moderna vaccine) and PRODUCT STORAGE ERROR (Expired dose stored in refrigerator/ administered expired dose to the patient) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Concomitant medication information was not provided by the reporter. Patient received second booster dose. The date when the vial was initially stored in the refrigerator was the same date that the dose was administered. The vial did not undergo any temperature excursions. The pharmacist thought the expiration date was 2069, like it was printed on the vial but the expiry date was 29-Apr-2022. Treatment information was not provided by the reporter.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Comments: The previous history of COVID-19 vaccination was unavailable.
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 69,0
- Geschlecht
- M
- Eingang
- 20.05.2022
- Impfdatum
- 01.04.2022
- Beginn
- 14.05.2022
- Tage bis Beginn
- 43,0
- Dosis
- 4
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
COVID-19
SARS-CoV-2 test positive
Symptomtext
Confirmed Outbreak 1st Dose - Moderna - 007M20A 010A21A 2nd Dose - Moderna 017F21A 3rdDose - Moderna 042J1A - 4th Dose - Moderna
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- COVID-19
- Hospital-Tage
- -
- Labordaten
- Confirmed COVID Test - 5/14/2021
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- AR
- Alter
- 83,0
- Geschlecht
- F
- Eingang
- 20.05.2022
- Impfdatum
- 06.04.2022
- Beginn
- 11.05.2022
- Tage bis Beginn
- 35,0
- Dosis
- 4
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: ja
COVID-19
Symptomtext
hospitalization with covid after being fully vaccinated and booster X2.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- COVID-19
- Hospital-Tage
- 2,0
- Labordaten
- -
- Aktuelle Erkrankungen
- unknown
- Vorgeschichte
- Deep Vein Thrombosis, Fracture, Hypertension and Renal Disease
- Andere Medikamente
- unknown
- Allergien
- morphine, warfarin sodium, nitrofurantoin, oxycodone
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 53,0
- Geschlecht
- M
- Eingang
- 20.05.2022
- Impfdatum
- 16.05.2022
- Beginn
- 16.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Symptomtext
Expired doses administered to 8 patients; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired doses administered to 8 patients) in a 53-year-old male patient who received mRNA-1273 (Spikevax) (batch no. 042J21A) for COVID-19 vaccination. No Medical History information was reported. On 16-May-2022, the patient received fourth dose of mRNA-1273 (Spikevax) (unknown route) .25 milliliter. On 16-May-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired doses administered to 8 patients). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired doses administered to 8 patients) outcome was unknown. For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments. No concomitant medication reported. No treatment medication reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- VA
- Alter
- 59,0
- Geschlecht
- F
- Eingang
- 18.05.2022
- Impfdatum
- 30.03.2022
- Beginn
- 30.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product storage error
Symptomtext
Error: Improper Storage (ex. temp./location)-
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- VA
- Alter
- 75,0
- Geschlecht
- M
- Eingang
- 18.05.2022
- Impfdatum
- 30.03.2022
- Beginn
- 30.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product storage error
Symptomtext
Error: Improper Storage (ex. temp./location)-
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- VA
- Alter
- 68,0
- Geschlecht
- F
- Eingang
- 18.05.2022
- Impfdatum
- 28.03.2022
- Beginn
- 28.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product storage error
Symptomtext
Error: Improper Storage (ex. temp./location)-
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NC
- Alter
- 30,0
- Geschlecht
- M
- Eingang
- 18.05.2022
- Impfdatum
- 29.03.2022
- Beginn
- 29.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product storage error
Symptomtext
Error: Improper Storage (ex. temp./location)-
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- VA
- Alter
- 58,0
- Geschlecht
- M
- Eingang
- 18.05.2022
- Impfdatum
- 29.03.2022
- Beginn
- 29.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product storage error
Symptomtext
Error: Improper Storage (ex. temp./location)-
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- VA
- Alter
- 61,0
- Geschlecht
- F
- Eingang
- 18.05.2022
- Impfdatum
- 28.03.2022
- Beginn
- 28.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product storage error
Symptomtext
Error: Improper Storage (ex. temp./location)-
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- VA
- Alter
- 59,0
- Geschlecht
- F
- Eingang
- 18.05.2022
- Impfdatum
- 28.03.2022
- Beginn
- 28.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product storage error
Symptomtext
Error: Improper Storage (ex. temp./location)-
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- VA
- Alter
- 53,0
- Geschlecht
- F
- Eingang
- 17.05.2022
- Impfdatum
- 25.03.2022
- Beginn
- 25.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product storage error
Symptomtext
Error: Improper Storage (ex. temp./location)-
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 23,0
- Geschlecht
- F
- Eingang
- 17.05.2022
- Impfdatum
- 27.03.2022
- Beginn
- 27.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product storage error
Symptomtext
Error: Improper Storage (ex. temp./location)-
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- VA
- Alter
- 21,0
- Geschlecht
- M
- Eingang
- 17.05.2022
- Impfdatum
- 27.03.2022
- Beginn
- 27.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product storage error
Symptomtext
Error: Improper Storage (ex. temp./location)-
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NY
- Alter
- 35,0
- Geschlecht
- F
- Eingang
- 17.05.2022
- Impfdatum
- 26.03.2022
- Beginn
- 26.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product storage error
Symptomtext
Error: Improper Storage (ex. temp./location)-
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- VA
- Alter
- 58,0
- Geschlecht
- F
- Eingang
- 17.05.2022
- Impfdatum
- 26.03.2022
- Beginn
- 26.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product storage error
Symptomtext
Error: Improper Storage (ex. temp./location)-
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- VA
- Alter
- 56,0
- Geschlecht
- F
- Eingang
- 17.05.2022
- Impfdatum
- 25.03.2022
- Beginn
- 25.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product storage error
Symptomtext
Error: Improper Storage (ex. temp./location)-
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WY
- Alter
- 59,0
- Geschlecht
- M
- Eingang
- 16.05.2022
- Impfdatum
- 08.04.2022
- Beginn
- 08.04.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Product storage error
Symptomtext
temperature excursion
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WY
- Alter
- 60,0
- Geschlecht
- F
- Eingang
- 16.05.2022
- Impfdatum
- 08.04.2022
- Beginn
- 08.04.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Product storage error
Symptomtext
temperature excursion
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WY
- Alter
- 70,0
- Geschlecht
- F
- Eingang
- 16.05.2022
- Impfdatum
- 08.04.2022
- Beginn
- 08.04.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Product storage error
Symptomtext
temperature excursion
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WY
- Alter
- 87,0
- Geschlecht
- M
- Eingang
- 16.05.2022
- Impfdatum
- 08.04.2022
- Beginn
- 08.04.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Product storage error
Symptomtext
temperature excursion
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WY
- Alter
- 81,0
- Geschlecht
- F
- Eingang
- 16.05.2022
- Impfdatum
- 08.04.2022
- Beginn
- 08.04.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Product storage error
Symptomtext
temperature excursion
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WY
- Alter
- 73,0
- Geschlecht
- M
- Eingang
- 16.05.2022
- Impfdatum
- 05.04.2022
- Beginn
- 05.04.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Product storage error
Symptomtext
temperature excursion
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WY
- Alter
- 71,0
- Geschlecht
- F
- Eingang
- 16.05.2022
- Impfdatum
- 08.04.2022
- Beginn
- 08.04.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Product storage error
Symptomtext
temperature excursion
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WY
- Alter
- 69,0
- Geschlecht
- F
- Eingang
- 16.05.2022
- Impfdatum
- 05.04.2022
- Beginn
- 05.04.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Product storage error
Symptomtext
temperature excursion
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WY
- Alter
- 80,0
- Geschlecht
- M
- Eingang
- 16.05.2022
- Impfdatum
- 05.04.2022
- Beginn
- 05.04.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Product storage error
Symptomtext
temperature excursion
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WY
- Alter
- 75,0
- Geschlecht
- M
- Eingang
- 16.05.2022
- Impfdatum
- 05.04.2022
- Beginn
- 05.04.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Product storage error
Symptomtext
temperature excursion
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WY
- Alter
- 68,0
- Geschlecht
- F
- Eingang
- 16.05.2022
- Impfdatum
- 05.04.2022
- Beginn
- 05.04.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Product storage error
Symptomtext
temperature excursion
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WY
- Alter
- 67,0
- Geschlecht
- M
- Eingang
- 16.05.2022
- Impfdatum
- 05.04.2022
- Beginn
- 05.04.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Product storage error
Symptomtext
temperature excursion
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WY
- Alter
- 57,0
- Geschlecht
- M
- Eingang
- 16.05.2022
- Impfdatum
- 05.04.2022
- Beginn
- 05.04.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Product storage error
Symptomtext
temperature excursion
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WY
- Alter
- 87,0
- Geschlecht
- F
- Eingang
- 16.05.2022
- Impfdatum
- 05.04.2022
- Beginn
- 05.04.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Product storage error
Symptomtext
temperature excursion
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WY
- Alter
- 73,0
- Geschlecht
- M
- Eingang
- 16.05.2022
- Impfdatum
- 05.04.2022
- Beginn
- 05.04.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Product storage error
Symptomtext
temperature excursion
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WY
- Alter
- 83,0
- Geschlecht
- M
- Eingang
- 16.05.2022
- Impfdatum
- 05.04.2022
- Beginn
- 05.04.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Product storage error
Symptomtext
temperature excursion
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WY
- Alter
- 84,0
- Geschlecht
- F
- Eingang
- 16.05.2022
- Impfdatum
- 01.04.2022
- Beginn
- 01.04.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Unevaluable event
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Unevaluable event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WY
- Alter
- 89,0
- Geschlecht
- M
- Eingang
- 16.05.2022
- Impfdatum
- 01.04.2022
- Beginn
- 01.04.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Product storage error
Symptomtext
temperature excursion
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WY
- Alter
- 72,0
- Geschlecht
- M
- Eingang
- 16.05.2022
- Impfdatum
- 01.04.2022
- Beginn
- 01.04.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Product storage error
Symptomtext
temperature excursion
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WY
- Alter
- 77,0
- Geschlecht
- F
- Eingang
- 16.05.2022
- Impfdatum
- 01.04.2022
- Beginn
- 01.04.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Product storage error
Symptomtext
temperature excursion
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WY
- Alter
- 75,0
- Geschlecht
- M
- Eingang
- 16.05.2022
- Impfdatum
- 01.04.2022
- Beginn
- 01.04.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Product storage error
Symptomtext
temperature excursion
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WY
- Alter
- 61,0
- Geschlecht
- M
- Eingang
- 16.05.2022
- Impfdatum
- 01.04.2022
- Beginn
- 01.04.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Product storage error
Symptomtext
temperature excursion
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WY
- Alter
- 78,0
- Geschlecht
- F
- Eingang
- 16.05.2022
- Impfdatum
- 01.04.2022
- Beginn
- 01.04.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Product storage error
Symptomtext
temperature excursion
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WY
- Alter
- 77,0
- Geschlecht
- F
- Eingang
- 16.05.2022
- Impfdatum
- 01.04.2022
- Beginn
- 01.04.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Product storage error
Symptomtext
temperature excursion
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WY
- Alter
- 80,0
- Geschlecht
- M
- Eingang
- 16.05.2022
- Impfdatum
- 01.04.2022
- Beginn
- 01.04.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Product storage error
Symptomtext
temperature excursion
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WY
- Alter
- 72,0
- Geschlecht
- M
- Eingang
- 16.05.2022
- Impfdatum
- 01.04.2022
- Beginn
- 01.04.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Product storage error
Symptomtext
temperature excursion
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WY
- Alter
- 66,0
- Geschlecht
- F
- Eingang
- 16.05.2022
- Impfdatum
- 01.04.2022
- Beginn
- 01.04.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Product storage error
Symptomtext
temperature excursion
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WY
- Alter
- 74,0
- Geschlecht
- F
- Eingang
- 16.05.2022
- Impfdatum
- 29.03.2022
- Beginn
- 29.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Product storage error
Symptomtext
temperature excursion
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WY
- Alter
- 64,0
- Geschlecht
- M
- Eingang
- 16.05.2022
- Impfdatum
- 29.03.2022
- Beginn
- 29.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Product storage error
Symptomtext
temperature excursion
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WY
- Alter
- 54,0
- Geschlecht
- F
- Eingang
- 16.05.2022
- Impfdatum
- 29.03.2022
- Beginn
- 29.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Product storage error
Symptomtext
temperature excursion
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WY
- Alter
- 37,0
- Geschlecht
- U
- Eingang
- 16.05.2022
- Impfdatum
- 29.03.2022
- Beginn
- 29.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product storage error
Symptomtext
temperature excursion
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WY
- Alter
- 42,0
- Geschlecht
- M
- Eingang
- 16.05.2022
- Impfdatum
- 29.03.2022
- Beginn
- 29.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Product storage error
Symptomtext
temperature excursion
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WY
- Alter
- 74,0
- Geschlecht
- F
- Eingang
- 16.05.2022
- Impfdatum
- 29.03.2022
- Beginn
- 29.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Product storage error
Symptomtext
temperature excursion
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WY
- Alter
- 90,0
- Geschlecht
- F
- Eingang
- 16.05.2022
- Impfdatum
- 29.03.2022
- Beginn
- 29.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Product storage error
Symptomtext
temperature excursion
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WY
- Alter
- 22,0
- Geschlecht
- F
- Eingang
- 16.05.2022
- Impfdatum
- 24.03.2022
- Beginn
- 24.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Product storage error
Symptomtext
temperature excursion
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WY
- Alter
- 44,0
- Geschlecht
- M
- Eingang
- 16.05.2022
- Impfdatum
- 24.03.2022
- Beginn
- 24.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Product storage error
Symptomtext
temperature excursion
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WY
- Alter
- 45,0
- Geschlecht
- F
- Eingang
- 16.05.2022
- Impfdatum
- 24.03.2022
- Beginn
- 24.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Product storage error
Symptomtext
temperature excursion
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- GA
- Alter
- 57,0
- Geschlecht
- M
- Eingang
- 16.05.2022
- Impfdatum
- 01.05.2022
- Beginn
- 01.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Symptomtext
received expired doses of the Moderna COVID19 vaccine; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (received expired doses of the Moderna COVID19 vaccine) in a 57-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042j21a) for COVID-19 vaccination. No Medical History information was reported. In May 2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In May 2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (received expired doses of the Moderna COVID19 vaccine). At the time of the report, EXPIRED PRODUCT ADMINISTERED (received expired doses of the Moderna COVID19 vaccine) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medication were reported. The type of dose was reported as a booster dose. Each vial was thawed the day before the appointment 3-May-2022, 07-May-2022 and 10-May-2022 Dates of administration of vaccine were 11-May2022, 4-May-2022, 8-May-2022 The vial did not undergo any temperature excursions. No treatment information were provided. This case was linked to MOD-2022-565522, MOD-2022-565551 (Patient Link). Most recent FOLLOW-UP information incorporated above includes: On 12-May-2022: Significant follow-up received : Added patient demographics and type of dose as booster.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- GA
- Alter
- 30,0
- Geschlecht
- M
- Eingang
- 16.05.2022
- Impfdatum
- -
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Symptomtext
Received expired doses of the Moderna COVID19 vaccine; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Received expired doses of the Moderna COVID19 vaccine) in a 30-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (Received expired doses of the Moderna COVID19 vaccine). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Received expired doses of the Moderna COVID19 vaccine) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medications were provided. The date of administration 11-May-2022, 04-May-2022 and 08-May-2022. Each vial (3 vails) was thawed the day before the appointment i.e. 03-May-2022, 07-May-2022 and 10-May-2022. The vial did not undergo temperature excursion. No treatment medications were provided. This case was linked to MOD-2022-565558, MOD-2022-565522 (Patient Link). Most recent FOLLOW-UP information incorporated above includes: On 12-May-2022: Live Follow-up document received on 12-May-2022 contains significant information include patient details and suspect dose details added.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- GA
- Alter
- 34,0
- Geschlecht
- M
- Eingang
- 16.05.2022
- Impfdatum
- 01.05.2022
- Beginn
- 01.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Symptomtext
Patient received expired dose of the Moderna COVID19 vaccine; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient received expired dose of the Moderna COVID19 vaccine) in a 34-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042j21a) for COVID-19 vaccination. No Medical History information was reported. In May 2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In May 2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient received expired dose of the Moderna COVID19 vaccine). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient received expired dose of the Moderna COVID19 vaccine) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Concomitant medications were not reported. Patient received booster dose. It was reported that each vial was thawed the day before the appointment 3-May-2022, 07-May-2022 and 10-May-2022 and date of administration of vaccine was reported as 04-May-2022, 08-May-2022 and 11-May-2022. Treatment information was not reported. This case was linked to MOD-2022-565551, MOD-2022-565558 (Patient Link). Most recent FOLLOW-UP information incorporated above includes: On 12-May-2022: Followup received contains significant information. Added patient demographics, start date, dose number, dosage text of vaccine, event start date and updated inarrative supplement.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WY
- Alter
- 30,0
- Geschlecht
- F
- Eingang
- 13.05.2022
- Impfdatum
- 15.03.2022
- Beginn
- 15.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Product storage error
Symptomtext
temperature excursion
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WY
- Alter
- 76,0
- Geschlecht
- F
- Eingang
- 13.05.2022
- Impfdatum
- 15.03.2022
- Beginn
- 15.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Product storage error
Symptomtext
temperature excursion
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- VA
- Alter
- 68,0
- Geschlecht
- F
- Eingang
- 13.05.2022
- Impfdatum
- 30.03.2022
- Beginn
- 30.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Product storage error
Symptomtext
Error: Improper Storage (ex. temp./location)-
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- VA
- Alter
- 53,0
- Geschlecht
- F
- Eingang
- 12.05.2022
- Impfdatum
- 29.03.2022
- Beginn
- 29.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Product storage error
Symptomtext
Error: Improper Storage (ex. temp./location)-
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- GA
- Alter
- 30,0
- Geschlecht
- M
- Eingang
- 11.05.2022
- Impfdatum
- 08.05.2022
- Beginn
- 11.05.2022
- Tage bis Beginn
- 3,0
- Dosis
- UNK
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- GA
- Alter
- 57,0
- Geschlecht
- M
- Eingang
- 11.05.2022
- Impfdatum
- 04.05.2022
- Beginn
- 11.05.2022
- Tage bis Beginn
- 7,0
- Dosis
- UNK
- Route/Site
- - / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- GA
- Alter
- 34,0
- Geschlecht
- M
- Eingang
- 11.05.2022
- Impfdatum
- 11.05.2022
- Beginn
- 11.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NC
- Alter
- -
- Geschlecht
- M
- Eingang
- 11.05.2022
- Impfdatum
- 06.05.2022
- Beginn
- 06.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Product storage error
Symptomtext
Vaccine moved from freezer to fridge on 6-May-2022 with expiration date of 29-Apr-2022; Patient received expired vaccine; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient received expired vaccine) and PRODUCT STORAGE ERROR (Vaccine moved from freezer to fridge on 6-May-2022 with expiration date of 29-Apr-2022) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 vaccination. No Medical History information was reported. On 06-May-2022, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-May-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient received expired vaccine). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine moved from freezer to fridge on 6-May-2022 with expiration date of 29-Apr-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient received expired vaccine) and PRODUCT STORAGE ERROR (Vaccine moved from freezer to fridge on 6-May-2022 with expiration date of 29-Apr-2022) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medications were provided by the reporter. Vaccine moved from freezer to fridge on 06-May-2022. No adverse events were noted. No treatment information was provided by the reporter.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NC
- Alter
- -
- Geschlecht
- F
- Eingang
- 10.05.2022
- Impfdatum
- 06.05.2022
- Beginn
- 06.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Product storage error
Symptomtext
patient received expired vaccine; Product Storage error; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (patient received expired vaccine) and PRODUCT STORAGE ERROR (Product Storage error) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 vaccination. No Medical History information was reported. On 06-May-2022, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-May-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (patient received expired vaccine) and PRODUCT STORAGE ERROR (Product Storage error). At the time of the report, EXPIRED PRODUCT ADMINISTERED (patient received expired vaccine) and PRODUCT STORAGE ERROR (Product Storage error) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Concomitant medications details were not reported by the reporter. Product moved from freezer to fridge on 06-MAY-2022. Treatment details was not reported by the reporter.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MA
- Alter
- 60,0
- Geschlecht
- F
- Eingang
- 07.05.2022
- Impfdatum
- 02.05.2022
- Beginn
- 02.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Symptomtext
Patient was administered with expired dose; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient was administered with expired dose) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 vaccination. No Medical History information was reported. On 02-May-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 02-May-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient was administered with expired dose). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient was administered with expired dose) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medications were reported. Number of doses/ vials administered 13doses from 2 vials. Date the vial was initially stored in the refrigerator was unknown. The vial had not undergone any temperature excursion. No treatment medications were reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MA
- Alter
- 64,0
- Geschlecht
- M
- Eingang
- 07.05.2022
- Impfdatum
- 03.05.2022
- Beginn
- 03.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Symptomtext
Expired doses administered to 13 patients; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired doses administered to 13 patients) in a 64-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 vaccination. No Medical History information was reported. On 03-May-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 03-May-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired doses administered to 13 patients). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired doses administered to 13 patients) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medication information provided. Number of doses/vials was 13 doses from 2 vials. Date the vial was initially stored in the refrigerator was unknown. The vial did not undergo any temperature excursions. It was unknown if the patient experienced any symptoms. No treatment medication information provided
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MA
- Alter
- 47,0
- Geschlecht
- F
- Eingang
- 07.05.2022
- Impfdatum
- 02.05.2022
- Beginn
- 02.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Symptomtext
Expired doses administered to 13 patients; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired doses administered to 13 patients) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 vaccination. No Medical History information was reported. On 02-May-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 02-May-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired doses administered to 13 patients). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired doses administered to 13 patients) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Concomitant medication was not provided. Date the vial was initially stored in the refrigerator was not known. The vial did not undergo any temperature excursions. It was unknown if any of the patients experienced any symptoms. Treatment medication was not provided.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- DE
- Alter
- -
- Geschlecht
- U
- Eingang
- 06.05.2022
- Impfdatum
- 03.05.2022
- Beginn
- 03.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Symptomtext
Dose administered after manufacturer date of expiry; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Dose administered after manufacturer date of expiry) in a patient of an unknown age and gender who received mRNA-1273 (Spikevax) (batch no. 042J21A) for COVID-19 vaccination. No Medical History information was reported. On 03-May-2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 03-May-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Dose administered after manufacturer date of expiry). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Dose administered after manufacturer date of expiry) outcome was unknown. For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments. No concomitant medications were reported. One of the medical assistants or nurses gave a Moderna COVID-19 vaccination after its expiration date. The expiration date tool states it is 29 Apr 2022 and they administered it on 03 May 2022. Vial did not undergo any temperature excursions. No treatment medications were reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- -
- Geschlecht
- U
- Eingang
- 06.05.2022
- Impfdatum
- 04.05.2022
- Beginn
- 04.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Product storage error
Symptomtext
Vaccine was expired on 29-Apr-2022, refrigerated on 03-May-2022 and administered on 04-May-2022; Administered with an expired vaccine; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administered with an expired vaccine) and PRODUCT STORAGE ERROR (Vaccine was expired on 29-Apr-2022, refrigerated on 03-May-2022 and administered on 04-May-2022) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 vaccination. No Medical History information was reported. On 04-May-2022 at 9:30 AM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-May-2022 at 9:30 AM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administered with an expired vaccine). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine was expired on 29-Apr-2022, refrigerated on 03-May-2022 and administered on 04-May-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Administered with an expired vaccine) and PRODUCT STORAGE ERROR (Vaccine was expired on 29-Apr-2022, refrigerated on 03-May-2022 and administered on 04-May-2022) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medications were reported. On 04-May-2022, one patient was administered expired booster dose of Moderna Covid-19 vaccine. The vial was initially stored in refrigerator on 03-May-2022 at 11am and the vial did not undergo any temperature excursions. No treatment medications was reported. Most recent FOLLOW-UP information incorporated above includes: On 04-May-2022: Live follow up received contains Significant information of Updated details about the expired vial received.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- -
- Geschlecht
- U
- Eingang
- 06.05.2022
- Impfdatum
- 02.05.2022
- Beginn
- 02.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Symptomtext
Patient received an expired vaccine which got expired on 29-Apr-2021; This spontaneous case was reported by a physician assistant and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient received an expired vaccine which got expired on 29-Apr-2021) in a patient of an unknown age and gender who received mRNA-1273 (Spikevax) (batch no. 042J21A) for COVID-19 vaccination. No Medical History information was reported. On 02-May-2022, the patient received second dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 02-May-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient received an expired vaccine which got expired on 29-Apr-2021). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient received an expired vaccine which got expired on 29-Apr-2021) outcome was unknown. For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments. No concomitant medications were provided by reporter. It was patient's 2nd dose. The patient was fine, has not reported any side effects. The date in which the vial was initially stored in the refrigerator was reported as it came directly from freezer on 02-May-2022. The vial did not undergo any temperature excursions. No treatment medications were provided by reporter.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MA
- Alter
- 54,0
- Geschlecht
- M
- Eingang
- 06.05.2022
- Impfdatum
- 03.05.2022
- Beginn
- 03.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Symptomtext
Expired doses administered to 13 patients; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired doses administered to 13 patients) in a 54-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 vaccination. No Medical History information was reported. On 03-May-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 03-May-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired doses administered to 13 patients). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired doses administered to 13 patients) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant product use was provided. Date the vial was initially stored in the refrigerator was unknown. The vial did not undergo any temperature excursions. It was unknown if the patient experienced any symptoms. No treatment medication was provided.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MA
- Alter
- 51,0
- Geschlecht
- F
- Eingang
- 06.05.2022
- Impfdatum
- 02.05.2022
- Beginn
- 02.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Symptomtext
Expired dose administered to patient; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired dose administered to patient) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 vaccination. No Medical History information was reported. On 02-May-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 02-May-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired dose administered to patient). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired dose administered to patient) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medication was reported. Date the vial was initially stored in the refrigerator was unknown. The vial did not undergo any temperature excursions. It was unknown if the patient experienced any symptoms. No treatment medications was reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MA
- Alter
- 75,0
- Geschlecht
- M
- Eingang
- 06.05.2022
- Impfdatum
- 03.05.2022
- Beginn
- 03.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Symptomtext
patients where vaccinated on 2May2022 and 3May2022 with expired doses of Moderna COVID-19 Vaccine; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (patients where vaccinated on 2May2022 and 3May2022 with expired doses of Moderna COVID-19 Vaccine) in a 75-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 vaccination. No Medical History information was reported. On 03-May-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 03-May-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (patients where vaccinated on 2May2022 and 3May2022 with expired doses of Moderna COVID-19 Vaccine). At the time of the report, EXPIRED PRODUCT ADMINISTERED (patients where vaccinated on 2May2022 and 3May2022 with expired doses of Moderna COVID-19 Vaccine) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant drug was reported. It was reported that 13 patients were vaccinated on 2-May-2022 and 3-May-2022 with expired doses of Moderna COVID-19 Vaccine. The vial did not undergo any temperature excursions It is unknown if any of the patients experienced any symptoms. No treatment drug was reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MA
- Alter
- 80,0
- Geschlecht
- F
- Eingang
- 06.05.2022
- Impfdatum
- 03.05.2022
- Beginn
- 03.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Symptomtext
Received vaccine expired on 29-Apr-2022; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Received vaccine expired on 29-Apr-2022) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 vaccination. No Medical History information was reported. On 03-May-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 03-May-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Received vaccine expired on 29-Apr-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Received vaccine expired on 29-Apr-2022) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medications were reported. It was reported that the vial did not undergo any temperature excursions. No treatment medications were reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MA
- Alter
- 51,0
- Geschlecht
- M
- Eingang
- 06.05.2022
- Impfdatum
- 02.05.2022
- Beginn
- 02.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Symptomtext
Expired dose administered to patient; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired dose administered to patient) in a 51-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 vaccination. No Medical History information was reported. On 02-May-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 02-May-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired dose administered to patient). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired dose administered to patient) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medications were reported. The vial did not undergo any temperature excursions. No treatment medications were reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MA
- Alter
- 69,0
- Geschlecht
- U
- Eingang
- 06.05.2022
- Impfdatum
- 03.05.2022
- Beginn
- 03.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Symptomtext
Vaccinated with expired dose of Moderna COVID-19 Vaccine; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccinated with expired dose of Moderna COVID-19 Vaccine) in a 69-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 vaccination. No Medical History information was reported. On 03-May-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 03-May-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccinated with expired dose of Moderna COVID-19 Vaccine). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccinated with expired dose of Moderna COVID-19 Vaccine) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medication was reported. Patient was administered with 0.25 ml of vaccine on 03-May-2022 (Expiry: 29-Apr-2022). It was unknown if the patient experienced any symptoms. The vial didn't undergo any temperature excursions. Date the vial was initially stored in the refrigerator was unknown. No treatment information was reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MA
- Alter
- 75,0
- Geschlecht
- F
- Eingang
- 06.05.2022
- Impfdatum
- 02.05.2022
- Beginn
- 02.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Symptomtext
Expired dose administered to patient / Dose administered after 30-day Use By Date or after manufacturer date of expiry; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired dose administered to patient / Dose administered after 30-day Use By Date or after manufacturer date of expiry) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 vaccination. No Medical History information was reported. On 02-May-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 02-May-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired dose administered to patient / Dose administered after 30-day Use By Date or after manufacturer date of expiry). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired dose administered to patient / Dose administered after 30-day Use By Date or after manufacturer date of expiry) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No Concomitant product use was reported. The reporter stated that the patient was vaccinated on 02-May-2022 with expired doses of Moderna COVID-19 Vaccine. The dose was administered after 30-day Use by Date or after manufacturer date of expiry. The date when the vial was initially stored in the refrigerator was unknown. Reportedly, the vial didn't undergo any temperature excursions. It was unknown if the patient had experienced any symptoms. No treatment information was provided.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MA
- Alter
- 78,0
- Geschlecht
- F
- Eingang
- 06.05.2022
- Impfdatum
- 02.05.2022
- Beginn
- 02.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Product storage error
Symptomtext
Dose administered after 30-day Use By Date or after manufacturer date of expiry; Expired doses administered to 13 patients; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired doses administered to 13 patients) and PRODUCT STORAGE ERROR (Dose administered after 30-day Use By Date or after manufacturer date of expiry) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 vaccination. No Medical History information was reported. On 02-May-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 02-May-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired doses administered to 13 patients). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Dose administered after 30-day Use By Date or after manufacturer date of expiry). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired doses administered to 13 patients) and PRODUCT STORAGE ERROR (Dose administered after 30-day Use By Date or after manufacturer date of expiry) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Vial did not undergo any temperature excursions. No relevant concomitant medications were reported. No treatment information was provided.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MA
- Alter
- 79,0
- Geschlecht
- M
- Eingang
- 06.05.2022
- Impfdatum
- 02.05.2022
- Beginn
- 02.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Symptomtext
Expired doses administered to 13 patients; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired doses administered to 13 patients) in a 79-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 vaccination. No Medical History information was reported. On 02-May-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 02-May-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired doses administered to 13 patients). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired doses administered to 13 patients) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medication information provided. Date the vial was initially stored in the refrigerator was unknown. The vial did not undergo any temperature excursions. It was unknown if the patient experienced any symptoms. No treatment medication information provided.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MA
- Alter
- 70,0
- Geschlecht
- F
- Eingang
- 05.05.2022
- Impfdatum
- 02.05.2022
- Beginn
- 02.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Symptomtext
Expired dose administered to patient; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired dose administered to patient) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 vaccination. No Medical History information was reported. On 02-May-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 02-May-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired dose administered to patient). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired dose administered to patient) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. vial didn't undergo any temperature excursions No Concomitant Products were reported. No Treatment information was reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 72,0
- Geschlecht
- F
- Eingang
- 02.05.2022
- Impfdatum
- 19.02.2022
- Beginn
- 25.04.2022
- Tage bis Beginn
- 65,0
- Dosis
- 1
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
COVID-19
Fall
SARS-CoV-2 test positive
Symptomtext
04/25/22 presents to EC ED for "fall". PMHx of "schizophrenia"
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- COVID-19
- Hospital-Tage
- -
- Labordaten
- 04/25/22 SARS-CoV-2 (COVID-19) by NAA detected
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- -
- Geschlecht
- U
- Eingang
- 28.04.2022
- Impfdatum
- 25.04.2022
- Beginn
- 25.04.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Product storage error
Symptomtext
Beyond the 30 day use by date, 22Apr2022; Inadvertently administered to a patient an expired dose of the Moderna COVID-19 vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Inadvertently administered to a patient an expired dose of the Moderna COVID-19 vaccine) and PRODUCT STORAGE ERROR (Beyond the 30 day use by date, 22Apr2022) in a patient of an unknown age and gender who received mRNA-1273 (Spikevax) (batch no. 042J21A) for COVID-19 vaccination. No Medical History information was reported. On 25-Apr-2022, the patient received second dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 25-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Inadvertently administered to a patient an expired dose of the Moderna COVID-19 vaccine). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Beyond the 30 day use by date, 22Apr2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Inadvertently administered to a patient an expired dose of the Moderna COVID-19 vaccine) and PRODUCT STORAGE ERROR (Beyond the 30 day use by date, 22Apr2022) outcome was unknown. For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments. No concomitant medication was reported. The vaccine was administered to the patient around lunch time on 25-Apr-2022 probably at 12 noon. The vial was stored in refrigerator on 23-Mar-2022. The vial doesn't undergone any temperature excursion. It was reported that it would be the second dose of vaccine. No treatment medications was reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 27,0
- Geschlecht
- F
- Eingang
- 25.04.2022
- Impfdatum
- 25.04.2022
- Beginn
- 25.04.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Expired product administered
Symptomtext
Administered on 04/25/22, expiration date 04/22/22
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- No know illness prior to vaccine
- Vorgeschichte
- -
- Andere Medikamente
- Effexor
- Allergien
- PCN-rash
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 74,0
- Geschlecht
- M
- Eingang
- 21.04.2022
- Impfdatum
- 20.04.2022
- Beginn
- 20.04.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Blood pressure decreased
Feeling abnormal
Vision blurred
Symptomtext
2 hours after vaccine, felt poorly and blurry vision. Nurse called to home. Blood pressure less than 70/40. Provided supportive care with oral fluids and rest. After 3 hours, all vitals returned to normal and felt "fine" again.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Blood pressure decreased
- Hospital-Tage
- -
- Labordaten
- None.
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- CHF, COPD
- Andere Medikamente
- Hydrocodone, Hydralazine, Amlodipine, ASA, Buspirone (taken in the am)
- Allergien
- Morphine, PCN, Loratadine, shellfish
- Vorherige Impfungen
- -
- Staat
- NY
- Alter
- 49,0
- Geschlecht
- M
- Eingang
- 20.04.2022
- Impfdatum
- 30.03.2022
- Beginn
- 30.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Inappropriate schedule of product administration
Symptomtext
Patient was given a booster of Moderna COVID vaccine on 3/30/22 which was too early. Due to late reporting (delay in data transfer. data had been referenced to verify eligibility for booster. During an audit it was discovered that the 1/19/22 booster administration information did not transfer in a timely fashion thus making it look like he was eligible for his booster on 3/30/22. Outpatient clinic treatment team leader notified patient and reminded him to contact his doctor.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Inappropriate schedule of product administration
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 52,0
- Geschlecht
- F
- Eingang
- 15.04.2022
- Impfdatum
- 02.04.2022
- Beginn
- 15.04.2022
- Tage bis Beginn
- 13,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Inappropriate schedule of product administration
Symptomtext
Patient received Moderna booster 1 on 12/17/21 and received Moderna booster 2 on 04/2/22 - 15 days earlier than recommended
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Inappropriate schedule of product administration
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NY
- Alter
- 16,0
- Geschlecht
- F
- Eingang
- 14.04.2022
- Impfdatum
- 31.03.2022
- Beginn
- 31.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Product administered to patient of inappropriate age
Symptomtext
Pt of 16 years old was given booster dose of .25mL Moderna covid vaccine on 03/31/2022. Was not noted until audit on 4/12/22. Notified Moderna on 04/13/22, spoke with patients parent on 04/13/22 to assess for symptoms/side effects/adverse events which patient was negative for. Moderna response not received at time of VAERS report submission.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product administered to patient of inappropriate age
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- allergic rhinitis, dysuria nos
- Vorgeschichte
- Seasonal Allergies and adjustment disorder
- Andere Medikamente
- Hydroxyzine HCl, Fluticasone propionate, melatonin, loratidine
- Allergien
- NKA
- Vorherige Impfungen
- -
- Staat
- IA
- Alter
- 16,0
- Geschlecht
- M
- Eingang
- 13.04.2022
- Impfdatum
- 06.04.2022
- Beginn
- 06.04.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product administered to patient of inappropriate age
Symptomtext
Patient given Moderna vaccine, which is not approved for persons under the age of 18. No known adverse events from this vaccine.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- no
- Vorgeschichte
- unknown
- Andere Medikamente
- unkown
- Allergien
- unknown
- Vorherige Impfungen
- -
- Staat
- VA
- Alter
- 16,0
- Geschlecht
- M
- Eingang
- 13.04.2022
- Impfdatum
- 12.04.2022
- Beginn
- 12.04.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Product administered to patient of inappropriate age
Symptomtext
A 16-year old patient was inadvertently administered dose 1 of MODERNA vaccine by volunteer vaccinator. Patient had no immediate adverse reaction, incident was discussed with Mom, counseled on monitoring, management and next doses to be scheduled .
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product administered to patient of inappropriate age
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- VA
- Alter
- 49,0
- Geschlecht
- F
- Eingang
- 08.04.2022
- Impfdatum
- 08.04.2022
- Beginn
- 08.04.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Inappropriate schedule of product administration
No adverse event
Symptomtext
Patient received booster dose (0.25ml) 16 days earlier than recommended time frame. No adverse reactions were noted at the time of administration. Primary series completed 11/24/21. Booster administered 04/08/22.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Inappropriate schedule of product administration
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- AK
- Alter
- 20,0
- Geschlecht
- F
- Eingang
- 03.04.2022
- Impfdatum
- 01.04.2022
- Beginn
- 01.04.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Inappropriate schedule of product administration
Interchange of vaccine products
Underdose
Symptomtext
Patient arrived for appointment and requested a "Moderna booster." Screening personnel failed to notice that patient had recently received her first dose of Pfizer vaccine in the primary COVID-19 vaccine series on 09 Mar 2022. Patient inadvertently received a booster 0.25mL dose of Moderna vaccine per her verbal request instead of the appropriate Pfizer second primary series dose. Once error was identified, patient had already left vaccination site. Patient contacted and notified of error. Corrective action per CDC's guidance was to administer another 0.25mL dose of Moderna vaccine same day to make a full 0.5mL dose of Moderna and patient would be considered to have a complete primary mixed series. Patient was able to return and received a second dose of 0.25mL Moderna vaccine. When reviewing record to submit a patient safety report, it was observed that it had only been 23 days since first dose of Pfizer, and patient did not meet minimum spacing of 28 days for a mixed primary series. This dose was given 5 days too early. Recommendation is to repeat dose 4 weeks later to ensure patient is protected. No known adverse events at this time.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Inappropriate schedule of product administration
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- IL
- Alter
- 80,0
- Geschlecht
- U
- Eingang
- 31.03.2022
- Impfdatum
- 16.03.2022
- Beginn
- 16.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Product storage error
Symptomtext
The vial was initially stored in the refrigerator on 31-Jan-2022 and administered to the patient on 16-Mar-2022; Moderna Covid-19 vaccine that was beyond 30 day use by date was given to 16 patients. This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Moderna Covid-19 vaccine that was beyond 30 day use by date was given to 16 patients.) and PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 31-Jan-2022 and administered to the patient on 16-Mar-2022) in an 80-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 vaccination. No Medical History information was reported. On 16-Mar-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Mar-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Moderna Covid-19 vaccine that was beyond 30 day use by date was given to 16 patients.). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 31-Jan-2022 and administered to the patient on 16-Mar-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Moderna Covid-19 vaccine that was beyond 30 day use by date was given to 16 patients.) and PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 31-Jan-2022 and administered to the patient on 16-Mar-2022) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medications were reported. It was reported that date the vial was initially stored in the refrigerator was on 31-Jan-2022. The vial did not undergo any temperature excursions. No treatment medications were reported. This case was linked to MOD-2022-525860 (Patient Link).
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- IL
- Alter
- 62,0
- Geschlecht
- U
- Eingang
- 31.03.2022
- Impfdatum
- 09.03.2022
- Beginn
- 09.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Product storage error
Symptomtext
Date the vial was initially stored in the refrigerator was 31Jan2022 and Administered on 09Mar2022; Moderna Covid-19 vaccine that was beyond 30 day use by date was given to patient; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Moderna Covid-19 vaccine that was beyond 30 day use by date was given to patient) and PRODUCT STORAGE ERROR (Date the vial was initially stored in the refrigerator was 31Jan2022 and Administered on 09Mar2022) in a 62-year-old patient of an unknown gender who received mRNA-1273 (Spikevax) (batch no. 042J21A) for COVID-19 vaccination. No Medical History information was reported. On 09-Mar-2022, the patient received second dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 09-Mar-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Moderna Covid-19 vaccine that was beyond 30 day use by date was given to patient). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Date the vial was initially stored in the refrigerator was 31Jan2022 and Administered on 09Mar2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Moderna Covid-19 vaccine that was beyond 30 day use by date was given to patient) and PRODUCT STORAGE ERROR (Date the vial was initially stored in the refrigerator was 31Jan2022 and Administered on 09Mar2022) outcome was unknown. For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments. No concomitant medications were reported. Reporter stated that the vial was initially stored in the refrigerator on 31-Jan-2022 and the vial did not undergo any temperature excursions. No treatment medications were reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- IL
- Alter
- 60,0
- Geschlecht
- U
- Eingang
- 31.03.2022
- Impfdatum
- 09.03.2022
- Beginn
- 09.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Product storage error
Symptomtext
Moderna Covid-19 vaccine that was beyond 30 day use by date was given to 16 patients.; Moderna Covid-19 vaccine that was beyond 30 day use by date was given to 16 patients.; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Moderna Covid-19 vaccine that was beyond 30 day use by date was given to 16 patients.) and PRODUCT STORAGE ERROR (Moderna Covid-19 vaccine that was beyond 30 day use by date was given to 16 patients.) in a 60-year-old patient of an unknown gender who received mRNA-1273 (Spikevax) (batch no. 042J21A) for COVID-19 vaccination. No Medical History information was reported. On 09-Mar-2022, the patient received second dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 09-Mar-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Moderna Covid-19 vaccine that was beyond 30 day use by date was given to 16 patients.). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Moderna Covid-19 vaccine that was beyond 30 day use by date was given to 16 patients.). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Moderna Covid-19 vaccine that was beyond 30 day use by date was given to 16 patients.) and PRODUCT STORAGE ERROR (Moderna Covid-19 vaccine that was beyond 30 day use by date was given to 16 patients.) outcome was unknown. For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments. No relevant concomitant medications were reported. Treatment information was unknown. This case was linked to MOD-2022-525860 (Patient Link).
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- IL
- Alter
- 45,0
- Geschlecht
- U
- Eingang
- 31.03.2022
- Impfdatum
- 09.03.2022
- Beginn
- 09.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Product storage error
Symptomtext
The vial was initially stored in the refrigerator on 31-Jan-2022 and administered to the patient on 09-Mar-2022; Moderna COVID-19 vaccine that was beyond 30 day use by date was given to patient.; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Moderna COVID-19 vaccine that was beyond 30 day use by date was given to patient.) and PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 31-Jan-2022 and administered to the patient on 09-Mar-2022) in a 45-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 vaccination. No Medical History information was reported. On 09-Mar-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Mar-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Moderna COVID-19 vaccine that was beyond 30 day use by date was given to patient.). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 31-Jan-2022 and administered to the patient on 09-Mar-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Moderna COVID-19 vaccine that was beyond 30 day use by date was given to patient.) and PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 31-Jan-2022 and administered to the patient on 09-Mar-2022) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medications were reported. It was reported that date the vial was initially stored in the refrigerator on 31-Jan-2022. The vial did not undergo any temperature excursions. No treatment medications were reported. This case was linked to MOD-2022-525860 (Patient Link).
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- IL
- Alter
- 50,0
- Geschlecht
- U
- Eingang
- 31.03.2022
- Impfdatum
- 09.03.2022
- Beginn
- 09.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Product storage error
Symptomtext
Vial was initially stored in the refrigerator on 31 Jan 2022 and administered on 09 Mar 2022; Moderna Covid-19 vaccine that was beyond 30 day use by date was given to 16 patients.; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Moderna Covid-19 vaccine that was beyond 30 day use by date was given to 16 patients.) and PRODUCT STORAGE ERROR (Vial was initially stored in the refrigerator on 31 Jan 2022 and administered on 09 Mar 2022) in a 50-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 vaccination. No Medical History information was reported. On 09-Mar-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Mar-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Moderna Covid-19 vaccine that was beyond 30 day use by date was given to 16 patients.). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vial was initially stored in the refrigerator on 31 Jan 2022 and administered on 09 Mar 2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Moderna Covid-19 vaccine that was beyond 30 day use by date was given to 16 patients.) and PRODUCT STORAGE ERROR (Vial was initially stored in the refrigerator on 31 Jan 2022 and administered on 09 Mar 2022) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medication was reported by the reporter. No treatment medication was reported by the reporter.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- IL
- Alter
- 60,0
- Geschlecht
- U
- Eingang
- 31.03.2022
- Impfdatum
- 09.03.2022
- Beginn
- 09.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Product storage error
Symptomtext
Date the vial was initially stored in the refrigerator 31-Jan-2022, Date(s) of administration of vaccine 09-Mar-2022; Moderna Covid-19 vaccine that was beyond 30 day use by date was given; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Moderna Covid-19 vaccine that was beyond 30 day use by date was given) and PRODUCT STORAGE ERROR (Date the vial was initially stored in the refrigerator 31-Jan-2022, Date(s) of administration of vaccine 09-Mar-2022) in a 60-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 vaccination. No Medical History information was reported. On 09-Mar-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Mar-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Moderna Covid-19 vaccine that was beyond 30 day use by date was given). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Date the vial was initially stored in the refrigerator 31-Jan-2022, Date(s) of administration of vaccine 09-Mar-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Moderna Covid-19 vaccine that was beyond 30 day use by date was given) and PRODUCT STORAGE ERROR (Date the vial was initially stored in the refrigerator 31-Jan-2022, Date(s) of administration of vaccine 09-Mar-2022) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medications were reported. On 31-Jan-2022 the vial was initially stored in the refrigerator. The vials did not undergo any temperature excursions. This case was linked to MOD-2022-525860, MOD-2022-525834, MOD-2022-525851, MOD-2022-525860, MOD-2022-525866, MOD-2022-525870, MOD-2022-525874, MOD-2022-525880, MOD-2022-525890, MOD-2022-525893, MOD-2022-525896, MOD-2022-525903, MOD-2022-525906, MOD-2022-525912, MOD-2022-525915, MOD-2022-525918 (Patient Link).
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- IL
- Alter
- 61,0
- Geschlecht
- U
- Eingang
- 31.03.2022
- Impfdatum
- 09.03.2022
- Beginn
- 09.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Product storage error
Symptomtext
Vial was initially stored in the refrigerator on 31-Jan-2022 and administered on 09-Mar-2022; Moderna Covid-19 vaccine that was beyond 30 day use by date was given to 16 patients. This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Moderna Covid-19 vaccine that was beyond 30 day use by date was given to 16 patients.) and PRODUCT STORAGE ERROR (Vial was initially stored in the refrigerator on 31-Jan-2022 and administered on 09-Mar-2022) in a 61-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 vaccination. No Medical History information was reported. On 09-Mar-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Mar-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Moderna Covid-19 vaccine that was beyond 30 day use by date was given to 16 patients.). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vial was initially stored in the refrigerator on 31-Jan-2022 and administered on 09-Mar-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Moderna Covid-19 vaccine that was beyond 30 day use by date was given to 16 patients.) and PRODUCT STORAGE ERROR (Vial was initially stored in the refrigerator on 31-Jan-2022 and administered on 09-Mar-2022) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Concomitant medication list was not provided. It was reported tat the patient took half dose booster. Vial was initially stored in the refrigerator on 31-Jan-2022. It was reported that the vial did not undergo any temperature excursions. Treatment information was not provided. This case was linked to MOD-2022-525860 (Patient Link).
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- IL
- Alter
- 49,0
- Geschlecht
- U
- Eingang
- 31.03.2022
- Impfdatum
- 09.03.2022
- Beginn
- 28.03.2022
- Tage bis Beginn
- 19,0
- Dosis
- 3
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Product storage error
Symptomtext
Moderna Covid-19 vaccine that was beyond 30 day use by date was given to 16 patients.; Moderna Covid-19 vaccine that was beyond 30 day use by date was given to 16 patients.; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Moderna Covid-19 vaccine that was beyond 30 day use by date was given to 16 patients.) and PRODUCT STORAGE ERROR (Moderna Covid-19 vaccine that was beyond 30 day use by date was given to 16 patients.) in a 49-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 vaccination. No Medical History information was reported. On 09-Mar-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Mar-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Moderna Covid-19 vaccine that was beyond 30 day use by date was given to 16 patients.). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Moderna Covid-19 vaccine that was beyond 30 day use by date was given to 16 patients.). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Moderna Covid-19 vaccine that was beyond 30 day use by date was given to 16 patients.) and PRODUCT STORAGE ERROR (Moderna Covid-19 vaccine that was beyond 30 day use by date was given to 16 patients.) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medication information provided. Date the vial was initially stored in the refrigerator: 31Jan2022. The vial did not undergo any temperature excursions. No treatment information provided. This case was linked to MOD-2022-525860 (Patient Link).
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- IL
- Alter
- 38,0
- Geschlecht
- U
- Eingang
- 31.03.2022
- Impfdatum
- 09.03.2022
- Beginn
- 09.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Product storage error
Symptomtext
Moderna COVID-19 vaccine that was beyond 30 day use by date was given to 16 patients; Moderna COVID-19 vaccine that was beyond 30 day use by date was given to 16 patients; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Moderna COVID-19 vaccine that was beyond 30 day use by date was given to 16 patients) and PRODUCT STORAGE ERROR (Moderna COVID-19 vaccine that was beyond 30 day use by date was given to 16 patients) in a 38-year-old patient of an unknown gender who received mRNA-1273 (Spikevax) (batch no. 042J21A) for COVID-19 vaccination. No Medical History information was reported. On 09-Mar-2022, the patient received first dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 09-Mar-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Moderna COVID-19 vaccine that was beyond 30 day use by date was given to 16 patients). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Moderna COVID-19 vaccine that was beyond 30 day use by date was given to 16 patients). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Moderna COVID-19 vaccine that was beyond 30 day use by date was given to 16 patients) and PRODUCT STORAGE ERROR (Moderna COVID-19 vaccine that was beyond 30 day use by date was given to 16 patients) outcome was unknown. For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments. No concomitant medications were reported. Vial did not undergo temperature excursions. It was reported that date the vial was initially stored in the refrigerator was on 31-Jan-2022. Treatment information was not provided. This case was linked to MOD-2022-525860 (Patient Link).
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- IL
- Alter
- 71,0
- Geschlecht
- U
- Eingang
- 31.03.2022
- Impfdatum
- 16.03.2022
- Beginn
- 16.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Product storage error
Symptomtext
The vial was initially stored in the refrigerator on 31-Jan-2022 and administered to the patient on 16-Mar-2022; Moderna Covid-19 vaccine that was beyond 30 day use by date was given to 16 patients.; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Moderna Covid-19 vaccine that was beyond 30 day use by date was given to 16 patients.) and PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 31-Jan-2022 and administered to the patient on 16-Mar-2022) in a 71-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 vaccination. No Medical History information was reported. On 16-Mar-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Mar-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Moderna Covid-19 vaccine that was beyond 30 day use by date was given to 16 patients.). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 31-Jan-2022 and administered to the patient on 16-Mar-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Moderna Covid-19 vaccine that was beyond 30 day use by date was given to 16 patients.) and PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 31-Jan-2022 and administered to the patient on 16-Mar-2022) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medications were reported. It was reported that date the vial was initially stored in the refrigerator was on 31-Jan-2022. No temperature excursion. No treatment medications were reported. This case was linked to MOD-2022-525860 (Patient Link).
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- IL
- Alter
- 85,0
- Geschlecht
- U
- Eingang
- 31.03.2022
- Impfdatum
- 16.03.2022
- Beginn
- 16.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Symptomtext
Moderna Covid-19 vaccine that was beyond 30 day use by date was given to 16 patients.; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Moderna Covid-19 vaccine that was beyond 30 day use by date was given to 16 patients.) in an 85-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 vaccination. No Medical History information was reported. On 16-Mar-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 16-Mar-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Moderna Covid-19 vaccine that was beyond 30 day use by date was given to 16 patients.). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Moderna Covid-19 vaccine that was beyond 30 day use by date was given to 16 patients.) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medication information provided. No treatment medication information provided. Date the vial was initially stored in the refrigerator was 31 Jan 2022 The vial did not undergo any temperature excursion. This case was linked to MOD-2022-525860.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- IL
- Alter
- 78,0
- Geschlecht
- U
- Eingang
- 31.03.2022
- Impfdatum
- 16.03.2022
- Beginn
- 16.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Product storage error
Symptomtext
Moderna Covid-19 vaccine that was beyond 30 day use by date was given to patient.; Moderna Covid-19 vaccine that was beyond 30 day use by date was given to patient.; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Moderna Covid-19 vaccine that was beyond 30 day use by date was given to patient.) and PRODUCT STORAGE ERROR (Moderna Covid-19 vaccine that was beyond 30 day use by date was given to patient.) in a 78-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 vaccination. No Medical History information was reported. On 16-Mar-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Mar-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Moderna Covid-19 vaccine that was beyond 30 day use by date was given to patient.). On an unknown date, the patient PRODUCT STORAGE ERROR (Moderna Covid-19 vaccine that was beyond 30 day use by date was given to patient.). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Moderna Covid-19 vaccine that was beyond 30 day use by date was given to patient.) and PRODUCT STORAGE ERROR (Moderna Covid-19 vaccine that was beyond 30 day use by date was given to patient.) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Concomitant medication list was not provided. It was reported that the patient took half dose booster. Vial was initially stored in the refrigerator on 31-Jan-2022. It was reported that the vial did not undergo any temperature excursions. Treatment information was not provided.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- IL
- Alter
- 61,0
- Geschlecht
- U
- Eingang
- 31.03.2022
- Impfdatum
- 16.03.2022
- Beginn
- 28.03.2022
- Tage bis Beginn
- 12,0
- Dosis
- 3
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Product storage error
Symptomtext
Moderna Covid-19 vaccine that was beyond 30 day use by date was given to patient; Moderna Covid-19 vaccine that was beyond 30 day use by date was given to patient; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Moderna Covid-19 vaccine that was beyond 30 day use by date was given to patient) and PRODUCT STORAGE ERROR (Moderna Covid-19 vaccine that was beyond 30 day use by date was given to patient) in a 61-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 vaccination. No Medical History information was reported. On 16-Mar-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Mar-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Moderna Covid-19 vaccine that was beyond 30 day use by date was given to patient). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Moderna Covid-19 vaccine that was beyond 30 day use by date was given to patient). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Moderna Covid-19 vaccine that was beyond 30 day use by date was given to patient) and PRODUCT STORAGE ERROR (Moderna Covid-19 vaccine that was beyond 30 day use by date was given to patient) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medications were reported. No treatment medications were reported. It was reported that date the vial was initially stored in the refrigerator was 31-Jan-2022. This case was linked to MOD-2022-525834, MOD-2022-525860, MOD-2022-525870, MOD-2022-525874, MOD-2022-525880, MOD-2022-525890, MOD-2022-525893, MOD-2022-525896, MOD-2022-525900, MOD-2022-525903, MOD-2022-525912, MOD-2022-525915, MOD-2022-525860 (Patient Link).
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- IL
- Alter
- 60,0
- Geschlecht
- U
- Eingang
- 31.03.2022
- Impfdatum
- 16.03.2022
- Beginn
- 16.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Product storage error
Symptomtext
Moderna Covid-19 vaccine that was beyond 30 day use by date was given to 16 patients.; Moderna Covid-19 vaccine that was beyond 30 day use by date was given to 16 patients.; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Moderna Covid-19 vaccine that was beyond 30 day use by date was given to 16 patients.) and PRODUCT STORAGE ERROR (Moderna Covid-19 vaccine that was beyond 30 day use by date was given to 16 patients.) in a 60-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 vaccination. No Medical History information was reported. On 16-Mar-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 16-Mar-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Moderna Covid-19 vaccine that was beyond 30 day use by date was given to 16 patients.). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Moderna Covid-19 vaccine that was beyond 30 day use by date was given to 16 patients.). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Moderna Covid-19 vaccine that was beyond 30 day use by date was given to 16 patients.) and PRODUCT STORAGE ERROR (Moderna Covid-19 vaccine that was beyond 30 day use by date was given to 16 patients.) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medications were reported. Treatment information was not provided.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- IL
- Alter
- 63,0
- Geschlecht
- U
- Eingang
- 31.03.2022
- Impfdatum
- 16.03.2022
- Beginn
- 16.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Product storage error
Symptomtext
Moderna Covid-19 vaccine that was beyond 30 day use by date was given to 16 patients.; Moderna Covid-19 vaccine that was beyond 30 day use by date was given to 16 patients.; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Moderna Covid-19 vaccine that was beyond 30 day use by date was given to 16 patients.) and PRODUCT STORAGE ERROR (Moderna Covid-19 vaccine that was beyond 30 day use by date was given to 16 patients.) in a 63-year-old patient of an unknown gender who received mRNA-1273 (Spikevax) (batch no. 042J21A) for COVID-19 vaccination. No Medical History information was reported. On 16-Mar-2022, the patient received first dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 16-Mar-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Moderna Covid-19 vaccine that was beyond 30 day use by date was given to 16 patients.). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Moderna Covid-19 vaccine that was beyond 30 day use by date was given to 16 patients.). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Moderna Covid-19 vaccine that was beyond 30 day use by date was given to 16 patients.) and PRODUCT STORAGE ERROR (Moderna Covid-19 vaccine that was beyond 30 day use by date was given to 16 patients.) outcome was unknown. For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments. No concomitant medications were reported. Vial did not undergo temperature excursions. It was reported that date the vial was initially stored in the refrigerator was 31-Jan-2022. No treatment medications were reported. This case was linked to MOD-2022-525860.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 27,0
- Geschlecht
- M
- Eingang
- 30.03.2022
- Impfdatum
- 11.03.2022
- Beginn
- 11.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Incorrect dose administered
Symptomtext
This dose was a booster after an initial Janssen dose. The dose should have been 0.25ml, however, a 0.5ml dose was given.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Incorrect dose administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- IL
- Alter
- 23,0
- Geschlecht
- U
- Eingang
- 30.03.2022
- Impfdatum
- 09.03.2022
- Beginn
- 09.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Product storage error
Symptomtext
Vial was initially stored in the refrigerator on 31-Jan-2022 and administered on 09-Mar-2022; Moderna Covid-19 vaccine that was beyond 30 day use by date was given to 16 patients.; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Moderna Covid-19 vaccine that was beyond 30 day use by date was given to 16 patients.) and PRODUCT STORAGE ERROR (Vial was initially stored in the refrigerator on 31-Jan-2022 and administered on 09-Mar-2022) in a 23-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 vaccination. No Medical History information was reported. On 09-Mar-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 09-Mar-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Moderna Covid-19 vaccine that was beyond 30 day use by date was given to 16 patients.). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vial was initially stored in the refrigerator on 31-Jan-2022 and administered on 09-Mar-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Moderna Covid-19 vaccine that was beyond 30 day use by date was given to 16 patients.) and PRODUCT STORAGE ERROR (Vial was initially stored in the refrigerator on 31-Jan-2022 and administered on 09-Mar-2022) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Concomitant product information was not provided. The vial was initially stored in the refrigerator on 31-Jan-2022. Treatment information was not provided. This case was linked to MOD-2022-525860 (Patient Link).
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- VA
- Alter
- 25,0
- Geschlecht
- F
- Eingang
- 28.03.2022
- Impfdatum
- 18.02.2022
- Beginn
- 28.02.2022
- Tage bis Beginn
- 10,0
- Dosis
- 3
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Erythema
Erythema nodosum
Nodule
Swelling
Tenderness
Symptomtext
10 days after receiving my booster, I developed bilateral red, tender nodules on my shins and calves as well as swelling in my ankles, calves, and knees. No other symptoms were present. The reaction appeared to be erythema nodosum. The number of nodules increased during the first 2 days and remained consistent for 2 weeks and then started to decrease during week 3. The swelling lasted for four weeks and will come back after standing for long periods of time. I took ibuprofen occasionally, wore compression stockings, and elevated my legs when possible.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Erythema
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- No other illnesses around the time of vaccination
- Vorgeschichte
- No chronic health conditions
- Andere Medikamente
- Portia - birth control, daily for 5 years, Zyrtec - daily for 10 years, Vitamin C gummies - daily for 1 year, Vitamin D - daily for 1 year
- Allergien
- NKDA, Allergic to shellfish, pollen, dust, cats
- Vorherige Impfungen
- -
- Staat
- SC
- Alter
- 33,0
- Geschlecht
- F
- Eingang
- 28.03.2022
- Impfdatum
- 25.03.2022
- Beginn
- 26.03.2022
- Tage bis Beginn
- 1,0
- Dosis
- 3
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Contusion
Swelling
Symptomtext
Patient received Moderna Booster shot Friday and experienced swelling on right side of neck (shot administered in right arm) the following day, Saturday. Also experienced bruising in right leg -describing it as comparable to a varicose vein. Patient worked Saturday and Sunday (12 hour shifts). We have not seen actual swelling on neck or leg. Have asked patient to send us pictures or come by. Patient states today, swelling has gone down but not completely resolved.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Contusion
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NC
- Alter
- 47,0
- Geschlecht
- M
- Eingang
- 23.03.2022
- Impfdatum
- 23.03.2022
- Beginn
- 23.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Incorrect dose administered
Underdose
Symptomtext
Patient scheduled for second dose of Moderna vaccine. Patient received booster dose (0.25ml.) instead of (0.5ml) dose which was the appropriate dose by RN. Phone call was made to the patient at 1205pm and voicemail message was left. Patient has not returned call as of this report.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Incorrect dose administered
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- Unknown
- Vorgeschichte
- Unknown
- Andere Medikamente
- Unknown
- Allergien
- Unknown
- Vorherige Impfungen
- -
- Staat
- NY
- Alter
- 16,0
- Geschlecht
- M
- Eingang
- 18.03.2022
- Impfdatum
- 26.01.2022
- Beginn
- 26.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Product administered to patient of inappropriate age
Symptomtext
It is documented that the patient received the Moderna Booster vaccine, but they are under 18 at time of getting it. Appointment was made for Moderna as well
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product administered to patient of inappropriate age
- Hospital-Tage
- -
- Labordaten
- n/a
- Aktuelle Erkrankungen
- n/a
- Vorgeschichte
- n/a
- Andere Medikamente
- n/a
- Allergien
- n/a
- Vorherige Impfungen
- -
- Staat
- IL
- Alter
- 42,0
- Geschlecht
- M
- Eingang
- 17.03.2022
- Impfdatum
- 28.01.2022
- Beginn
- 28.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Incorrect dose administered
Interchange of vaccine products
Symptomtext
Participant received Janssen on 10/29/2021, at vaccine clinic partnered by Rehab Facility and Clinic, RN administered primary dose of Moderna at 0.5mL vs booster dose Moderna 0.25 mL on 1/28/2021. RN informed participant of error after vaccine clinic, denied SE. Instructed to monitor for symptoms. Participant verbalized understanding of plan of care.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Incorrect dose administered
- Hospital-Tage
- -
- Labordaten
- N/A.
- Aktuelle Erkrankungen
- None noted
- Vorgeschichte
- hx hep , opioid use hx
- Andere Medikamente
- -
- Allergien
- NKA
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 17,0
- Geschlecht
- F
- Eingang
- 16.03.2022
- Impfdatum
- 02.02.2022
- Beginn
- 02.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Product administered to patient of inappropriate age
Symptomtext
Patient under age of 18 received Moderna vaccine, which is not approved for patients >18 years old. Pt reports no adverse medical effects from vaccine.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product administered to patient of inappropriate age
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- Depot-provera injection
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 16,0
- Geschlecht
- F
- Eingang
- 12.03.2022
- Impfdatum
- 12.03.2022
- Beginn
- 12.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Product administered to patient of inappropriate age
Symptomtext
This patient is a 16yo who was given the Moderna vaccine for 1st dose at a different clinic, when presented to this clinic brought in card, asked for Moderna and was given the 2nd dose as a Moderna which is and unauthorized age group 12-17
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product administered to patient of inappropriate age
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- Skin infection
- Vorgeschichte
- DMII, Asthma,
- Andere Medikamente
- Lantus, Humalog, Metformin, Ertugliflozin, Albuterol
- Allergien
- NKDA
- Vorherige Impfungen
- -
- Staat
- GA
- Alter
- -
- Geschlecht
- U
- Eingang
- 12.03.2022
- Impfdatum
- 26.02.2022
- Beginn
- 26.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Symptomtext
administered the Moderna vaccine about 36 hours after the use by date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (administered the Moderna vaccine about 36 hours after the use by date) in a patient of an unknown age and gender who received mRNA-1273 (Spikevax) (batch no. 042J21A) for COVID-19 vaccination. No Medical History information was reported. On 26-Feb-2022, the patient received dose of mRNA-1273 (Spikevax) (Intramuscular) 1 dosage form. On 26-Feb-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (administered the Moderna vaccine about 36 hours after the use by date). At the time of the report, EXPIRED PRODUCT ADMINISTERED (administered the Moderna vaccine about 36 hours after the use by date) outcome was unknown. For mRNA-1273 (Spikevax) (Intramuscular), the reporter did not provide any causality assessments. The reporter was a pharmacist. Concomitant medication of the patient was not reported. Date the vial was initially stored in the refrigerator was on 25-Jan-2022 and the vial did not undergo any temperature excursions. The reporter did not have more information about the patient. No treatment information was provided by the reporter.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 31,0
- Geschlecht
- F
- Eingang
- 11.03.2022
- Impfdatum
- 11.03.2022
- Beginn
- 11.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Symptomtext
No symptoms or adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- N/A
- Andere Medikamente
- N/A
- Allergien
- N/A
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- -
- Geschlecht
- U
- Eingang
- 11.03.2022
- Impfdatum
- -
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Symptomtext
Received a vaccine after the 30-day Use By Date; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Received a vaccine after the 30-day Use By Date) in a patient of an unknown age and gender who received mRNA-1273 (Spikevax) (batch no. 042J21A) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (Received a vaccine after the 30-day Use By Date). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Received a vaccine after the 30-day Use By Date) outcome was unknown. For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments. The caller wanted to look up for an expiration date of a Moderna Covid-19 vaccine Lot number 042J21A. Agent entered Moderna's look up tool an provide the caller the expiration date 29Apr2022. Then, the caller asked how to proceed with a patient that received a vaccine after the 30-day Use By Date. No concomitant medication was provided by the reporter. No treatment was provided by the reporter.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- HI
- Alter
- 66,0
- Geschlecht
- F
- Eingang
- 09.03.2022
- Impfdatum
- 04.03.2022
- Beginn
- 04.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Extra dose administered
No adverse event
Symptomtext
Due to misinformation, a 4th booster dose(0.25 ml) of the Moderna vaccine was administered to the patient on 3/4/2022. There were no acute signs and symptoms that occurred at the time of the event. The patients case manager, family, and primary care provider were informed of the event. Multiple follow up interactions were done and the patient's caregiver reported no adverse reactions.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Extra dose administered
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- Schizophrenia, depression
- Andere Medikamente
- Abilify 5 mg, clozapine 100 mg, clozapine 200 mg, clozapine 50 mg, sertraline 50 mg
- Allergien
- N/A
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 23,0
- Geschlecht
- M
- Eingang
- 09.03.2022
- Impfdatum
- 07.03.2022
- Beginn
- 07.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
No adverse event
Symptomtext
No adverse event. Patient stated he felt fine. Advised patient of common side effects. Patient was advised to contact the clinic if symptoms worsen or new symptoms show.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- not known
- Vorgeschichte
- not known
- Andere Medikamente
- No know medication
- Allergien
- No know allergies
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 14,0
- Geschlecht
- M
- Eingang
- 08.03.2022
- Impfdatum
- 04.03.2022
- Beginn
- 04.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product administered to patient of inappropriate age
Symptomtext
Child is under 18 years of age. He was administered Moderna vaccine which is not approved for under 18. He previously had the 2 doses of Pfizer vaccine.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product administered to patient of inappropriate age
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- NOT KNOWN
- Vorgeschichte
- NOT KNOWN
- Andere Medikamente
- NONE
- Allergien
- NONE
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 52,0
- Geschlecht
- M
- Eingang
- 08.03.2022
- Impfdatum
- 21.02.2022
- Beginn
- 21.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Product storage error
Symptomtext
On the day of administration , the Moderna vaccine was past its 30 days of refrigeration. We reached out to the manufacturer and they responded with the following, "Thank you for your patience. Analysis of the vials associated with your storage excursion is complete. The vaccine administered on February 14, 2022, February 15, 2022, February 16, 2022, February 18, 2022, and February 21, 2022 from lot number 042J21A maintained the activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration."
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 27,0
- Geschlecht
- F
- Eingang
- 08.03.2022
- Impfdatum
- 21.02.2022
- Beginn
- 21.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Product storage error
Symptomtext
On the day of administration , the Moderna vaccine was past its 30 days of refrigeration. We reached out to the manufacturer and they responded with the following, "Thank you for your patience. Analysis of the vials associated with your storage excursion is complete. The vaccine administered on February 14, 2022, February 15, 2022, February 16, 2022, February 18, 2022, and February 21, 2022 from lot number 042J21A maintained the activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration."
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 59,0
- Geschlecht
- F
- Eingang
- 08.03.2022
- Impfdatum
- 21.02.2022
- Beginn
- 21.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Product storage error
Symptomtext
On the day of administration , the Moderna vaccine was past its 30 days of refrigeration. We reached out to the manufacturer and they responded with the following, "Thank you for your patience. Analysis of the vials associated with your storage excursion is complete. The vaccine administered on February 14, 2022, February 15, 2022, February 16, 2022, February 18, 2022, and February 21, 2022 from lot number 042J21A maintained the activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration."
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 51,0
- Geschlecht
- F
- Eingang
- 08.03.2022
- Impfdatum
- 21.02.2022
- Beginn
- 21.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Product storage error
Symptomtext
On the day of administration , the Moderna vaccine was past its 30 days of refrigeration. We reached out to the manufacturer and they responded with the following, "Thank you for your patience. Analysis of the vials associated with your storage excursion is complete. The vaccine administered on February 14, 2022, February 15, 2022, February 16, 2022, February 18, 2022, and February 21, 2022 from lot number 042J21A maintained the activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration."
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 36,0
- Geschlecht
- M
- Eingang
- 08.03.2022
- Impfdatum
- 21.02.2022
- Beginn
- 21.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Expired product administered
Symptomtext
On the day of administration , the Moderna vaccine was past its 30 days of refrigeration. We reached out to the manufacturer and they responded with the following, "Thank you for your patience. Analysis of the vials associated with your storage excursion is complete. The vaccine administered on February 14, 2022, February 15, 2022, February 16, 2022, February 18, 2022, and February 21, 2022 from lot number 042J21A maintained the activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration."
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- IL
- Alter
- -
- Geschlecht
- U
- Eingang
- 08.03.2022
- Impfdatum
- 21.02.2022
- Beginn
- 21.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Product storage error
Product temperature excursion issue
Symptomtext
Frozen vials, removed and transported at refrigerated temp, re-frozen at the time of arrival; Total duration of the excursion refrigerated temps for max of 4 hrs; They have been accidentally administering refrozen vials to their patients (more than 30 days after moving to fridge); This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (They have been accidentally administering refrozen vials to their patients (more than 30 days after moving to fridge)), PRODUCT STORAGE ERROR (Frozen vials, removed and transported at refrigerated temp, re-frozen at the time of arrival) and PRODUCT TEMPERATURE EXCURSION ISSUE (Total duration of the excursion refrigerated temps for max of 4 hrs) in a patient of an unknown age and gender who received mRNA-1273 (Spikevax) (batch no. 042J21A) for COVID-19 vaccination. No Medical History information was reported. On 21-Feb-2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 21-Feb-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (They have been accidentally administering refrozen vials to their patients (more than 30 days after moving to fridge)). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Frozen vials, removed and transported at refrigerated temp, re-frozen at the time of arrival) and PRODUCT TEMPERATURE EXCURSION ISSUE (Total duration of the excursion refrigerated temps for max of 4 hrs). At the time of the report, EXPIRED PRODUCT ADMINISTERED (They have been accidentally administering refrozen vials to their patients (more than 30 days after moving to fridge)), PRODUCT STORAGE ERROR (Frozen vials, removed and transported at refrigerated temp, re-frozen at the time of arrival) and PRODUCT TEMPERATURE EXCURSION ISSUE (Total duration of the excursion refrigerated temps for max of 4 hrs) outcome was unknown. For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments. No concomitant medication were reported. Vial was moved to fridge on 19-Jan-2022.Temperature was fluctuated Frozen-refrigerated and again re frozen. Frozen vails removed and transported ate refrigerated temperature and refrozen at time of arrival. Total duration of excursion refrigerated temperature for max 4 hours. Temperature reached to 8 degrees Celsius. Vials size was 5.5 mL and 7.5 Ml. Partially thawed liquid state at the time of excursion. No treatment drug were reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- IL
- Alter
- -
- Geschlecht
- U
- Eingang
- 08.03.2022
- Impfdatum
- 22.02.2022
- Beginn
- 22.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Product storage error
Product temperature excursion issue
Symptomtext
They just recently found out that the vials are received in refrigerated temperatures and not frozen/ They have been accidentally administering refrozen vials to their patients; Frozen vials, removed and transported at refrigerated temp, re-frozen at ti me of arrival; They just recently found out that the vials are received in refrigerated temperatures and not frozen/ They have been accidentally administering refrozen vials to their patients; This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT STORAGE ERROR (They just recently found out that the vials are received in refrigerated temperatures and not frozen/ They have been accidentally administering refrozen vials to their patients), EXPIRED PRODUCT ADMINISTERED (They just recently found out that the vials are received in refrigerated temperatures and not frozen/ They have been accidentally administering refrozen vials to their patients) and PRODUCT TEMPERATURE EXCURSION ISSUE (Frozen vials, removed and transported at refrigerated temp, re-frozen at ti me of arrival) in a patient of an unknown age and gender who received mRNA-1273 (Spikevax) (batch no. 042J21A) for COVID-19 vaccination. No Medical History information was reported. On 22-Feb-2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 22-Feb-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (They just recently found out that the vials are received in refrigerated temperatures and not frozen/ They have been accidentally administering refrozen vials to their patients). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (They just recently found out that the vials are received in refrigerated temperatures and not frozen/ They have been accidentally administering refrozen vials to their patients) and PRODUCT TEMPERATURE EXCURSION ISSUE (Frozen vials, removed and transported at refrigerated temp, re-frozen at ti me of arrival). At the time of the report, PRODUCT STORAGE ERROR (They just recently found out that the vials are received in refrigerated temperatures and not frozen/ They have been accidentally administering refrozen vials to their patients), EXPIRED PRODUCT ADMINISTERED (They just recently found out that the vials are received in refrigerated temperatures and not frozen/ They have been accidentally administering refrozen vials to their patients) and PRODUCT TEMPERATURE EXCURSION ISSUE (Frozen vials, removed and transported at refrigerated temp, re-frozen at ti me of arrival) outcome was unknown. For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments. No concomitant medications were reported. The vial was moved to the fridge on 19 Jan 2022 and administered post 30 days from the initial storage at 2 degree Celsius to 8 degree Celsius. It was unknown if the vial was undergone a previous temperature excursion. The storage condition at the time of the excursion was frozen storage/refrigerated storage. The state of the vaccine at the time of the excursion was partially thawed/liquid. The maximum temperature reached was 8?C. the total duration of the excursion refrigerated temps for max of 4 hours. The temperature fluctuations occurred as frozen-refrigerated and refrozen. No treatment information was reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- IL
- Alter
- -
- Geschlecht
- U
- Eingang
- 08.03.2022
- Impfdatum
- 22.02.2022
- Beginn
- 22.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Product storage error
Product temperature excursion issue
Symptomtext
They just recently found out that the vials are received in refrigerated temperatures and not frozen/ They have been accidentally administering refrozen vials to their patients; Frozen vials, removed and transported at refrigerated temp, re-frozen at ti me of arrival; They just recently found out that the vials are received in refrigerated temperatures and not frozen/ They have been accidentally administering refrozen vials to their patients; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (They just recently found out that the vials are received in refrigerated temperatures and not frozen/ They have been accidentally administering refrozen vials to their patients), PRODUCT STORAGE ERROR (They just recently found out that the vials are received in refrigerated temperatures and not frozen/ They have been accidentally administering refrozen vials to their patients) and PRODUCT TEMPERATURE EXCURSION ISSUE (Frozen vials, removed and transported at refrigerated temp, re-frozen at ti me of arrival) in a patient of an unknown age and gender who received mRNA-1273 (Spikevax) (batch no. 042J21A) for COVID-19 vaccination. No Medical History information was reported. On 22-Feb-2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 22-Feb-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (They just recently found out that the vials are received in refrigerated temperatures and not frozen/ They have been accidentally administering refrozen vials to their patients). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (They just recently found out that the vials are received in refrigerated temperatures and not frozen/ They have been accidentally administering refrozen vials to their patients) and PRODUCT TEMPERATURE EXCURSION ISSUE (Frozen vials, removed and transported at refrigerated temp, re-frozen at ti me of arrival). At the time of the report, EXPIRED PRODUCT ADMINISTERED (They just recently found out that the vials are received in refrigerated temperatures and not frozen/ They have been accidentally administering refrozen vials to their patients), PRODUCT STORAGE ERROR (They just recently found out that the vials are received in refrigerated temperatures and not frozen/ They have been accidentally administering refrozen vials to their patients) and PRODUCT TEMPERATURE EXCURSION ISSUE (Frozen vials, removed and transported at refrigerated temp, re-frozen at ti me of arrival) outcome was unknown. For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments. No concomitant medication were reported Vial was moved to fridge on 19 Jan 2022. It was reported that the vaccines were frozen, shipped in refrigerated temperature and then refroze for storage once arrive at facility. The facility thought that the vials are received frozen from Moderna so they had unpacked them and put them back into the facility freezer. They just recently found out that the vials are received in refrigerated temperatures and not frozen. They have been accidentally administering refrozen vials to their patients. Temperature was fluctuated Frozen-refrigerated and again re frozen. Total duration of excursion refrigerated temperature for max 4 hours. Temperature reached to 8 degrees Celsius. Vials size was 5.5 mL and 7.5 Ml. Partially thawed liquid state at the time of excursion No treatment drug were reported. This case was linked to MOD-2022-496015, MOD-2022-501703 (Patient Link).
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- IL
- Alter
- -
- Geschlecht
- U
- Eingang
- 08.03.2022
- Impfdatum
- 25.02.2022
- Beginn
- 25.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Product storage error
Product temperature excursion issue
Symptomtext
They just recently found out that the vials are received in refrigerated temperatures and not frozen/ They have been accidentally administering refrozen vials to their patients; Frozen vials, removed and transported at refrigerated temp, re-frozen at ti me of arrival; They just recently found out that the vials are received in refrigerated temperatures and not frozen/ They have been accidentally administering refrozen vials to their patients; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (They just recently found out that the vials are received in refrigerated temperatures and not frozen/ They have been accidentally administering refrozen vials to their patients), PRODUCT STORAGE ERROR (They just recently found out that the vials are received in refrigerated temperatures and not frozen/ They have been accidentally administering refrozen vials to their patients) and PRODUCT TEMPERATURE EXCURSION ISSUE (Frozen vials, removed and transported at refrigerated temp, re-frozen at ti me of arrival) in a patient of an unknown age and gender who received mRNA-1273 (Spikevax) (batch no. 042J21A) for COVID-19 vaccination. No Medical History information was reported. On 25-Feb-2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 25-Feb-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (They just recently found out that the vials are received in refrigerated temperatures and not frozen/ They have been accidentally administering refrozen vials to their patients). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (They just recently found out that the vials are received in refrigerated temperatures and not frozen/ They have been accidentally administering refrozen vials to their patients) and PRODUCT TEMPERATURE EXCURSION ISSUE (Frozen vials, removed and transported at refrigerated temp, re-frozen at ti me of arrival). At the time of the report, EXPIRED PRODUCT ADMINISTERED (They just recently found out that the vials are received in refrigerated temperatures and not frozen/ They have been accidentally administering refrozen vials to their patients), PRODUCT STORAGE ERROR (They just recently found out that the vials are received in refrigerated temperatures and not frozen/ They have been accidentally administering refrozen vials to their patients) and PRODUCT TEMPERATURE EXCURSION ISSUE (Frozen vials, removed and transported at refrigerated temp, re-frozen at ti me of arrival) outcome was unknown. For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments. No concomitant medications were reported. The vials were frozen, shipped in refrigerated temperature and then refroze for storage once arrive at facility. On 19 Jan 2021 vaccine was moved to fridge and vaccine administered past 30 days from the initial storage at 2 degree Celsius to 8 degree Celsius. The facility thought that the vials were received frozen from Moderna, so they have been unpacking them and putting them back into the facility freezer. They just recently found out that the vials are received in refrigerated temperatures and not frozen. They have been accidentally administering refrozen vials to their patients. No treatment medications were reported. This case was linked to MOD-2022-496015 (Patient Link).
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- IL
- Alter
- 25,0
- Geschlecht
- F
- Eingang
- 08.03.2022
- Impfdatum
- 22.02.2022
- Beginn
- 22.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Symptomtext
Expired booster dose administered more than 12 hours post puncture; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired booster dose administered more than 12 hours post puncture) in a 25-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 vaccination. No Medical History information was reported. On 22-Feb-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Feb-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired booster dose administered more than 12 hours post puncture). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired booster dose administered more than 12 hours post puncture) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medications were reported. The vial was initially stored in the refrigerator on 15-feb-2022. Date and time vial was first punctured: 21-feb-2022 at unknown time. Vial was stored post puncture in refrigerator. Vials did not undergo any temperature excursion. Punctured vial was kept in the refrigerator 3 hours more than 12 hours post puncture. No treatment medications were reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 50,0
- Geschlecht
- M
- Eingang
- 07.03.2022
- Impfdatum
- 18.02.2022
- Beginn
- 18.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Expired product administered
Symptomtext
On the day of administration , the Moderna vaccine was past its 30 days of refrigeration. We reached out to the manufacturer and they responded with the following, "Thank you for your patience. Analysis of the vials associated with your storage excursion is complete. The vaccine administered on February 14, 2022, February 15, 2022, February 16, 2022, February 18, 2022, and February 21, 2022 from lot number 042J21A maintained the activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration."
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 70,0
- Geschlecht
- M
- Eingang
- 07.03.2022
- Impfdatum
- 18.02.2022
- Beginn
- 18.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Expired product administered
Symptomtext
On the day of administration, vaccine was past its 30 days of refrigeration. We reached out to the manufacturer and they responded with the following, "Thank you for your patience. Analysis of the vials associated with your storage excursion is complete. The vaccine administered on February 14, 2022, February 15, 2022, February 16, 2022, February 18, 2022 and February 21, 2022 from lot number 042J21A maintained the activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration."
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 57,0
- Geschlecht
- F
- Eingang
- 07.03.2022
- Impfdatum
- 18.02.2022
- Beginn
- 18.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Expired product administered
Symptomtext
On the day of administration , the Moderna vaccine was past its 30 days of refrigeration. We reached out to the manufacturer and they responded with the following, "Thank you for your patience. Analysis of the vials associated with your storage excursion is complete. The vaccine administered on February 14, 2022, February 15, 2022, February 16, 2022, February 18, 2022, and February 21, 2022 from lot number 042J21A maintained the activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration."
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 43,0
- Geschlecht
- F
- Eingang
- 07.03.2022
- Impfdatum
- 18.02.2022
- Beginn
- 18.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Expired product administered
Symptomtext
On the day of administration , the Moderna vaccine was past its 30 days of refrigeration. We reached out to the manufacturer and they responded with the following, "Thank you for your patience. Analysis of the vials associated with your storage excursion is complete. The vaccine administered on February 14, 2022, February 15, 2022, February 16, 2022, February 18, 2022, and February 21, 2022 from lot number 042J21A maintained the activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration."
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 65,0
- Geschlecht
- F
- Eingang
- 07.03.2022
- Impfdatum
- 18.02.2022
- Beginn
- 18.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Product storage error
Symptomtext
On the day of administration , the Moderna vaccine was past its 30 days of refrigeration. We reached out to the manufacturer and they responded with the following, "Thank you for your patience. Analysis of the vials associated with your storage excursion is complete. The vaccine administered on February 14, 2022, February 15, 2022, February 16, 2022, February 18, 2022, and February 21, 2022 from lot number 042J21A maintained the activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration."
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 48,0
- Geschlecht
- M
- Eingang
- 07.03.2022
- Impfdatum
- 16.02.2022
- Beginn
- 16.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Product storage error
Symptomtext
On the day of administration , the Moderna vaccine was past its 30 days of refrigeration. We reached out to the manufacturer and they responded with the following, "Thank you for your patience. Analysis of the vials associated with your storage excursion is complete. The vaccine administered on February 14, 2022, February 15, 2022, February 16, 2022, February 18, 2022, and February 21, 2022 from lot number 042J21A maintained the activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration."
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 67,0
- Geschlecht
- F
- Eingang
- 07.03.2022
- Impfdatum
- 16.02.2022
- Beginn
- 16.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Product storage error
Symptomtext
On the day of administration , the Moderna vaccine was past its 30 days of refrigeration. We reached out to the manufacturer and they responded with the following, "Thank you for your patience. Analysis of the vials associated with your storage excursion is complete. The vaccine administered on February 14, 2022, February 15, 2022, February 16, 2022, February 18, 2022, and February 21, 2022 from lot number 042J21A maintained the activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration."
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 73,0
- Geschlecht
- F
- Eingang
- 07.03.2022
- Impfdatum
- 15.02.2022
- Beginn
- 15.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Product storage error
Symptomtext
On the day of administration, the Moderna vaccine was past its 30 days of refrigeration. We reached out to the manufacturer and they responded with the following, "Thank you for your patience. Analysis of the vials associated with your storage excursion is complete. The vaccine administered on February 14, 2022, February 15, 2022, February 16, 2022, February 18, 2022, and February 21, 2022 from lot number 042J21A maintained the activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration".
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 70,0
- Geschlecht
- M
- Eingang
- 07.03.2022
- Impfdatum
- 15.02.2022
- Beginn
- 15.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Product storage error
Symptomtext
On the day of administration , the Moderna vaccine was past its 30 days of refrigeration. We reached out to the manufacturer and they responded with the following, "Thank you for your patience. Analysis of the vials associated with your storage excursion is complete. The vaccine administered on February 14, 2022, February 15, 2022, February 16, 2022, February 18, 2022, and February 21, 2022 from lot number 042J21A maintained the activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration."
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 48,0
- Geschlecht
- F
- Eingang
- 07.03.2022
- Impfdatum
- 15.02.2022
- Beginn
- 15.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Product storage error
Symptomtext
On the day of administration , the Moderna vaccine was past its 30 days of refrigeration. We reached out to the manufacturer and they responded with the following, "Thank you for your patience. Analysis of the vials associated with your storage excursion is complete. The vaccine administered on February 14, 2022, February 15, 2022, February 16, 2022, February 18, 2022, and February 21, 2022 from lot number 042J21A maintained the activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration."
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 27,0
- Geschlecht
- M
- Eingang
- 07.03.2022
- Impfdatum
- 15.02.2022
- Beginn
- 15.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Product storage error
Symptomtext
On the day of administration , the Moderna vaccine was past its 30 days of refrigeration. We reached out to the manufacturer and they responded with the following, "Thank you for your patience. Analysis of the vials associated with your storage excursion is complete. The vaccine administered on February 14, 2022, February 15, 2022, February 16, 2022, February 18, 2022, and February 21, 2022 from lot number 042J21A maintained the activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration."
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 79,0
- Geschlecht
- F
- Eingang
- 07.03.2022
- Impfdatum
- 15.02.2022
- Beginn
- 15.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Product storage error
Symptomtext
On the day of administration , the Moderna vaccine was past its 30 days of refrigeration. We reached out to the manufacturer and they responded with the following, "Thank you for your patience. Analysis of the vials associated with your storage excursion is complete. The vaccine administered on February 14, 2022, February 15, 2022, February 16, 2022, February 18, 2022, and February 21, 2022 from lot number 042J21A maintained the activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration."
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 42,0
- Geschlecht
- F
- Eingang
- 07.03.2022
- Impfdatum
- 15.02.2022
- Beginn
- 15.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Product storage error
Symptomtext
On the day of administration , the Moderna vaccine was past its 30 days of refrigeration. We reached out to the manufacturer and they responded with the following, "Thank you for your patience. Analysis of the vials associated with your storage excursion is complete. The vaccine administered on February 14, 2022, February 15, 2022, February 16, 2022, February 18, 2022, and February 21, 2022 from lot number 042J21A maintained the activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration."
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 45,0
- Geschlecht
- M
- Eingang
- 07.03.2022
- Impfdatum
- 15.02.2022
- Beginn
- 15.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Product storage error
Symptomtext
On the day of administration , the Moderna vaccine was past its 30 days of refrigeration. We reached out to the manufacturer and they responded with the following, "Thank you for your patience. Analysis of the vials associated with your storage excursion is complete. The vaccine administered on February 14, 2022, February 15, 2022, February 16, 2022, February 18, 2022, and February 21, 2022 from lot number 042J21A maintained the activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration."
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 67,0
- Geschlecht
- F
- Eingang
- 07.03.2022
- Impfdatum
- 15.02.2022
- Beginn
- 15.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Product storage error
Symptomtext
On the day of administration , the Moderna vaccine was past its 30 days of refrigeration. We reached out to the manufacturer and they responded with the following, "Thank you for your patience. Analysis of the vials associated with your storage excursion is complete. The vaccine administered on February 14, 2022, February 15, 2022, February 16, 2022, February 18, 2022, and February 21, 2022 from lot number 042J21A maintained the activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration."
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- VA
- Alter
- 16,0
- Geschlecht
- F
- Eingang
- 04.03.2022
- Impfdatum
- 23.02.2022
- Beginn
- 23.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Product administered to patient of inappropriate age
Symptomtext
16-year-old given Moderna as first dose.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product administered to patient of inappropriate age
- Hospital-Tage
- -
- Labordaten
- None.
- Aktuelle Erkrankungen
- Unknown
- Vorgeschichte
- Unknown
- Andere Medikamente
- Unknown
- Allergien
- Unknown
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 17,0
- Geschlecht
- F
- Eingang
- 04.03.2022
- Impfdatum
- 03.03.2022
- Beginn
- 03.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
No adverse event
Product administered to patient of inappropriate age
Symptomtext
Patient was seeing her PCP for a physical. Patient was given a Moderna vaccine before the age of 18. No adverse reactions were noted. Patient was assessed by nursing staff after vaccine was given. Patient tolerated vaccine well.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Depression
- Andere Medikamente
- Etonogestrel Implant
- Allergien
- No known allergies
- Vorherige Impfungen
- -
- Staat
- LA
- Alter
- 49,0
- Geschlecht
- F
- Eingang
- 03.03.2022
- Impfdatum
- 12.02.2022
- Beginn
- 12.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Limb injury
Symptomtext
Error: Shoulder Joint Injury (prolonged pain, tingling, etc.)-
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Limb injury
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WA
- Alter
- 26,0
- Geschlecht
- F
- Eingang
- 03.03.2022
- Impfdatum
- 04.02.2022
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Inappropriate schedule of product administration
No adverse event
Symptomtext
No adverse reaction. Immunization was given 5 days early.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Inappropriate schedule of product administration
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- none
- Andere Medikamente
- Sprintec (28) 0.25 mg-35 mcg tablet
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 17,0
- Geschlecht
- M
- Eingang
- 02.03.2022
- Impfdatum
- 01.03.2022
- Beginn
- 01.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Interchange of vaccine products
Product administered to patient of inappropriate age
Symptomtext
PATIENT REQUESTED AND RECEIVED A MODERNA COVID VACCINE BOOSTER. PATIENT HAD PREVIOUSLY RECEIVED 2 DOSES OF PFIZER AT APPROPRIATE INTERVALS. PATIENT IS 17 YEARS OLD. MODERNA COVID VACCINE IS CURRENTLY APPROVED/RECOMMENDED FOR PATIENTS 18 YEARS OLD AND ABOVE.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Interchange of vaccine products
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 49,0
- Geschlecht
- M
- Eingang
- 02.03.2022
- Impfdatum
- 15.02.2022
- Beginn
- 15.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Expired product administered
Product storage error
Symptomtext
On the day of administration , the Moderna vaccine was past its 30 days of refrigeration. We reached out to the manufacturer and they responded with the following, "Thank you for your patience. Analysis of the vials associated with your storage excursion is complete. The vaccine administered on February 14, 2022, February 15, 2022, February 16, 2022, February 18, 2022, and February 21, 2022 from lot number 042J21A maintained the activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration."
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 20,0
- Geschlecht
- F
- Eingang
- 02.03.2022
- Impfdatum
- 15.02.2022
- Beginn
- 15.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Expired product administered
Product storage error
Symptomtext
On the day of administration , the Moderna vaccine was past its 30 days of refrigeration. We reached out to the manufacturer and they responded with the following, "Thank you for your patience. Analysis of the vials associated with your storage excursion is complete. The vaccine administered on February 14, 2022, February 15, 2022, February 16, 2022, February 18, 2022, and February 21, 2022 from lot number 042J21A maintained the activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration."
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 76,0
- Geschlecht
- F
- Eingang
- 02.03.2022
- Impfdatum
- 14.02.2022
- Beginn
- 14.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Product storage error
Symptomtext
On the day of administration , the Moderna vaccine was past its 30 days of refrigeration. We reached out to the manufacturer and they responded with the following, "Thank you for your patience. Analysis of the vials associated with your storage excursion is complete. The vaccine administered on February 14, 2022, February 15, 2022, February 16, 2022, February 18, 2022, and February 21, 2022 from lot number 042J21A maintained the activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration."
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 36,0
- Geschlecht
- F
- Eingang
- 02.03.2022
- Impfdatum
- 14.02.2022
- Beginn
- 14.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Product storage error
Symptomtext
On the day of administration , the Moderna vaccine was past its 30 days of refrigeration. We reached out to the manufacturer and they responded with the following, "Thank you for your patience. Analysis of the vials associated with your storage excursion is complete. The vaccine administered on February 14, 2022, February 15, 2022, February 16, 2022, February 18, 2022, and February 21, 2022 from lot number 042J21A maintained the activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration."
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 41,0
- Geschlecht
- F
- Eingang
- 02.03.2022
- Impfdatum
- 14.02.2022
- Beginn
- 14.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Expired product administered
Product storage error
Symptomtext
On the day of administration , the Moderna vaccine was past its 30 days of refrigeration. We reached out to the manufacturer and they responded with the following, "Thank you for your patience. Analysis of the vials associated with your storage excursion is complete. The vaccine administered on February 14, 2022, February 15, 2022, February 16, 2022, February 18, 2022, and February 21, 2022 from lot number 042J21A maintained the activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration."
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 17,0
- Geschlecht
- M
- Eingang
- 01.03.2022
- Impfdatum
- 24.01.2022
- Beginn
- 24.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product administered to patient of inappropriate age
Symptomtext
This individual was less than 18 years of age at the time of vaccination. His age on the application form list as 18 hoverer, the Date of Birth is listed as August 12, 2004.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product administered to patient of inappropriate age
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- Unknown
- Vorgeschichte
- Unknown
- Andere Medikamente
- Unknown
- Allergien
- Unknown
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 17,0
- Geschlecht
- M
- Eingang
- 28.02.2022
- Impfdatum
- 01.02.2022
- Beginn
- 01.03.2022
- Tage bis Beginn
- 28,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Product administered to patient of inappropriate age
Symptomtext
Patient received Moderna underage; eligibility is 18 years old; patient was 2 weeks shy from 18 year old at the time of vaccination for his booster shot
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product administered to patient of inappropriate age
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- none known
- Vorgeschichte
- none known
- Andere Medikamente
- none known
- Allergien
- none known
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 12,0
- Geschlecht
- F
- Eingang
- 28.02.2022
- Impfdatum
- 22.02.2022
- Beginn
- 22.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product administered to patient of inappropriate age
Symptomtext
Error: Patient Too Young for Vaccine Administered-
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product administered to patient of inappropriate age
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 20,0
- Geschlecht
- M
- Eingang
- 28.02.2022
- Impfdatum
- 14.02.2022
- Beginn
- 14.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Expired product administered
Product storage error
Symptomtext
On the day of administration , the Moderna vaccine was past its 30 days of refrigeration. We reached out to the manfacturer and they responded with the following, "Thank you for your patience. Analysis of the vials associated with your storage excursion is complete. The vaccine administered on February 14, 2022, February 15, 2022, February 16, 2022, February 18, 2022, andFebruary 21, 2022 from lot number 042J21A maintained the activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration."
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 76,0
- Geschlecht
- F
- Eingang
- 28.02.2022
- Impfdatum
- 05.02.2021
- Beginn
- 18.12.2021
- Tage bis Beginn
- 316,0
- Dosis
- 3
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
COVID-19
SARS-CoV-2 test positive
Vaccine breakthrough infection
Symptomtext
event occurred after 2nd vaccine; breakthrough case admssion
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- COVID-19
- Hospital-Tage
- -
- Labordaten
- 12/18/21 COVID+
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 52,0
- Geschlecht
- M
- Eingang
- 26.02.2022
- Impfdatum
- 01.02.2022
- Beginn
- 01.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Symptomtext
doses administered past the 30-day use by date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (doses administered past the 30-day use by date) in a 52-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 vaccination. No Medical History information was reported. In February 2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In February 2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (doses administered past the 30-day use by date). At the time of the report, EXPIRED PRODUCT ADMINISTERED (doses administered past the 30-day use by date) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medications were provided. Reporter called to report they gave 26 doses after the 30-day use by date. It was reported that the vial was initially stored in the refrigerator on 14 Jan 2022. The dates of vaccine administration were 14 Feb 2022, 15 Feb 2022, 16 Feb 2022, 18 Feb 2022, 21 Feb 2022. The vial did not undergo any temperature excursions. No treatment medications were provided.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 36,0
- Geschlecht
- M
- Eingang
- 26.02.2022
- Impfdatum
- 01.02.2022
- Beginn
- 01.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Symptomtext
doses administered past the 30-day use by date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (doses administered past the 30-day use by date) in a 36-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 vaccination. No Medical History information was reported. In February 2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In February 2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (doses administered past the 30-day use by date). At the time of the report, EXPIRED PRODUCT ADMINISTERED (doses administered past the 30-day use by date) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medications were reported. No treatment medications were reported. Total 26 doses/vials were reported. Dates of administration of vaccine were 14 ,15 , 16 , 18 and 21-FEB-2022. The vials did not undergo any temperature excursions.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 70,0
- Geschlecht
- M
- Eingang
- 26.02.2022
- Impfdatum
- -
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 3
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Symptomtext
doses administered past the 30-day use by date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (doses administered past the 30-day use by date) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (doses administered past the 30-day use by date). At the time of the report, EXPIRED PRODUCT ADMINISTERED (doses administered past the 30-day use by date) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medications were reported. Pharmacist stated that they gave 26 doses after the 30-day use by date and would like to know if those doses were viable or not. The date when the vial was initially stored in the refrigerator was 14-Jan-2022. The vial did not undergo any temperature excursions. The date(s) of administration of vaccine were as follows: 14-Feb-2022, 15-Feb-2022, 16-Feb-2022, 18-Feb-2022, 21-Feb-2022. No treatment information was reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 50,0
- Geschlecht
- M
- Eingang
- 26.02.2022
- Impfdatum
- 01.02.2022
- Beginn
- 01.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Symptomtext
doses administered past the 30-day use by date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (doses administered past the 30-day use by date) in an adult male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 vaccination. No Medical History information was reported. In February 2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In February 2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (doses administered past the 30-day use by date). At the time of the report, EXPIRED PRODUCT ADMINISTERED (doses administered past the 30-day use by date) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medication was provided The vaccine was administered on 14Feb2022, 15Feb2022, 16Feb2022, 18Feb2022, 21Feb2022. The vial was initially stored in the refrigerator on 14Jan2022. No treatment medication was provided
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 48,0
- Geschlecht
- M
- Eingang
- 26.02.2022
- Impfdatum
- 01.02.2022
- Beginn
- 01.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Symptomtext
doses administered past the 30-day use by date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (doses administered past the 30-day use by date) in a 48-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 vaccination. No Medical History information was reported. In February 2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In February 2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (doses administered past the 30-day use by date). At the time of the report, EXPIRED PRODUCT ADMINISTERED (doses administered past the 30-day use by date) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medication reported. No treatment information was provided. Reporter stated that vial does not undergo any temperature excursions. The vial was initially stored in the refrigerator on 14Jan2022 The administration of vaccine was 14Feb2022, 15Feb2022, 16Feb2022, 18Feb2022, 21Feb2022.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 71,0
- Geschlecht
- M
- Eingang
- 26.02.2022
- Impfdatum
- 01.02.2022
- Beginn
- 01.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Symptomtext
Doses administered past the 30-day use by date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Doses administered past the 30-day use by date) in a 71-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 vaccination. No Medical History information was reported. In February 2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In February 2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Doses administered past the 30-day use by date). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Doses administered past the 30-day use by date) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant products were reported. Date the vial was initially stored in the refrigerator on 14-JAN-2022. Patient took booster dose in February 2022. No Treatment information was reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- -
- Geschlecht
- M
- Eingang
- 26.02.2022
- Impfdatum
- -
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 3
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Symptomtext
doses administered past the 30-day use by date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (doses administered past the 30-day use by date) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (doses administered past the 30-day use by date). At the time of the report, EXPIRED PRODUCT ADMINISTERED (doses administered past the 30-day use by date) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medication was provided by reporter. No treatment medication was provided by reporter.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 27,0
- Geschlecht
- M
- Eingang
- 26.02.2022
- Impfdatum
- 01.02.2022
- Beginn
- 01.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Symptomtext
doses administered past the 30-day use by date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (doses administered past the 30-day use by date) in a 27-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 vaccination. No Medical History information was reported. In February 2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In February 2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (doses administered past the 30-day use by date). At the time of the report, EXPIRED PRODUCT ADMINISTERED (doses administered past the 30-day use by date) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medications details were reported. Pharmacist reported that they gave 26 doses after the 30-day use by date. Pharmacist would like to know if those doses were viable or not. Number of doses/vials: 26 Date the vial was initially stored in the refrigerator : 14Jan2022 Date(s) of administration of vaccine: 14Feb2022, 15Feb2022, 16Feb2022, 18Feb2022, 21Feb2022.Vial did not undergo any temperature excursions. No treatment information details were reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 45,0
- Geschlecht
- M
- Eingang
- 26.02.2022
- Impfdatum
- 01.02.2022
- Beginn
- 01.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Symptomtext
doses administered past the 30-day use by date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (doses administered past the 30-day use by date) in a 45-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 vaccination. No Medical History information was reported. In February 2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In February 2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (doses administered past the 30-day use by date). At the time of the report, EXPIRED PRODUCT ADMINISTERED (doses administered past the 30-day use by date) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant products were reported Pharmacist reported that they gave 26 doses after the 30-day use by date. Pharmacist would like to know if those doses were viable or not. Number of doses/vials: 26 Date the vial was initially stored in the refrigerator : 14Jan2022 Date(s) of administration of vaccine: 14Feb2022, 15Feb2022, 16Feb2022, 18Feb2022, 21Feb2022.Vial did not undergo any temperature excursions. No treatment information was reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 20,0
- Geschlecht
- M
- Eingang
- 26.02.2022
- Impfdatum
- 01.02.2022
- Beginn
- 01.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Product storage error
Symptomtext
doses administered past the 30-day use by date; Dose administered past the 30-day use by date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Dose administered past the 30-day use by date) and PRODUCT STORAGE ERROR (doses administered past the 30-day use by date) in a 20-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 vaccination. No Medical History information was reported. In February 2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In February 2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Dose administered past the 30-day use by date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (doses administered past the 30-day use by date). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Dose administered past the 30-day use by date) and PRODUCT STORAGE ERROR (doses administered past the 30-day use by date) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. It was reported that the vial was initially stored in the refrigerator on 14-Jan-2022. The administration of vaccines were 14-Feb-2022, 15-Feb-2022, 16-Feb-2022, 18-Feb-2022, 21-Feb-2022. No concomitant medications were reported. The vial had not undergone any temperature excursions. No treatment medications were reported. This case was linked to MOD-2022-492833 (Patient Link).
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- -
- Geschlecht
- F
- Eingang
- 26.02.2022
- Impfdatum
- -
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 3
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Symptomtext
doses administered past the 30-day use by date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (doses administered past the 30-day use by date) in an adult female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (doses administered past the 30-day use by date). At the time of the report, EXPIRED PRODUCT ADMINISTERED (doses administered past the 30-day use by date) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Pharmacist called because they gave 26 doses after the 30-day use by date. Pharmacist would like to know if those doses were viable or not. Dose administered after 30-day Use by Date or after manufacturer date of expiry Total number of doses/vials was 26. On 14-Jan-2022, the vial was initially stored in the refrigerator. Date(s) of administration of vaccine on 14-Feb-2022, 15-Feb-2022, 16-Feb-2022, 18-Feb-2022 and 21-Feb-2022. vial did not undergo any temperature excursions. No treatment drug were reported. No concomitant medication were reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 27,0
- Geschlecht
- F
- Eingang
- 26.02.2022
- Impfdatum
- 01.02.2022
- Beginn
- 01.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Symptomtext
doses administered past the 30-day use by date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (doses administered past the 30-day use by date) in a 27-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 vaccination. No Medical History information was reported. In February 2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In February 2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (doses administered past the 30-day use by date). At the time of the report, EXPIRED PRODUCT ADMINISTERED (doses administered past the 30-day use by date) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medications were provided. No treatment medications were provided.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 51,0
- Geschlecht
- F
- Eingang
- 26.02.2022
- Impfdatum
- 01.02.2022
- Beginn
- 01.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Symptomtext
This spontaneous case reported by a pharmacist, describes the occurrence of administered expired product (administered past the 30-day use-by-date) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 vaccine, batch/lot# 042J21A) for COVID-19 immunization. No medical history reported. February 2022, patient received the third dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. February 2022, patient administered expired product (administered past the 30-day use-by-date). At the time of the report, administered expired product (administered past the 30-day use-by-date) outcome: unknown. The reporter did not provide any causality assessments, concomitant medication or treatment information. Reportedly, 26 doses given after the 30-day use-by-date. It was reported the vial was initially stored in the refrigerator on Jan 14, 2022. The dates of vaccine administration were Feb 14, 2022; Feb 15, 2022; Feb 16, 2022; Feb 18, 2022 and Feb 21, 2022.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 57,0
- Geschlecht
- F
- Eingang
- 26.02.2022
- Impfdatum
- 01.02.2022
- Beginn
- 01.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Symptomtext
Doses administered past the 30-day use by date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Doses administered past the 30-day use by date) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 vaccination. No Medical History information was reported. In February 2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In February 2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Doses administered past the 30-day use by date). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Doses administered past the 30-day use by date) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medication was reported by reporter. Patient took booster dose. On 14-Jan-2022 the vial was initially stored in the refrigerator. The vial did not undergo any temperature excursions. No treatment medication was reported by reporter.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 43,0
- Geschlecht
- F
- Eingang
- 26.02.2022
- Impfdatum
- 01.02.2022
- Beginn
- 01.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Symptomtext
doses administered past the 30-day use by date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (doses administered past the 30-day use by date) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 vaccination. No Medical History information was reported. In February 2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In February 2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (doses administered past the 30-day use by date). At the time of the report, EXPIRED PRODUCT ADMINISTERED (doses administered past the 30-day use by date) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medication information was provided. The vial was initially stored in the refrigerator 14Jan2022. The vaccine was administered on 14Feb2022, 15Feb2022, 16Feb2022, 18Feb2022, 21Feb2022. No treatment medication information was provided.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 65,0
- Geschlecht
- F
- Eingang
- 26.02.2022
- Impfdatum
- 01.02.2022
- Beginn
- 01.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Symptomtext
Doses administered past the 30-day use by date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Doses administered past the 30-day use by date) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 vaccination. No Medical History information was reported. In February 2022, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In February 2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Doses administered past the 30-day use by date). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Doses administered past the 30-day use by date) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medication was reported. Reporter called to report they gave 26 doses after the 30-day use by date. It was reported that the vial was initially stored in the refrigerator on 14 Jan 2022. The dates of vaccine administration were 14 Feb 2022, 15 Feb 2022, 16 Feb 2022, 18 Feb 2022, 21 Feb 2022. No treatment medication was reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 67,0
- Geschlecht
- F
- Eingang
- 26.02.2022
- Impfdatum
- 01.02.2022
- Beginn
- 01.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Symptomtext
doses administered past the 30-day use by date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (doses administered past the 30-day use by date) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 vaccination. No Medical History information was reported. In February 2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In February 2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (doses administered past the 30-day use by date). At the time of the report, EXPIRED PRODUCT ADMINISTERED (doses administered past the 30-day use by date) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Date the vial was initially stored in the refrigerator: 14Jan2022 Dates of administration of vaccine: 14Feb2022, 15Feb2022, 16Feb2022, 18Feb2022, 21Feb2022. No concomitant and treatment medication details
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 73,0
- Geschlecht
- F
- Eingang
- 26.02.2022
- Impfdatum
- 01.02.2022
- Beginn
- 01.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Symptomtext
doses administered past the 30-day use by date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (doses administered past the 30-day use by date) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 vaccination. No Medical History information was reported. In February 2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In February 2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (doses administered past the 30-day use by date). At the time of the report, EXPIRED PRODUCT ADMINISTERED (doses administered past the 30-day use by date) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medications were reported. Date the vial was initially stored in the refrigerator on 14Jan2022. Reporter stated that vial does not undergo any temperature excursions. No treatment medications were reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- -
- Geschlecht
- F
- Eingang
- 26.02.2022
- Impfdatum
- -
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 3
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Symptomtext
doses administered past the 30-day use by date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (doses administered past the 30-day use by date) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (doses administered past the 30-day use by date). At the time of the report, EXPIRED PRODUCT ADMINISTERED (doses administered past the 30-day use by date) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant and treatment drugs were reported. Number of doses/vials: 26 Date the vial was initially stored in the refrigerator: 14Jan2022. Dates of administration of vaccine reported as 14Feb2022, 15Feb2022, 16Feb2022, 18Feb2022, 21Feb2022.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 79,0
- Geschlecht
- F
- Eingang
- 26.02.2022
- Impfdatum
- 01.02.2022
- Beginn
- 01.02.2021
- Tage bis Beginn
- -
- Dosis
- 3
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Symptomtext
Doses administered past the 30-day use by date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Doses administered past the 30-day use by date) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 vaccination. No Medical History information was reported. In February 2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In February 2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Doses administered past the 30-day use by date). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Doses administered past the 30-day use by date) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Pharmacist reported that they gave 26 doses after the 30-day use by date. Pharmacist would like to know if those doses were viable or not. Number of doses/vials: 26 Date the vial was initially stored in the refrigerator : 14Jan2022 Date(s) of administration of vaccine: 14Feb2022, 15Feb2022, 16Feb2022, 18Feb2022, 21Feb2022.Vial did not undergo any temperature excursions. No concomitant products were reported. No treatment information was reported. .
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 48,0
- Geschlecht
- F
- Eingang
- 26.02.2022
- Impfdatum
- 01.02.2022
- Beginn
- 01.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Symptomtext
Doses administered past the 30-day use by date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Doses administered past the 30-day use by date) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 vaccination. No Medical History information was reported. In February 2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In February 2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Doses administered past the 30-day use by date). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Doses administered past the 30-day use by date) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant products were reported Pharmacist reported that they gave 26 doses after the 30-day use by date. Pharmacist would like to know if those doses were viable or not. Number of doses/vials: 26 Date the vial was initially stored in the refrigerator : 14Jan2022 Date(s) of administration of vaccine: 14Feb2022, 15Feb2022, 16Feb2022, 18Feb2022, 21Feb2022.Vial did not undergo any temperature excursions. No treatment information was reported. .
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- -
- Geschlecht
- F
- Eingang
- 26.02.2022
- Impfdatum
- 01.02.2022
- Beginn
- 01.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Symptomtext
doses administered past the 30-day use by date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (doses administered past the 30-day use by date) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 vaccination. No Medical History information was reported. In February 2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In February 2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (doses administered past the 30-day use by date). At the time of the report, EXPIRED PRODUCT ADMINISTERED (doses administered past the 30-day use by date) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. The vial was initially stored in the refrigerator included 14Jan2022. The administration of vaccine included 14Feb2022, 15Feb2022, 16Feb2022, 18Feb2022, 21Feb2022. The vial did not undergo any temperature excursions. No concomitant medications were reported. No treatment medications were reported. This case was linked to MOD-2022-492833 (Patient Link).
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 66,0
- Geschlecht
- F
- Eingang
- 26.02.2022
- Impfdatum
- 01.02.2021
- Beginn
- 01.02.2022
- Tage bis Beginn
- 365,0
- Dosis
- 3
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Symptomtext
doses administered past the 30-day use by date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (doses administered past the 30-day use by date) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 vaccination. No Medical History information was reported. In February 2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In February 2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (doses administered past the 30-day use by date). At the time of the report, EXPIRED PRODUCT ADMINISTERED (doses administered past the 30-day use by date) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medications were reported. Reporter called to report they gave 26 doses after the 30-day use by date. It was reported that the vial was initially stored in the refrigerator on 14 Jan 2022. The dates of vaccine administration were 14 Feb 2022, 15 Feb 2022, 16 Feb 2022, 18 Feb 2022, 21 Feb 2022. No treatment medications were reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 36,0
- Geschlecht
- F
- Eingang
- 26.02.2022
- Impfdatum
- 01.02.2022
- Beginn
- 01.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Symptomtext
doses administered past the 30-day use by date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (doses administered past the 30-day use by date) in a 36-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 vaccination. No Medical History information was reported. In February 2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In February 2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (doses administered past the 30-day use by date). At the time of the report, EXPIRED PRODUCT ADMINISTERED (doses administered past the 30-day use by date) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. It was reported that vial initially stored in the refrigerator on 14 Jan 2022 and did not undergo temperature excursions. No concomitant medications were reported. No treatment medications were reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 41,0
- Geschlecht
- F
- Eingang
- 26.02.2022
- Impfdatum
- 01.02.2022
- Beginn
- 01.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Symptomtext
doses administered past the 30-day use by date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (doses administered past the 30-day use by date) in a 41-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 vaccination. No Medical History information was reported. In February 2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In February 2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (doses administered past the 30-day use by date). At the time of the report, EXPIRED PRODUCT ADMINISTERED (doses administered past the 30-day use by date) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medication was reported. vial was initially stored in the refrigerator on 14-jan-2022. Date(s) of administration of vaccine was 14Feb2022, 15Feb2022, 16Feb2022, 18Feb2022, 21Feb2022. Pharmacist reported that they gave 26 doses after the 30-day use by date. No treatment information was provided
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MA
- Alter
- 39,0
- Geschlecht
- M
- Eingang
- 26.02.2022
- Impfdatum
- 18.02.2022
- Beginn
- 18.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Symptomtext
a 39-year-old patient received expired booster dose of Moderna COVID-19 vaccine; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (a 39-year-old patient received expired booster dose of Moderna COVID-19 vaccine) in a 39-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 vaccination. No Medical History information was reported. On 18-Feb-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Feb-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (a 39-year-old patient received expired booster dose of Moderna COVID-19 vaccine). At the time of the report, EXPIRED PRODUCT ADMINISTERED (a 39-year-old patient received expired booster dose of Moderna COVID-19 vaccine) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Did the vial undergo any temperature excursions was given No Expiration date :31-DEC-1969 Date the vial was initially stored in the refrigerator: 13-JAN-2022 No concomitant drug information was provided.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 87,0
- Geschlecht
- F
- Eingang
- 26.02.2022
- Impfdatum
- 04.03.2021
- Beginn
- 14.01.2022
- Tage bis Beginn
- 316,0
- Dosis
- 3
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
COVID-19
SARS-CoV-2 test positive
Vaccine breakthrough infection
Symptomtext
Event occurred after 2nd vaccine; breakthrough case admission
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- COVID-19
- Hospital-Tage
- -
- Labordaten
- 1/14/2022 COVID +
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 59,0
- Geschlecht
- F
- Eingang
- 26.02.2022
- Impfdatum
- 18.03.2021
- Beginn
- 22.02.2022
- Tage bis Beginn
- 341,0
- Dosis
- 3
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
COVID-19
SARS-CoV-2 test positive
Vaccine breakthrough infection
Symptomtext
event occurred after 3rd vaccine; breakthrough case admission
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- COVID-19
- Hospital-Tage
- -
- Labordaten
- 2/22/202 COVID +
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 44,0
- Geschlecht
- M
- Eingang
- 25.02.2022
- Impfdatum
- 16.02.2022
- Beginn
- 16.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Extra dose administered
Symptomtext
Patient received J&J on 3/9/2021.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Extra dose administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 77,0
- Geschlecht
- F
- Eingang
- 25.02.2022
- Impfdatum
- 01.02.2022
- Beginn
- 01.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Symptomtext
This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (doses administered past the 30-day use by date) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 vaccination. No Medical History information was reported. In February 2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In February 2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (doses administered past the 30-day use by date). At the time of the report, EXPIRED PRODUCT ADMINISTERED (doses administered past the 30-day use by date) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Concomitant medication was not provided by reporter. Pharmacist gave 26 doses after the 30-day use by date. Pharmacist would like to know if those doses were viable or not. Dose administered after 30-day Use By Date or after manufacturer date of expiry. Date the vial was initially stored in the refrigerator 14-Jan-2022. Date(s) of administration of vaccines were reported as 14-Feb-2022, 15-Feb-2022, 16-Feb-2022, 18-Feb-2022, 21-Feb-2022. The vial did not undergo any temperature excursions. Treatment medication was not provided by reporter.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 67,0
- Geschlecht
- M
- Eingang
- 22.02.2022
- Impfdatum
- 22.02.2022
- Beginn
- 22.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Incorrect dose administered
Symptomtext
PATIENT RECEIVED 0.5MLS INSTEAD OF 0.25MLS OF VACCINE
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Incorrect dose administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- NONE
- Vorgeschichte
- LUPUS, ASTHMA
- Andere Medikamente
- PLAQUENIL, SYMBICORT, PERCOCET
- Allergien
- NONE
- Vorherige Impfungen
- -
- Staat
- MN
- Alter
- 15,0
- Geschlecht
- F
- Eingang
- 22.02.2022
- Impfdatum
- 09.02.2022
- Beginn
- 09.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Product administered to patient of inappropriate age
Symptomtext
MODERNA VACCINE ADMINISTERED TO A PATIENT YOUNGER THAN 18 YEARS OF AGE
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product administered to patient of inappropriate age
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- NONE REPORTED
- Vorgeschichte
- NONE REPORTED
- Andere Medikamente
- NOT AWARE OF ANY
- Allergien
- NO KNOWN DURG ALLERGY
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 41,0
- Geschlecht
- M
- Eingang
- 22.02.2022
- Impfdatum
- 17.02.2022
- Beginn
- 17.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Symptomtext
3 patients received Moderna Covid-19 vaccine from vial punctured more than 12 hours ago; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (3 patients received Moderna Covid-19 vaccine from vial punctured more than 12 hours ago) in a 41-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 vaccination. Previously administered products included for Product used for unknown indication: Pfizer and Pfizer. Past adverse reactions to the above products included No adverse event with Pfizer and Pfizer. On 17-Feb-2022 at 10:45 AM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Feb-2022 at 10:45 AM, after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (3 patients received Moderna Covid-19 vaccine from vial punctured more than 12 hours ago). At the time of the report, EXPIRED PRODUCT ADMINISTERED (3 patients received Moderna Covid-19 vaccine from vial punctured more than 12 hours ago) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medications was reported. No treatment drug details was reported. Pharmacist is not aware of any other adverse event complaints. The vial was initially stored in the refrigerator on 07-Feb-2022. The vial had no temperature excursions. This case was linked to MOD-2022-487948, MOD-2022-487957 (Patient Link). Most recent FOLLOW-UP information incorporated above includes: On 17-Feb-2022: Follow up received contains no new information.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- PR
- Alter
- 76,0
- Geschlecht
- F
- Eingang
- 21.02.2022
- Impfdatum
- 19.02.2022
- Beginn
- 19.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Extra dose administered
Symptomtext
Administration error: A 76-year-old woman with a first series of Modera and a booster dose of Moderna, is inoculated with a fourth dose of 0.5ml of Moderna on February 19, 2022, an action which was not consulted with the leading professionals in charge of vaccination and did not follow the established guidelines for the booster dose of patients with immunological compromise.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Extra dose administered
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Rheumatoid arthritis
- Andere Medikamente
- Plaquenil 200mg daily, ATACAND, CADUAL 20mg, LINZESS, Neurontin 300mg, KEVZARA. 200mg q. 14 days
- Allergien
- NAK
- Vorherige Impfungen
- -
- Staat
- MA
- Alter
- 39,0
- Geschlecht
- M
- Eingang
- 21.02.2022
- Impfdatum
- 18.02.2022
- Beginn
- 18.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product storage error
Symptomtext
The Dose was administered past the expiration/beyond use date
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 69,0
- Geschlecht
- F
- Eingang
- 18.02.2022
- Impfdatum
- 17.02.2022
- Beginn
- 17.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Product storage error
Symptomtext
Error: Improper Storage (temperature)-
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 41,0
- Geschlecht
- M
- Eingang
- 18.02.2022
- Impfdatum
- 17.02.2022
- Beginn
- 17.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Product storage error
Symptomtext
Error: Improper Storage (temperature)-
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 22,0
- Geschlecht
- F
- Eingang
- 18.02.2022
- Impfdatum
- 17.02.2022
- Beginn
- 17.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Product storage error
Symptomtext
Error: Improper Storage (temperature)-
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 64,0
- Geschlecht
- M
- Eingang
- 16.02.2022
- Impfdatum
- 11.02.2022
- Beginn
- 11.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Interchange of vaccine products
Symptomtext
Patient came to clinic on 2/11/22 for 2nd dose of COVID vaccine. At the time of appointment pt. did not have vaccine card. Pt. was scheduled for Moderna vaccine therefor Moderna was given. Upon submitting charges staff noticed patient had received Pfizer as 1st dose. Medical provider was made aware as well as the patient.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Interchange of vaccine products
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- Leg cramps Heroin addiction Heroin use Constipation, slow transit Impacted cerumen of right ear Serum creatinine raised Elevated blood urea nitrogen Decreased GFR Drug abuse Homeless
- Vorgeschichte
- Chronic HTN
- Andere Medikamente
- AMLODIPINE 5MG Aspir-Low 81 mg tablet,delayed release lisinopril 20 mg tablet
- Allergien
- NKDA
- Vorherige Impfungen
- -
- Staat
- NY
- Alter
- 32,0
- Geschlecht
- F
- Eingang
- 13.02.2022
- Impfdatum
- 12.02.2022
- Beginn
- 12.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Incorrect product formulation administered
Symptomtext
Error: Wrong Vaccine Formulation (ex. different manufact. initial and booster)-
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Incorrect product formulation administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- ME
- Alter
- 46,0
- Geschlecht
- F
- Eingang
- 11.02.2022
- Impfdatum
- 09.02.2022
- Beginn
- 09.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Symptomtext
Expired vaccine dose administered/Dose administered >12 hours post puncture; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine dose administered/Dose administered >12 hours post puncture) in a 46-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 vaccination. Previously administered products included for Product used for unknown indication: Pfizer vaccine on 02-Jun-2021 and Pfizer vaccine on 23-Jun-2021. Past adverse reactions to the above products included No adverse event with Pfizer vaccine and Pfizer vaccine. On 09-Feb-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .25 milliliter. On 09-Feb-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine dose administered/Dose administered >12 hours post puncture). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired vaccine dose administered/Dose administered >12 hours post puncture) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Concomitant product use was not provided by the reporter. Reporter stated that their facility administered an expired booster dose of Moderna COVID-19 vaccine to 1 patient. The vaccine was given at 10am EST on 09-Feb-2022 from a vial that expired yesterday, 08-Feb-2022 at11:30pm. She stated that only 1 dose was given from after it was expired which was a booster dose. Dose was administered after 12 hours post puncture. Date the vial was initially stored in the refrigerator was on 08-Feb-2022, Date and time vial was first punctured was on 08-Feb-2022 at 8:30am, Date and time of administration of vaccine was on 09-Feb-2022 at 10am EST, the vial was stored post puncture in Fridge, the vial did not undergo temperature excursions. No treatment information was provided.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 52,0
- Geschlecht
- F
- Eingang
- 10.02.2022
- Impfdatum
- 04.02.2022
- Beginn
- 06.02.2022
- Tage bis Beginn
- 2,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Nodule
Peripheral swelling
Skin discolouration
Swelling
Symptomtext
Received shot on a Friday and symptoms showed up on Sunday. Swelling upper quadrant of shoulder, knot around lymphnodes, cheek turned yellow and left arm swollen. She received Moderna all three shots.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Nodule
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- N/A
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 62,0
- Geschlecht
- F
- Eingang
- 10.02.2022
- Impfdatum
- 10.02.2022
- Beginn
- 10.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Incorrect dose administered
Symptomtext
Client jerked arm away during injection of 3rd dose, only received partial dose, though only small amt lost (appears to have rec'd half or more of 0.5 ml dose).
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Incorrect dose administered
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- H/o Melanoma w/ chemotherapy, Longtime smoker
- Vorgeschichte
- Smoker >30 yr
- Andere Medikamente
- Unk
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- PA
- Alter
- 48,0
- Geschlecht
- M
- Eingang
- 09.02.2022
- Impfdatum
- 08.02.2022
- Beginn
- 09.02.2022
- Tage bis Beginn
- 1,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Hypoaesthesia
Symptomtext
THE NEXT MORNING AFTER PATIENT GOT MODERNA VACCINE HE HAS NUMBNESS ON BOTH OF HIS HAND. WHOLE LEFT HAND HAS NUMBNESS AND IN THE RIGHT HAND HE HAS NUMBNESS FROM FINGERS TO HALF WAY TO PALM
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Hypoaesthesia
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- NKDA
- Vorherige Impfungen
- -
- Staat
- ME
- Alter
- 46,0
- Geschlecht
- F
- Eingang
- 09.02.2022
- Impfdatum
- 09.02.2022
- Beginn
- 09.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Expired product administered
Symptomtext
The vaccine was given 2/9/22 at 10am from a vial that was opened 2/8/22 and expired at 1130pm on 2/8/22
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- Nasal congestion
- Vorgeschichte
- hyperlipids, Well controlled DM
- Andere Medikamente
- Glipizide, Fexofenadine
- Allergien
- Amlodipine, Metformin, Sulfa, Vicodiin
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 62,0
- Geschlecht
- M
- Eingang
- 09.02.2022
- Impfdatum
- 08.02.2022
- Beginn
- 08.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- N/A
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Incorrect dose administered
Symptomtext
Error: Wrong Dose of Vaccine - Too High-
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Incorrect dose administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- SC
- Alter
- 58,0
- Geschlecht
- M
- Eingang
- 07.02.2022
- Impfdatum
- 07.02.2022
- Beginn
- 07.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Extra dose administered
No adverse event
Symptomtext
No adverse reaction was noted. Pt. received Moderna booster on 1/11/22 -pt. didn't make us aware, didn't have card available, and it wasn't in his chart under Immunizations . We gave a second Moderna booster today (2/7/22). Pt. was in the office for an office visit . Denies any complaints at present. Dr. was made aware. No new orders was made.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Extra dose administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- Diabetes Hypertension Vitamin D deficiency Hyperlipidemia Asymptomatic HIV infection
- Vorgeschichte
- -
- Andere Medikamente
- Norvasc Lipitor Biktarvy Steglatro Basaglar Humalog Losartan/HCTZ Metformin
- Allergien
- NKDA
- Vorherige Impfungen
- -
- Staat
- IA
- Alter
- 68,0
- Geschlecht
- M
- Eingang
- 07.02.2022
- Impfdatum
- 01.02.2022
- Beginn
- 01.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- OT / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Expired product administered
Symptomtext
Vaccine was administrated more than 12 hours after first puncture; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine was administrated more than 12 hours after first puncture) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 vaccination. No Medical History information was reported. On 01-Feb-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Feb-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine was administrated more than 12 hours after first puncture). On 01-Feb-2022, EXPIRED PRODUCT ADMINISTERED (Vaccine was administrated more than 12 hours after first puncture) had resolved. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Concomitant medication of the patient was not reported. The patient had not reported any symptoms after the administration of the vaccine. No treatment information was provided by the reporter. Date the vial was initially stored in the refrigerator was 31-Jan-2022; date(s) and time(s) vial was first punctured was 31-Jan-2022 at 9 am; the vaccine was administered in the morning of 01-Feb-2022; the vial was the vial stored in the fridge at correct range temperature post puncture and the vial did not undergo any temperature excursions. Total amount of time the vial was exposed to room temperature range (8? to 25?C= 46? to 77?F): as per reporter the nurse took the vial out of the freezer on Friday night and put it on the fridge, which was on appropriate range temperature, then the first puncture was made on 31-Jan-2022 at 9 o'clock.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- PR
- Alter
- 23,0
- Geschlecht
- M
- Eingang
- 06.02.2022
- Impfdatum
- 04.02.2022
- Beginn
- 04.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Wrong product administered
Symptomtext
Nurse requests Moderna 0.5ml vaccine for the second dose. She proceeds to inoculate the patient from Janssen primary series since the patient had requested to do the mix match with Moderna. Which the one that was suppose to be was a Moderna booster dose of 0.25ml according to the CDC.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Wrong product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- n/a
- Vorgeschichte
- n/a
- Andere Medikamente
- n/a
- Allergien
- n/a
- Vorherige Impfungen
- -
- Staat
- MA
- Alter
- 28,0
- Geschlecht
- F
- Eingang
- 06.02.2022
- Impfdatum
- 05.02.2022
- Beginn
- 05.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Incorrect dose administered
Symptomtext
Error: Wrong dose of vaccine - too low.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Incorrect dose administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NY
- Alter
- 16,0
- Geschlecht
- M
- Eingang
- 05.02.2022
- Impfdatum
- 05.02.2022
- Beginn
- 05.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
No adverse event
Product administered to patient of inappropriate age
Symptomtext
Moderna first dose given to a 16-year-old. No adverse reactions to report.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- Morbid obesity; high triglycerides; high serum cholesterol
- Vorgeschichte
- Morbid obesity; high triglycerides; high serum cholesterol
- Andere Medikamente
- None
- Allergien
- NKA
- Vorherige Impfungen
- -
- Staat
- MD
- Alter
- 52,0
- Geschlecht
- F
- Eingang
- 05.02.2022
- Impfdatum
- 05.02.2022
- Beginn
- 05.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Ageusia
Anxiety
Chest discomfort
Cold sweat
Feeling hot
Hot flush
Skin warm
Tongue disorder
Symptomtext
5 minutes after receiving vaccine became warm and clammy. Thought it was hot flash. Hx of HBP. BP 180/120 HR 86 and Pulsox99 started felling better and BP 174/110 but then began with chest tightness and warmth. Very clammy as well. Very anxious initially at entrance because had reactions of tongue thickness with loss of taste for one week after both Pfizer vaccines. 911 called and pt transported to hospital
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Ageusia
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- High BP
- Andere Medikamente
- Lisinopril
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- WA
- Alter
- 67,0
- Geschlecht
- M
- Eingang
- 05.02.2022
- Impfdatum
- 02.02.2022
- Beginn
- 02.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Incorrect dose administered
Symptomtext
Error: Wrong Dose of Vaccine - Too High-
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Incorrect dose administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 14,0
- Geschlecht
- F
- Eingang
- 04.02.2022
- Impfdatum
- 31.01.2022
- Beginn
- 31.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Product administered to patient of inappropriate age
Symptomtext
inadvertently administered booster to 14 year old; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (inadvertently administered booster to 14 year old) in a 14-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 vaccination. No Medical History information was reported. On 31-Jan-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 31-Jan-2022, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (inadvertently administered booster to 14 year old). On 31-Jan-2022, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (inadvertently administered booster to 14 year old) had resolved. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No Concomitant medications were reported. No Treatment medications were reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product administered to patient of inappropriate age
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 13,0
- Geschlecht
- F
- Eingang
- 03.02.2022
- Impfdatum
- 27.01.2022
- Beginn
- 27.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Product administered to patient of inappropriate age
Symptomtext
Not age indicated.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product administered to patient of inappropriate age
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- unknown
- Vorgeschichte
- unknown
- Andere Medikamente
- unknown
- Allergien
- unknown
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 17,0
- Geschlecht
- M
- Eingang
- 02.02.2022
- Impfdatum
- 31.01.2022
- Beginn
- 31.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
No adverse event
Product administered to patient of inappropriate age
Symptomtext
Patient was given Moderna as first dose even though not approved for ages <18. No adverse effects noted at time of administration or follow-up period of 5 hours later.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 57,0
- Geschlecht
- F
- Eingang
- 01.02.2022
- Impfdatum
- 01.02.2022
- Beginn
- 01.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Extra dose administered
Symptomtext
PATIENT REQUESTED 'BOOSTER' AND PRESENTED A VACCINE CARD WITH TWO VACCINE DOSES (3/18/21 AND 4/15/21) I ADMINISTERED WHAT I BELIEVED TO BE HER 3RD SHOT OR BOOSTER AS IT WOULD BE 5 MONTHS FROM THE SECOND AND APPROPRIATE. SHE ASKED WHAT TO EXPECT FROM THE BOOSTER AND WE DISCUSSED. AFTER WHILE REPORTING TO THE STATE RECORD-KEEPING SITE, IT WAS DISCOVERED SHE HAD ALREADY GOTTEN A BOOSTER AT ANOTHER PHARMACY AT 8/29/21 WHICH SHE HAD CONCEALED FROM US. THE ONE THAT I GAVE WAS ACTUALLY A 4TH WHICH SHE DID NOT QUALIFY FOR.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Extra dose administered
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- UNKNOWN
- Vorgeschichte
- PT STATES NO HEALTH CONDITIONS OR TREATMENTS THAT MADE HER MODERATELY OR SEVERELY IMMUNOCOMPROMISED, NO HISTORY OF MYOCARDITIS OR PERICARDITIS, NO TREATMENT WITH MONOCLONAL ANTIBODIES OR CONVALESCENT SERIUM, NEVER DIAGNOSED WITH MIS-C OR MIS-A, NO HISTORY OF GUILLIAN-BARRE SYNDROME, NO BLEEDING DISORDER, NOT PREGNANT OR BREASTFEEDING, AND HAS NOT RECEIVED HEMATOPOIETIC CELL TRANSPLANT OR CAR-T-CELL THERAPIES. NO TREATMENT FOR CANCER OR HIV, NO ORGAN TRANSPLANT OR IMMUNOSUPPRESSIVE THERAPY OR HIGH DOSE CORTICOSTEROIDS.
- Andere Medikamente
- UNKNOWN
- Allergien
- UNKNOWN
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 24,0
- Geschlecht
- F
- Eingang
- 01.02.2022
- Impfdatum
- 28.01.2022
- Beginn
- 28.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Hypoaesthesia
Symptomtext
At 15 post vaccination patient complained of numbness in her left arm. Patient denied chest pain, dizziness, difficulty breathing, blurred vision or pain. Patient was evaluated by RN, vitals obtained, no signs of swelling, arm elevated at heart level. Patient alert and oriented, Range of motion within normal range. Circulation check at fingers conducted, all within normal range. Vital within normal range. Patient observed for 30 additional minutes. Vital repeated at 10:20am, all within normal range. Patient verbalized numbness is less, circulation check normal. Patient left observation area at 10:30 with no signs of distress. Patient advised to continue to monitor any change in symptoms on contact clinic or PCP with any changes. Patient verbalized understanding.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Hypoaesthesia
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- Milk
- Vorherige Impfungen
- -
- Staat
- MA
- Alter
- -
- Geschlecht
- U
- Eingang
- 28.01.2022
- Impfdatum
- 25.01.2022
- Beginn
- 25.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Expired product administered
Symptomtext
2 booster doses administered past 12 hours post puncture; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (2 booster doses administered past 12 hours post puncture) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 vaccination. No Medical History information was reported. On 25-Jan-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Jan-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (2 booster doses administered past 12 hours post puncture). On 25-Jan-2022, EXPIRED PRODUCT ADMINISTERED (2 booster doses administered past 12 hours post puncture) had resolved. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medication reported. No treatment information was provided. 1st booster was administered 25Jan2022 at 10:35 AM and the 2nd booster was administered 25-Jan-2022 at 11:45 AM. Date the vial was initially stored in the refrigerator: 18-Jan-2022 at 7:05 AM. Date and time vial was first punctured: 24-Jan-2022 at 9:20AM. Total amount of time the vial was exposed to room temperature range (8? to 25?C= 46? to 77?F): 24-Jan-2022 9:20 AM until 10:35 AM 25-Jan-2022 and until 2nd administration at 11:45 AM 25-Jan-2022.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MA
- Alter
- 24,0
- Geschlecht
- F
- Eingang
- 26.01.2022
- Impfdatum
- 25.01.2022
- Beginn
- 25.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product storage error
Symptomtext
Error: Improper Storage (temperature)-
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MA
- Alter
- 53,0
- Geschlecht
- M
- Eingang
- 26.01.2022
- Impfdatum
- 25.01.2022
- Beginn
- 25.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product storage error
Symptomtext
Error: Improper Storage (temperature)-
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -